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Summary
Previous investigations have reported  differences in the affinity of 
hepatic glucocorticoid receptors (GR) for glucocorticoids between the 
Milan hypertensive (MHS) and normotensive (MNS) strains (Kenyon et al.,
1994), the Zucker lean and obese strains (White and Martin, 1990) and 
hypertensive SHR and normotensive WKY strains of ra t (Panarelli et al.,
1995). To determine the possible causes of this phenotypic variation, a 
series of investigations were carried out into the molecular genetics of 
strain specific allelic variants of rat GR.
The original cloning of the rat GR cDNA (Miesfeld eta /., 1986) reported a 
polyglutamine encoding triplet (CAG)n repeat sequence in the amino 
term inal m odulatory  dom ain of the receptor. Given the highly 
polymorphic nature of simple sequence repeats, I investigated the repeats 
as potential mediators and as genetic linkage markers, of altered receptor 
function. CAG repeat length polymorphisms were identified. The GR alleles 
of the hypertensive strains, MHS and SHR, were found to have triplet 
repeat lengths shorter by one codon than in controls; MNS 21, MHS 20, WKY 
20 and SHR 19-CAG repeats. GR triplet repeat lengths in Zucker rats did not 
differ between strains.
As part of a collaborative investigation using the Milan strains of rat, the 
GR triplet repeat polymorphism was used to screen for genetic linkage 
between Grl and glucocorticoid related phenotypes in F2 rats of a 
reciprocal MHS x MNS cross. A significant association (p < 0.005) was found 
between the MHS Grl allele and hypercalcuria in female rats. Homozygous 
MHS alleles were also found to be weakly associated (P < 0.01-0.02) with 
reduced systolic blood pressure in female and reduced body weight in male 
rats.
Optimised typing methods were used to characterise a further 61 inbred rat 
strains and substrains and 155 wild rats from England and central Scotland. 
A discontinuous distribution was found: no GR alleles with repeat lengths of
less than 7, 8-16 or greater than 23 CAG repeats were identified, suggesting 
that these alleles are either absent, or at least are significantly under­
represented. In the 155 wild rats analysed, homozygotes were found for 
each allele, with the exception of GrlCAG17, indicating that the observed 
alleles are compatible with significant viability. The presence of a gap in 
the allelic distribution of GR raised fundamental questions regarding the 
genetic origin of this discontinuity. The observed rGR alleles may have a 
selective advantage through their function as transcription factors or 
alternatively, may reflect a non-random  mechanism by which triplet 
repeats expand and contract.
The reported differences in affinity for glucocorticoids of GR from hyper- 
and normotensive and of Zucker strains, indicated the possibility of a 
primary sequence difference between receptors. The coding sequence of 
GR was therefore determined in MHS, MNS, SHR, WKY and Zucker lean and 
obese rats. Each was found to differ from the published sequence. Re­
sequencing of rat hepatoma cell line 6.10.2.-derived GR cDNA, which was 
used in determination of the original published sequence, indicated that 
the differences were probably due to mistakes in the original report. Apart 
from the polyglutamine tract, no in trastrain  coding differences were 
found. Silent substitutions were detected at nucleotide positions 198, 531, 
and 711. All three were present in MHS and SHR strains, none were present 
in MNS and only that at position 711 was present in WKY. The GR sequences 
of Zucker lean and obese rats were identical.
The four sites of genetic variation identified in rat GR lie in close proximity 
(within about 500 bp), constituting six distinct haplotypes in which the 
rate of recombination is expected to be low. These haplotypes were useful 
in helping to confirm the genetic relationship of ra t strains reported by 
others (Greenhouse et al., 1990; Hedrich, 1990). The Milan rat GR haplotypes 
were distinct, suggesting the separation of GR alleles for thousands of 
generations before fixation in the Milan selection lines (Bianchi et al., 
1984).
xiii
To address the difference between MHS and MNS in GR ligand binding in 
liver cytosol preparations, I investigated the possible effect of differences 
in CAG repeat length. Accordingly, cDNA alleles, GrlGAG2°  (MHS) and 
Qr\CAG21 (MNS) were constructed and expressed in CV-1 cells, together with 
GR cDNAs with 7 and 18 CAG repeats. Western blotting and Scatchard 
analysis of steroid binding properties of the expressed GR proteins showed 
no differences, either in stability, or affinity (Kd) for dexamethasone and 
corticosterone.
Whether or not the gap in the distribution of rat GR CAG repeats reflected 
abnormal receptor properties, was addressed by the construction of full 
length GR cDNAs with 4, 8, 10, 20, and 80 CAG repeats and their expression 
in CV-1 cells. GR steroid binding properties were determined as for natural 
GR proteins. Receptor affinity and capacity (Rl) was not different between 
alleles, implying that intra-allelic differences in the length of the 
polyglutamine tract are unlikely to affect receptor affinity. However, the 
binding affinity for dexamethasone and corticosterone was significantly 
higher for construct, compared with natural alleles (p < 0.001 for dex and 
B). This difference in affinity was n o t  the resu lt of inter-allelic 
differences in the length of the long homopolymeric repeats in the 
different alleles. The difference in sequence between the natural and 
construct GR alleles is shown in bold in the following figure for residues 
on the flanks of the homopolymer:
20Q (natural allele):
66 67 68 69 70 71 72 73 74 75 76 77 78-96 97 98 99 100 101 102 103 104 105 106 107
NH2> F S K G S T S N V Q Q R  (Q)i8 p g l s k v s l s m g  <c o o h
20Q (construct allele):
66 67 68 69 70 71 72 73 74 75 76 77 78-98 99 100 101 102 103 104 105
NH2>F S T L A C G S L E E D  (Q)20 g  v  r  y  g  m  g  <c o o h
Amino acid differences between natural and construct rat GR alleles.
Altered residues are shown in bold.
xiv
It is not known which residue differences contribute to the change in 
receptor affinity, but the phenomenon strongly implies that the structure 
of the m odulatory domain can influence the function of the LBD, 
presumably through a proximity effect in the native molecule. This raises 
the more general question of whether the amino and carboxyl termini are 
able to affect each other's activity, either by contact, or through a mediator 
such as HSP90.
The transcriptional regulatory properties of the different GR alleles has 
been tested in two types of transactivation system:
1.) As activators of MMTV-lacZ
All of the GR variants (natural and construct) showed a similar ability to 
activate MMTV-lacZ through a GRE-containing prom oter following 
hormonal induction. This implies that none of the structural differences 
between GR molecules had any measurable effect on their ability to bind a 
GRE and activate transcription.
2.) As modulators of STAT5
Because of the remaining possibility of tissue or promoter-specific effects 
involving interaction of GR with other transcriptional regulators, studies 
of the gene modulatory effects of GR have also been addressed. GR can 
in teract synergistically with the signal transducer and activator of 
transcription, STAT5, to enhance p-casein gene transcription (Stocklin et 
al., 1996). This work is currently in progress.
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Chapter 1 
Introduction
1
Part 1
Cellular and molecular aspects of glucocorticoid action
1.1.) Endocrine hormones
From the early 1900s, there has been an enormous increase in our 
understanding of endocrine organs and the diverse physiology that they 
coordinate. The hormones that these organs secrete have been shown to be 
profoundly im portan t for controlling verteb ra te  developm ent and 
physiology and maintaining homeostasis. Consequently, each has become a 
major focus of biological and clinical investigation.
In general, hormones can be described as substances produced by cells or 
tissues which, following secretion, have a defined physiological effect on 
their target tissue(s) or cell(s). Hormones which affect the cells which 
secrete them are termed autocrine, whilst those affecting other cells in 
their local environment are termed paracrine in function. In contrast, 
endocrine hormones are secreted by one tissue and exert their effect on 
another distant tissue, normally carried to their site of action by the 
circulation. Some hormones such as cortisol have auto, para and endocrine 
functions.
Endocrine hormones can be classified biochemically as peptides (e.g. 
insulin), amines (e.g. thyroxine) or steroids (e.g. cortisol). Their effects are 
mediated following the binding of the hormone to a specific receptor 
molecule, either on the surface, or in the cytosol or nucleus of the target 
cell. Resultant effects are either direct (e.g. on gene transcription) or 
indirect via an intracellular second messenger. Regulation of hormone 
action is possible at several levels: synthesis, secretion, transport in the 
circulation, d istribution , clearance, tissue uptake a n d /o r  receptor 
interaction, receptor down regulation and signal transduction. The 
experiments described in this thesis concern glucocorticoid hormone
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action. To pu t the results in context, this introduction will include 
inform ation specifically about regulation involving the glucocorticoid 
receptor (GR).
1.2.) Steroids and the adrenal gland
1.2.1.) Adrenal zonation
Glucocorticoid hormones are secreted by the adrenal gland, which in 
mammals consists of two major parts of different embryonal origin, an 
inner medulla synthesising catecholamines (adrenaline, noradrenaline 
and their precursor, dopamine) and an outer cortex which produces a large 
number of steroids, some of which are hormones (McNicol, 1992). The 
cortex can be further subdivided into three histologically distinct regions 
called, from centre to periphery, the zona reticularis, zona fasciculata and 
zona glomerulosa.
There are three major categories of cortical steroids; the adrenal 
androgens, which are required for the expression of secondary male sexual 
characteristics, and the glucocorticoids and mineralocorticoids controlling 
intermediary metabolism and salt and water balance, respectively. Figure
1.1. shows the main steps in the pathways for adrenal corticosteroid 
biosynthesis. All share a common precursor cholesterol, the basic ring 
structure of which is maintained throughout enzymatic conversion.
1.2.2.) Steroid hormone biosynthesis
Adrenocortical steroidogenesis proceeds via a series of cytochrome P-450 
hydroxylase and dehydrogenase enzymes. Enzymatic conversions are 
com partm entalised, depending on the subcellular localisation of the 
enzymes involved. Cholesterol from cholesterol esters, de-novo synthesis or 
from dietary uptake, is initially transported from the cytosol to the inner 
mitochondrial membrane where cytochrome P450scc (side chain cleavage), 
also known as cholesterol desmolase, cleaves the side chain of cholesterol at 
C21 to form pregnenolone. This is the rate limiting step in steroidogenesis.
3
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Fig. 1.1. S tero id  b iosynthetic  pathw ays in the adrenal 
cortex.
The branching pathways for g lucocorticoids, m ineralocorticoids 
and adrenal androgens and the structures of these steroids 
and their b iosynthetic precursors are shown. The biosynthetic 
e nzym es, m ost of w hich a re  cy to ch rom e  P-450s, are 
re p re se n te d  by the  boxes. 3(3-HSD; 3(3-hydroxysteroid 
dehydrogenase (from W illiam s Textbook of Endocrinology).
Mitochondrial 3p-hydroxysteroid dehydrogenase (3P-HSD) then converts a 
portion of the newly synthesised pregnenolone to progesterone. Both of 
these compounds act as intermediates, providing the substrates for two 
further enzymes associated with the endoplasmic reticulum, P450cl7 (17a- 
hydroxylase) and P450c21 (21-hydroxylase). These enzymes catalyse 
hydroxylations at positions C l7 and C21 of the steroid ring respectively, in 
separate biosynthetic pathways. Corticosterone and cortisol are formed 
from the respective lip -hyd roxy la tion  of deoxycorticosterone and 
deoxycortisol by m itochondrial 1 lp-hydroxylase ( c y p l lb l) .  The end 
products of corticosteroid biosynthesis fall into two main catagories, the 
C21 steroids, which have a two carbon side chain at position C l7 and the C19 
steroids with either a hydroxyl or a keto group a t position C l7. 
Glucocorticoid and mineralocorticoid activities are attributed to the C21 
steroids, which display only small structural differences (Fig. 1.1.). 
Aldosterone is derived from deoxycorticosterone in three steps by the 
actions of a single enzyme, aldosterone synthase (cypllb2).
In m an, C19 s te ro id s  w ith  w eak a n d ro g e n ic  a c tiv ity , 
dehydroepiandrosterone (DHEA) and its sulphate (DHEAS), are the most 
abundant products of the adrenal cortex. They are derived from 17 a- 
hydroxypregnenolone and 17a-progesterone by the enzyme P450C17 (Fig.
1.1.). The products of this reaction, DHEA and androstenedione are 
subsequently converted to low levels of testosterone in the periphery. 
DHEA is known to have anti-glucocorticoid properties (Svec et al., 1995).
The adrenal cortex is functionally zonate. Aldosterone, the most important 
mineralocorticoid in rats and man, is synthesised only in the zona 
glomerulosa while the m ajor glucocorticoids, cortisol in man and 
corticosterone in the rat and the adrenal androgens are synthesised in the 
inner cortical zones (Berne and Levy, 1993). The conversion of 
corticosterone to cortisol requires 17-hydroxylation, which is absent in the 
rat. Therefore, the synthesis of cortisol and adrenal androgens does not 
occur in this species.
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1.3.) The control of adrenocortical secretions
The norm al secretion pattern  of mineralocorticoid and glucocorticoid 
hormones is maintained by different trophic stimuli; aldosterone secretion 
is regulated by angiotensin II and dietary potassium and is also affected by 
ACTH (Quinn and Williams, 1988). In the zona fasciculata, ACTH is the most 
im portant factor regulating the secretion of glucocorticoids (Waterman 
and Simpson, 1989; White eta/., 1994).
ACTH is produced by the anterior pituitary gland as the derivative of a 
precursor peptide, proopiomelanocorticotrophin [POMC] (Eipper and Mains, 
1980). Multiple hormonal factors regulate ACTH secretion (Antoni, 1986; 
Antoni, 1993), the most im portant being the peptide horm one CRF 
(corticotrophin releasing factor). Neural mechanisms stimulate the release 
of CRF from the hypothalamus. This causes a rise in pituitary ACTH, which 
in tu rn  stim ulates the zona fasciculata, increasing the secretion of 
glucocorticoids (Fraser, 1992). Elevated levels of glucocorticoid in the 
plasma inhibits further ACTH secretion (by feedback inhibition of POMC 
gene expression; Drouin et al., 1989) and CRF gene transcrip tion  
(Lundbland and Roberts, 1988) and consequently, further glucocorticoid 
secretion. The basis of this negative feedback inhibition process is outlined 
in Figure 1.2. The stimulation of ACTH by CRF is potentiated by vasopressin 
(AVP), which can also stimulate ACTH secretion directly. In addition, 
catecholamines, angiotensin II, serotonin, oxytocin, atrial natriuretic 
factor and several others have been implicated in the control of ACTH 
secretion (Rivier and Vale 1983; Antoni, 1993).
ACTH generally regulates glucocorticoid output through the hypothalamo- 
pituitary-adrenal (HPA) axis. Under normal circumstances in man, ACTH 
and therefore cortisol output is controlled in the long term in a circadian 
fashion (Kreiger et al., 1971) and is increased by various types of physical 
and psychological stress (Weitzman eta/., 1971).
5
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and other areas 
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I
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Fig. 1.2. Diagram showing the essential com ponents of G lucocorticoid feedback inhibition  
of secretion from the adrenal cortex.CRF, Vasopressin and other horm onal factors stim ulate 
ACTH secretion from the hypothalamus, which leads to the eventual secretion of glucocorticoids 
from  the adrenal cortex. Most of the circulating glucocorticoid is associated with plasm a binding 
proteins [such as; CBG, 80-90%; album in and SHBG, the remainder] (Dunn et al., 1981), which 
renders it biologically inactive. The active fraction which remains free in the circulation is normally 
in the nM range, which in man constitutes arround 3-4% of the total. Sites of feedback inhibition 
due to excessive  g lucocortico id  secre tion  are shown (see text fo r de ta ils ). S: s tim ulus; 
env ironm en ta l, phys ica l or p sycho log ica l, CRF: co rtico trop h in  re leas ing  fac to r, ACTH: 
adrenocorticotrophic hormone, CBG: corticostero id binding globulin, SHBG: sex steroid binding 
globulin. Circled arrow relates to high endogenous level.
Since steroids are not stored to any great extent, biosynthesis rates must be 
increased on demand. ACTH stimulates steroidogenesis (Fig. 1.1.) through 
the classical receptor-adenylate cyclase system. Ligand binding to ACTH 
receptors in the cell membrane (Mountjoy et al., 1992) increases adenylate 
cyclase activity, causing stimulation of a G-protein. This in turn leads to 
higher endogenous levels of cyclic AMP (cAMP). The resultant activation 
of a cytoplasmic protein kinase causes the phosphorylation of regulatory 
proteins which induce the process of steroidogenesis.
The secretion of aldosterone is also under tight physiological control. Both 
angiotensin II and potassium act as specific zona glomerulosa agonists 
which stimulate aldosterone synthesis. Angiotensin II is a pressor hormone 
generated in the circulation under the control of the enzyme renin from 
the kidney (Brown et al., 1983). Figure 1.3. summarises the main 
components of the renin-angiotensin system. The inactive precursor 
angiotensin I is first formed by the splitting of the renin substrate 
angotensinogen, which is converted to angiotensin II by angiotensin I 
converting enzyme (ACE). In keeping with blood pressure control, the 
plasma concentration of angiotensin II, through the action of renin is 
directly linked to sodium levels. The normal physiological response to 
sodium depletion is the release of renin, which leads to an increased 
angiotensin II output followed by a respective increase in aldosterone 
secretion. The resultant effect is sodium and water retention, which 
inhibits further renin release and causes an expansion in plasma volume 
(Fraser et al., 1981). Small increases in plasma potassium  leads to 
aldosterone synthesis. In contrast to sodium, large increases in dietary 
potassium  and hyperkalem ia inhibit aldosterone synthesis through 
inhibition of renin release (Beretta-Picoli et al., 1983).
Both potassium and angiotensin II regulate aldosterone synthesis by their 
effects on calcium metabolism (Radke et al., 1989). Increases in potassium 
depolarises the cell membrane, opening voltage-dependent calcium 
channels; angiotensin II also opens calcium channels, as well as 
stimulating the release of stored Ca^+ within adrenocortical cells via a
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Fig. 1.3. The m olecular com ponents of the renin-angiotensin system.
The diverse range of physiological processes responsive to angiotensin II is shown. ACE: angiotensin 
converting enzyme, ADH: antidiuretic hormone.
cascade of events involving phospholipase C and the release of IP3. Ca^ + 
activates cholesterol side chain cleavage and the steroidogenic conversion 
of cholesterol to aldosterone (see Fig. 1.1.).
1.4.) The major physiological roles of adrenal corticosteroids
1.4.1.) Glucocorticoids
The glucocorticoids are of fundamental importance, exerting a multiplicity 
of actions in a wide range of tissues. They play im portant roles in the 
control of intermediary metabolism, aspects of cardiovascular regulation 
such as the regulation of vascular tone and in the function of skeletal 
muscle, lymphoid and connective tissue and the central nervous system. 
They perform a permissive function in many tissues by potentiating the 
actions of other cellular mediators such as catecholamines. Glucocorticoids 
have a well recognised anti-inflammatory effect and are known to be 
secreted in response to various forms of stress originating from internal or 
external environments. The activities of glucocorticoids are summarised in 
Figure 1.4.
Glucocorticoids generally have an anabolic effect on the liver. In their 
m aintenance of hepatic glycogen stores, glucocorticoids both activate 
glycogen synthase (Hornbrook et al., 1966) and inactivate the glycogen 
mobilising enzyme, glycogen phosphorylase (Stalmans and Laloux, 1979). 
Hepatic glucose production via gluconeogenesis is increased by promoting 
substrate availability and stimulating the release of glucogenic amino acids 
from peripheral tissues such a skeletal muscle. Glucocorticoids mediate this 
process by activating key gluconeogenic enzymes, such as glucose-6- 
phosphatase and phosphoenol pyruvate carboxykinase (PEPCK) (Exton, 
1979)
A catabolic effect is elicited in most other tissues. Lipolysis is acutely 
activated by glucocorticoids in adipose tissue (Fain, 1979). The glycerol
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Fig. 1.4. The principal m etabolic effects of glucocorticoids.
Hepatic g lucose m etabolism  and peripheral tissue m etabolism  of protein and fats are all 
regulated by glucocorticoids. Stim ulation is indicated by + signs and inhibition by - signs (from 
W illiam s Textbook of Endocrinology).
released during lipolysis provides a substrate for glucose production and 
the liberated fatty acids provide an energy source for the process. The 
breakdown of proteins (Fain, 1979) and reduction of glucose uptake from 
the circulation and its utilization by peripheral tissues (LeBoeuf et al., 1962; 
Munck, 1962) are also mediated by glucocorticoids. The net effect is to keep 
plasma glucose and free fatty acid levels high. The catabolic effects on 
muscle protein provide an explanation for the profound myopathy seen in 
conditions of glucocorticoid excess.
Glucocorticoids exert a direct and indirect effect on bone metabolism. 
Indirectly, glucocorticoids have been shown to inhibit calcium absorption 
from the gut (Lukert and Adams, 1976) and enhance urinary calcium 
excretion by decreasing reabsorption in the kidney (Laake, 1960). 
Excessive exposure to glucocorticoids reduces or inhibits osteoblastic 
activity, leading to osteoporosis (Cheng et al., 1994). This suggests the 
possibility of a direct steroid effect on bone cells.
Distribution and behaviour of cells of the immune system; T cells , (Gillis et 
al., 1979), B cells (Cupps et al., 1985), monocytes, neutrophils and 
granulocytes (Dale et al., 1975) is affected by glucocorticoids, which may be 
m anifest as im m unodeficiency (O rth et al., 1992). Endogenous 
glucocorticoid excess generally suppresses immune responses (Graham and 
Tucker, 1984). Glucocorticoids also modulate the activity of components 
which mediate local inflammatory responses. The anti-inflammatory and 
immunosuppressive effects of glucocorticoids are well established (Cato and 
Wade, 1996). The activities of histamine, a potent vasoactive agent (Fauci, 
1979) and prostaglandins (Russo-Marie et al., 1979) are both inhibited by 
these steroids (see Fig 1.4.).
Supraphysiological concentrations of glucocorticoids inhibit linear growth 
in children, possibly due to the direct inhibitory effects on bone and 
connective tissue (Ferraris and Pasqualini, 1993). In the lung, 
glucocorticoids stimulate the maturation and differentiation of many cell 
types (Snyder et al., 1992). They are also responsible for regulation of
surfactant production by type II pneumocytes (Boggaram and Mendelson,
1988). Lower glucocorticoid levels are stim ulatory, higher levels are 
inh ib ito ry . In the nervous system, glucocorticoids regulate  the 
development of neural crest epithelial cells, the precursors of more 
d ifferen tiated  cell types including autonom ic ganglion cells and 
adrenom edullary cells, into cromaffin cells. Under the influence of 
glucocorticoids, neural crest precursor cells that invade the embryonic 
adrenal gland cease to express 'neurone-specific' gene products such as 
neu ro filam en ts and  acquire the c h arac te ris tic  m orphology of 
adrenomedullary chromaffin cells (Federoff etal., 1988).
Evidence for glucocorticoid effects on blood pressure (reviewed more 
extensively in part 2 of this chapter) comes largely from patients with 
glucocorticoid excess or deficiency. Those with glucocorticoid excess 
usually develop hypertension, often w ithout evidence of functional 
mineralocorticoid excess (Saruta et al., 1986). Patients with glucocorticoid 
deficiency show defective water clearance with increased arginine 
vasopressin (AVP) concentrations (Raff, 1987). Glucocorticoid deficiency 
increases AVP mRNA synthesis in the paraventricular nucleus where it is 
synthesised and secreted (Sonnenblick et al., 1979). Increased AVP levels 
may play a role in maintaining blood pressure in states of adrenal 
insufficiency, such as in Addison's disease. Glucocorticoids also have direct 
effects on ion transport in the colon (Sandle, and McGlone, 1987). The use 
of glucocorticoid analogues, specific for the glucocorticoid receptor 
produce a saturable sodium transport (Bastl, 1987), which is not diminished 
by specific mineralocorticoid receptor antagonists (Bastl, 1988). In the rat 
descending colon, Na-K-APTase a i and (3-subunit gene expression is acutely 
regulated by dexamethasone, but not aldosterone (Fuller and Verity, 1990).
1.4.2.) Mineralocorticoids
The main physiological role of mineralocorticoids is to promote sodium 
retention and potassium excretion in transporting epithelia such as the
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distal nephron of the kidney, salivary and sweat glands and the colon 
(Morris, 1981). In excess, m ineralocorticoids cause hypertension and 
increases in body sodium. Aldosterone effects may also be seen in non- 
epithelial tissues. There is evidence for aldosterone induced activity in the 
brain (McEwen et al., 1986). Intracerebroventricular (icv) infusions of low 
doses of aldosterone effects salt seeking behaviour and ingestion. These 
effects are no t m im icked or blocked by equ ivalen t or higher 
concentrations of corticosterone, but are effectively blocked by specific 
aldosterone antagonists (McEwen e ta l., 1986). The effects of aldosterone in 
both m ononuclear leukocytes and vascular tissues, m ediated through 
mechanisms which do not require MR activation, will be discussed in the 
following section.
1.5.) Non-genomic responses to steroids
Although the majority of evidence suggests that steroid hormones induce 
genomic responses through specific nuclear receptor activation (Beato and 
Sanchez-Pacheco, 1996; Hagar et al., 1996; Jenster eta l., 1997), there is also 
implication of direct steroid effects mediated via membrane receptors. Some 
steroid effects, particularly of an electrophysiogical and behavioural 
nature occur too rapidly to be explained in terms of a classical genomic 
response (McEwan, 1991), which are normally manifest after a period of 
hours, or even days (Steimer and Hutchison, 1981). The rapid induction of 
steroid effects which are not blocked by protein synthesis inhibitors 
(Nabekura et al., 1986) and the modulation of binding characteristics of 
neurotransm itter receptors implies the possibility of steroid hormone 
binding to neuronal membranes (Schumacker etal., 1990).
In female rats, rapid behavioural effects due to short-term  progesterone 
administration have been documented (Kubli-Garfias and Whalen, 1977). 
Progesterone causes a rap id  (40-60s) and tran sien t increase in 
intracellular Ca2+ concentrations in amphibian oocytes, a necessary first 
step in the resumption of meiosis and eventual m aturation (Wasserman et
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al., 1980). Progesterone receptors have also been identified on the surface 
of human sperm and have been implicated in initiating rapid calcium 
influx, a prerequisite for acrosomal exocytosis (Tesarik et al., 1993). 
Oestrogens have been shown to produce adenylate cyclase mediated 
increases in cyclic AMP (cAMP) in target breast cancer and uterine cells 
and intact uterus in vivo by a mechanism that does not involve the 
genomic action of this hormone (Aronica et al., 1994). Corticosterone- 
specific receptors in the synaptic membranes of amphibian brains appear 
to influence male reproductive behaviour (Orchinik et al., 1991). More 
recently, the rapid  in vitro effects of aldosterone on intracellu lar 
electrolytes, cell volume, and the sodium-proton antiporter have been 
described in human mononuclear leukocytes and vascular smooth muscle 
cells, which respond with a sustained rise in free intracellular calcium 
levels within 1-5 mins following aldosterone administration (Schneider et 
al., 1997). The full length cDNA sequence of a progesterone membrane- 
binding protein of porcine vascular smooth muscle cells has now been 
described (Falkenstein etal., 1996).
The rem ainder of this thesis will focus on the classical mechanisms of 
steroid action, with particular emphasis on glucocorticoids.
1.6.) Steroid hormone receptors: an overview
Classically, steroid hormone receptors are viewed as the cellular mediators 
of steroid hormone responses at the level of the genome. Corticosteriods 
bind to cytosolic receptors, the resulting complex interacting with the 
steroid responsive elements of a wide variety of genes, altering messenger 
RNA (mRNA) synthesis. Subsequent altera tions in cellular protein  
synthesis lead to changes in peptide and protein secretion, enzyme levels, 
the synthesis of components of cell-signalling systems, such as adenylate 
cyclase and finally, growth (Miesfeld, 1989). Perhaps the earliest evidence 
that steroid hormones regulate gene expression came from experiments 
showing that ecdysteroid-induction of m etam orphosis in insects is
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associated with changes in chromosome structure (Ashberner, 1980). It is 
now well established that all steroid hormones, as well as thyroid hormone 
and retinoic acid, act by binding to specific intracellular receptors, 
coordinating complex biological events by regulating the expression of 
genes or gene networks (Yamamoto, 1985). The discovery of receptors and 
receptor-related molecules for these hormones in a wide range of species 
suggests that the general mechanisms underlying morphogenesis and 
homeostasis may be ubiquitous.
1.7.) Nuclear receptor superfamily
The expression cloning of the human glucocorticoid receptor provided the 
first completed structure of a steroid hormone receptor and revealed a 
segment of extensive homology with the viral oncogene, erbA (Hollenberg 
etal., 1985; Debuire eta/., 1984). The independent cloning of the human and 
rat receptors for androgen (AR), oestrogen (ER), progesterone (PR), and 
aldosterone (MR), over the following 2-3 years produced evidence for a 
family of related hormone binding molecules (O'Malley, 1990; Laudet et al., 
1992). Further to these advances, the identification of the erbA  
protooncogene product (c-erbA) as the thyroid  horm one receptor 
(Weinberger et al., 1986) gave a unifying element to steroid receptor 
structure and hormone action as well as suggesting a common receptor 
origin from a primordial ancestral regulatory gene.
Figure 1.5. Shows the major com ponents of the steroid  receptor 
superfamily. These molecules form a subgroup of a much larger multigene 
family of nuclear receptors (reviewed by O'Malley, 1990; Evans, 1988), 
including those which mediate responses to thyroid hormone, T3Ra and 
T3Rp; vitamin D3, VDR and retenoic acid, RARa, RARp and RARy (Laudet e t 
al., 1992). The molecules in Figure 1.5. are aligned on the basis of regions of 
maximum protein homology (Johnson and Doolittle, 1986). Each functions 
as a ligand-dependent transcription factor with diverse roles in growth, 
development and homeostasis (Hollenberg and Evans, 1988). Their primary
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Fig. 1.5. Schematic amino acid comparison showing examples of mem bers of the 
nuclear hormone receptor superfamily.
Structures are based on the results of molecular cloning studies (References in text). Primary 
amino acid sequences are aligned on the basis of regions of maximum homology (Johnson 
and Doolittle, 1986). Numbers indicate the percentage amino acid identity to hGR. Common 
domains shown: modulatory; N-terminal domain of variable sequence, required for maximum 
receptor activity, DNA; 66-68 amino acid DNA-binding core and hormone; the COOH-terminal 
hormone binding domain. The amino acid position of each domain boundary is shown. All 
receptors represent the human forms with the exception of v-erbA (viral oncogene), USP and 
E75 (from Drosophila). Receptors are grouped as A, the steroid/thyroid retinoic acid subfamily, 
for which an endogenous ligand activator has been identified: GR, glucocorticoid receptor; AR, 
androgen receptor; MR, mineralocorticoid receptor, PR, progesterone receptor; ER, oestrogen 
receptor; VDR, vitamin D3 receptor; T3R(5 and T3Roc, thyroid hormone receptors and RARa, (3, 
y, retinoic acid receptors and B, the orphan receptors: ERR1 and ERR2, estrogen receptor- 
related 1 and 2; RXRot, retinoid X receptor; USP, ultraspiracle and E75, for which endogenous 
ligands have not been identified.
sequences have since been characterised in detail (reviewed by Evans, 
1988; O'Malley, 1990).
The observation that hormones, unrelated structurally or biosynthetically 
bind structurally conserved receptors, implies the existence of further 
unidentified genes, the products of which are also likely to be ligand- 
responsive tran scrip tion  factors. The search for these in itially  
hypothetical receptor genes was based on low stringency hybridisation 
techniques using cDNA sequences of already characterised receptor 
molecules (see Arriza et al., 1987). Several new nuclear receptor coding 
genes have now been identified. By 1995, more than fifty members were 
reported, including at least thirty for which an endogenous ligand had not 
been recognised. Such receptors (exampled in Figure 1.5.) are referred to 
as 'orphans' (reviewed by Laudet etal., 1992; Laudet and Adelmant, 1995). 
Some of the first examples of this class of molecule include the oestrogen 
receptor related proteins, ERR1 and ERR2, (Giguere et al., 1988) and a 
homologue of the retinoic acid receptor subfamily, the retinoid X receptor 
(RXR) which is capable of mediating cellular responses to retinoic acid, but 
for which the true cellular ligand remains unknown (Kliewer etal., 1992). 
The reasons for receptor m ultiplicity are debatable. They could be 
im portant in promoter-specific regulation, controlling the expression of 
overlapping gene networks, requiring  tissue-specific p a tte rn s of 
expression (see section 1.13.). Alternatively, they may respond to different 
hormone metabolites. In contrast to positive gene regulatory roles, both 
COUP-TF (Wang et al., 1989) and the closely related homologue EAR2 
(Miyajima et al., 1988) can specifically modulate the cellular retinoic acid 
response by in terfering  with RXR-mediated transactivation . This 
a ttenuation  assigns a negative regulatory function to these orphan 
receptors (Kliewer et al., 1992).
Several gene products with structural similarities to steroid receptors have 
also been identified in Drosophila. Examples include the gap segmentation 
gene, kn irps  (kn i) (Nusslein etal., 1980), knirps-rela ted  (kn rl) (Ore etal.,
1988) and ultraspiracle (usp), required maternally and zygotically and the
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products of the E75 locus, active in chromosome puffing (Segraves and 
Hogness, 1990). This inter-species homology between steroid receptor-like 
transcrip tion  factors suggests that sim ilar chem ical cues underlie 
morphogenic signalling in vertebrate and invertebrate systems and an 
evolutionary conservation of fundam entally im portant transcriptional 
regulatory motifs.
1.8.) The molecular mechanism of glucocorticoid activity
The first clue to the mechanism by which relatively simple steroid 
molecules could elicit diverse and complex physiological responses came 
from the identification of their cellular receptors through the use of 
radiolabelled ligands in the early 1960s (Jensen and DeSombre, 1972; Tata et 
al., 1972). In each case, the hormone induced a change in the receptor 
which was then able to associate with high affinity binding sites in 
nuclear chromatin. This in turn led to the induction or repression of a 
limited number of genes (50-100 per cell) (Ivarie and O'Farrell 1978).
In addition to their influence over the rate of gene transcription, the 
stability and consequent turnover of mRNA may also be affected by 
steroids. These effects support observations that the general nuclear 
localisation of steroid hormone receptors is consistent with the site of 
action of their respective hormone ligands.
1.8.1.) Glucocorticoid signal transduction pathway
The overall molecular mechanism of the glucocorticoid signal transduction 
pathway and subsequent gene regulation is shown in Figure 1.6. (points 1- 
6). The first step (1) involves the passage of the steroid hormone across the 
cell membrane. The exact mechanism by which this is achieved is unclear, 
although processes of both passive diffusion, aided by the highly lipophilic 
nature of steroid hormones and specific uptake mechanisms involving
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transport proteins have been proposed (Brann, et al., 1995, and references 
therein).
1.8.1a.) Hormone-receptor interaction and receptor activation 
In Step 2 (Fig. 1.6.), the glucocorticoid hormone interacts with its cognate 
receptor. Inactive GR exists in the cytoplasm as a hetero-oligomeric 
complex (Pratt, 1993). The normal cellular location of other steroid receptor 
family members is in the nucleus (King, 1987). The complete GR molecule 
consists of one receptor polypeptide (the 4s monomeric form), one subunit 
each of HSP70, HSP56 and a smaller HSP of around 27 kd, an immunophillin 
of the FK506 class of cytosolic binding proteins and two molecules of HSP90 
(Pratt, 1993; Hutchinson et al., 1994). The HSP90 molecules perform two 
essential functions. By interacting with the GR ligand binding domain, 
they maintain the receptor in an inactive state in the absence of hormone 
(Dobson et al., 1989; Picard et al., 1988). HSP90 is also required for high 
affinity ligand binding, since in its absence, the receptor can still bind 
hormone but with a much lower affinity (Kauffman et al., 1992). Binding of 
the horm one ligand causes molecular dissociation of the receptor 
heterocomplex and receptor dimerization (Eriksson et al., 1991), liberating 
an activated receptor in a state competent for nuclear translocation (step 3) 
(Carson-Jurica et al., 1990). Cellular HSP90 content can determ ine 
sensitivity to glucocorticoids, through its interaction with GR (Picard et al., 
1990).
1.8.1b.) Receptor dimerisation
Nuclear receptor family members can be sub-divided, depending on 
dimerisation properties. Classically, receptors such as GR are viewed to 
function as homodimers in gene activation mechanisms which involve 
DNA binding (Bamberger et al., 1996). However, more recent evidence 
suggestes that heterodim ers between steroid receptor family members, 
such as GR/MR (Trapp et al., 1995) and GR/AR (Chen et al., 1997) may be 
commonplace in the process of transcriptional modulation. TR, RAR and 
VDR can also bind DNA as homodimers, but this binding is relatively weak. 
DNA-binding is enhanced by a further member of the nuclear receptor
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Fig. 1.7. Binding of the glucocorticoid receptor to DNA.
a.) Zinc fingers predicted from the conserved and variable am ino acids in the DNA binding 
domains of hGR, hT3Rp and hER. Amino acids are represented by the one letter code and 
dots respectively. Two zinc ions are coordinated between two clusters of four cysteines (C1- 
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b.) Model of the dimeric complex between the glucocorticoid receptor DNA-binding domain and 
the glucocorticoid rsponse element (GRE) (taken from Hard et al., 1990).
superfamily, the retinoid X receptor, RXR (Yu et al., 1991; Leid et al., 1992). 
Both RXRot and RXR(3 stimulate binding of TR and RAR subtypes, VDR COUP- 
TF and PRAP to their respective DNA response elements, suggesting that 
these receptors most likely function as heterodimers (Kleiwer et al., 1992; 
Zhang et al., 1992). Other nuclear receptors, such as NGFI-B and FTZ-F1 
appear to function as monomers (Parker, 1993).
1.8.1c.) Translocation
Activated GR is transported into the nucleus as a homodimer (Wrange et al.,
1989), a process aided by nuclear localisation signals. One of these signals 
(NL1) is located towards the carboxyl terminal end of the DNA-binding 
domain, the second (NL2) is a composite part of the ligand binding domain 
(Picard and Yamamoto, 1987). Steps 5 and 6 depict the final stages of the 
signalling pathway, which involves specific binding of the receptor to 
nuclear chromatin, or interaction with other gene regulatory proteins and 
the subsequent regulation/modulation of gene transcription (Bamberger et 
al., 1996).
1.8.Id.) Target gene recognition
The selective DNA binding of different steroid hormone receptors is 
achieved via two components, the receptor DNA binding domain, which 
forms a zinc finger binding motif (Green and Chambon, 1987; Severne et 
al., 1988: see Fig. 1.7a.) and the hormone responsive elements (HREs). HREs 
(Table 1.1.) are discrete cis-acting nucleotide sequences which mediate the 
binding of nuclear receptors to the promoters of their regulated genes 
(Geisse et al., 1982; Payver et al., 1983). They function in a position and 
orientation-independent fashion, behaving like transcriptional enhancers 
(Benoist and Chambon 1981; Chandler et al., 1983), but are dependent on the 
presence of hormone for activity (Scheiderit et al., 1983; Ostrowski etal., 
1984). HREs all follow a consensus nucleotide sequence but maintain a 
specificity high enough to direct the binding of only the correct hormone 
receptor species (Beato, 1989). For example the glucocorticoid responsive 
elem ent (GRE), can be shown to preferentially  bind glucocorticoid 
receptors in vitro with high specificity (Willman and Beato, 1986).
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Invert repeats Binding receptors
1.) GRE (+) GGTACAnnnTGTTCT GR, PR, AR, MR
2.) ERE AGGTCAnnnTGACCT ER
3.) TRE/RRE TCAGGTCAnnnTGACCTGA TR, RAR
4.) GRE (-) ATYACNnnnTGATCW GR
Direct repeats
5.) DR-1 AGGTCAn AGGTCA RXR-RXR, RAR-RXR,
COUP-TF-RXR
6.) DR-2 AGGTCAnn AGGTCA RAR-RXR
7.) DR-3 AGGTCAnnn AGGTCA VDR-RXR
8.) DR-4 AGGTCAnnnn AGGTCA TR-RXR
9.) DR-5 AGGTCAnnnnn AGGTCA RAR-RXR
Table.1.1. Consensus response elements for nuclear receptors.
GRE (+), positive glucocorticoid response element; GRE (-), negative glucocorticoid response 
element; ERE, oestrogen response element; TR E/R R E, thyroid/retinoic acid response 
element. The central core around the axis of symmetry for invert repeats shows a nucleotide 
conservation of 50%  or more (Umesono and Evans, 1989). DR-(n); direct repeat with (n) 
number of nucleotides between direct repeats (Umesono etal.,  1991). N; any Nucleotide.
Gene transfer studies, particularly with the mouse mammary tumour virus 
(MMTV) prom oter and the human m etallothionein IIA prom oter have 
shown that these elements can confer hormonal responsiveness (Robins et 
al., 1982). Most HREs identified have a dyad symmetry, which suggests 
interaction with receptor dimers. It has been shown that selectivity of 
vitamin D3, thyroid hormone and retinoic acid receptors in binding to HRE 
direct repeat half sites is specified by the num ber of nucleotides which 
separates them (the 3-4-5 rule: Umesono et al., 1991). Other steroid 
receptor-related molecules show different binding preferences which are 
detailed in Table 1.1.
1.8. le.) DNA binding
The zinc fingers of steroid receptor DNA binding domains contain zinc 
atoms, essential for DNA binding. The first (N-terminal) finger helps 
distinguish between steroid response elements. M utational analysis has 
identified three residues at the C-terminus of the first finger and in the 
interfinger region that specify GRE recognition. The second (C-terminal) 
finger is required for stabilisation of the binding reaction (Danielsen etal.,
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1989). Nuclear magnetic resonance analysis (NMR) of the GR DNA-binding 
domain expressed in E. coll has shown that the region contacting the DNA is 
an alpha-helical structure located between the two zinc fingers (Hard etal.,
1990). This observation was substantiated by the solution structure of GR 
complexed with DNA (Fig. 1.7b). The crystallographic model of the hGR-GRE 
complex (Luisi et al., 1991) revealed that amino acids in the two zinc 
fingers, im portant for target gene recognition, are found in a helical 
structure which makes direct contact with the major groove of the DNA. 
The residues in the second zinc finger are involved in dimerisation of the 
DNA binding domain.
DNA response elements bound by steroid receptors consist of only a limited 
number of sequence motifs, related to either AGAACT or AGGTCA. DNA- 
binding specificity seems to be determined by the orientation and relative 
spacing of these motifs. For example, GR, MR, AR and PR can all bind to a 
GRE inverted repeat of sequence AGAACA, separated by three nucleotides 
(see Table 1.1. and accompanying references). These recognition sequences 
for DNA-binding help determine hormonal specificity. However, additional 
factors in the DNA recognition process must operate to avoid unwanted 
cross-talk between hormonal responses.
1.8.2.) Transcriptional regulation by GR
Selectivity of gene regulation by steroid receptors is achieved, in part, by 
the restricted expression of receptors to specific cell or tissue types. A 
fu rther level of selectivity may be achieved through variation in 
chromatin structure, which is uniquely organised as a result of cellular 
differentiation, leading to DNA condensation. This in turn  is likely to 
influence the accessibility of the receptor to different subsets of genes. 
There is also increasing evidence that steroid receptors contain promoter- 
specific and cell-type specific transcriptional activation domains, leading 
to restricted transcriptional activity (Horwitz etal., 1996; Guido et al., 1996).
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1.8.2a.) Activation and repression o f gene transcription
Many glucocorticoid-responsive genes have been isolated and shown to be 
regulated at the transcriptional level, e.g. angiotensinogen, ACE, arginine 
synthase, POMC and (3-casein (Parks et al., 1974; Ringold et al., 1975; Karin et 
al., 1980; Evans et al., 1982; Doppler etal., 1989).
Various m odels have been proposed to explain the process of 
transcriptional activation by steroid receptors. Some of the first, developed 
originally for prokaryotic promoters (Ptashne, 1986) suggest that their 
gene regulatory effects are based on the interaction of the DNA-bound 
horm one-receptor complex with other proteinaceous components of the 
cellular transcription machinery (see Fig. 1.8. and section 1.8.2b for a 
cu rren t view). Under conditions of positive gene regulation, basal 
components of the prom oter initiation complex such as TATA-binding 
protein (TBP), TAFs (TBP-associated factors) and RNA polymerase II, are 
thought to either 'initiate' or stabilise at the promoter.
Protein-protein interactions at the DNA level are m ediated by specialised 
domains of GR, which for the process of gene activation are termed trans­
activation domains (Webster etal., 1988). The precise mechanisms by which 
steroid receptors affect gene transcription are still poorly understood. 
Another possibility is that of nucleosom e displacem ent, allowing 
transcription factor recognition of previously inaccessible genes causing 
either gene induction or repression (Beato and Sanchez-Pacheco, 1996).
The mechanisms of gene repression by steroid hormone receptors are also 
dependent on specific regulatory surfaces, which may or may not require 
DNA binding by the receptor to promote their activity. For GR, novel 
repression mechanisms have been proposed (Drouin e t al., 1993). For 
example, the gene encoding POMC contains a negative GRE (nGRE), of 
sequence GGAAGGTCAGGTCCA, which binds three GR molecules. A GR 
homodimer binds to the GRE, followed by a GR monomer on the opposite side 
of the double helix. GR inhibition of transcription may be mediated by
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interference with the activity of o ther  t ranscr iption factors, including 
basal components.
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Fig 1.8. Assem bly of the transcription  initiation com plex on a horm one-responsive  
minim al promoter.
Two possible a lternate pathways are predicted. On the left, the recruitm ent of the complete 
RNA Pol-ll holoenzym e; on the right, the stepw ise assem bly of the individual components. In 
both pathways, interaction with the receptors (shown as arrows) could be direct, or mediated 
by one or multiple coactivators (TIF).
(Taken from Beato and Sanchez-Pacheco, 1996).
Gel mobility shift experiments show that GR and the proto-oncogenenic 
t ranscr ip t ion factor jun/API can repress  each others  t ranscr iptional 
act ivi ty  in a rec iprocal  m anner ,  th ro u g h  d i rec t  p ro te in -p ro te in  
interaction which is independent  of DNA binding. Transfection analysis 
using transcription factor mutants shows that multiple domains of GR and 
the leucine zipper of jun/API are involved in this process, either at  the 
level of GR and jun/AP-1, or involving a common unidentified component 
of the transcriptional machinery (Schule etal., 1990).
2 0
The interaction between steroid receptor superfamily and AP-1 family 
members in the regulation of gene transcription is well documented 
(Miner and Yamamoto, 1991; Miner and Yamamoto, 1992). It has been shown 
that the ability of GR to stim ulate proliferin gene transcrip tion is 
enhanced  by c-jun hom odim ers, bu t rep ressed  by c-jun/c-fos 
heterodimers. These effects are also mediated by an nGRE which is capable 
of binding both GR and AP-1 (see also Table 1.1.).
1.8.2b) Transcriptional modula tion by GR
Signal transduction pathways enable many extracellular signals to activate 
latent transcription factors in the cytoplasm. Following common steps of 
dimerization, translocation to the nucleus and specific DNA or protein 
binding, these factors are able to regulate gene transcription. Different 
signalling pathways may even converge on the same prom oter. The 
resultan t transcrip tional regulatory effects depend on the array of 
transcrip tion  factors present at the prom oter and their m olecular 
interactions.
Eukaryotic transcriptional activation is largely dependent on prom oter 
context. Simple promoters containing a series of GREs in association with a 
minimal TATA box (e.g. the tyrosine aminotransferase promoter) depend 
solely on the functional properties of liganded GR for transcriptional 
activation (Jantzen et al., 1987; Grange etal., 1990). Composite promoters, on 
the other hand, are relatively more complex (e.g. the MMTV promoter) and 
contain additional binding sites for widely expressed and tissue-specific 
transcription factors, including OCT-1 (Truss etal., 1995) and NF-1 (Granner 
et al., 1996). NF-1 binding to the MMTV promoter is essential for activation 
by GR. The OCT-1 site modulates both basal and glucocorticoid-induced 
transcription (Granner et al., 1996). Thus, protein-protein, as well as 
protein-DNA and protein-ligand interactions, which most likely take place 
through distinct polypeptide surfaces are all capable of influencing the 
activity of GR.
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The efficiency with which GR activates transcription relies, in part, on the 
affinity of GR for its GRE, a property which depends on both the nucleotide 
sequence of the GRE and the receptor structure specified by the binding 
ligand (Delabre et al., 1993; Lefstin et al., 1995). For example, the 
glucocorticoid antagonist RU38486 can stimulate the translocation of GR to 
the nucleus and binding to a GRE, but the activated receptor is likely to 
rem ain transcriptionally  inactive (Guido e t al., 1996). RU38486 can 
maintain a suppressed state of transcription, even in the presence of a  
constitutive GRE activator (C-terminally truncated  GR). The effect of 
transcriptional repression elicited by an antagonist-activated receptor is 
thought not to result from the sequestering of an accessory transcription 
factor (the same effect can be reproduced in vitro), but from a receptor 
conformation, possibly influenced by the DNA binding sequence, which 
blocks the transfer of promoter activating signals from other factors. It is 
possible that different GREs induce different conformational changes in 
the bound GR in a manner analogous to different ligands, exposing unique 
receptor surfaces for activity with other cofactors. Different subsets of 
cofactors may in turn be required for different functional states of the 
promoter.
The idea that separate transcriptional regulatory sufaces of GR are 
required for promoter specific activity can be demonstrated using receptor 
mutants in which key residues are altered. For example, mutation of residue 
K442G in the DNA binding domain of hGR at one end of the DNA recognition 
helix affects function, not by inhibiting binding to DNA as might be 
expected, but by affecting the interaction of the receptor with other 
accessory proteins bound at the promoter (Montano et al., 1995). Mutation 
of critical amino acid residues can genetically distinguish the promoter 
activity of GR, implying that different residues are im portant for 
in te rac tion  with d ifferen t gene regulators. Consistent w ith this 
observation, hGR mutant K422G fails to repress AP-1 activity and activates 
promoters with AP-1 elements (Heck et al., 1994; Starr et al., 1996). Residue 
442 is therefore probably involved in the transfer of information between 
the GRE and other parts of the GR protein and has implications regarding 
the flow of information between different domains of the receptor.
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i.) Coregulators
Interactions between steroid receptors and basal transcription factors is 
necessary, but not sufficient for efficient transcriptional control. Recent 
evidence shows that apart from contacting the basal transcrip tion 
machinery directly, nuclear receptors recruit an array of coactivators and 
corepressors, which are im portant in the mechanism of hormonally 
induced transcrip tional regulation (Horwitz et al., 1996). This third 
category of factors are thought to stabilise promoter specific interactions, 
providing transcriptional specificity (Goodrich et al., 1993). A growing list 
of such molecules has been described. For example, the gene regulatory 
function of GR in yeast cells is dependent on the SWI/SNF family of 
transcrip tion factors, which act to reverse the repressive effects of 
chromatin components (Chiba et al., 1994). The human homologues of these 
factors, hSNFs also enhance the activity of GR as well as other steroid 
receptors (Muchardt et al., 1993). The exact mechanism of action of these 
coactivators is still unclear, but for SWI/SNF factors, the currently 
favoured model is a stabilisation of the transactivator-PolII holoenzyme 
complex through the complim entary destabilisation of nucleosomes 
(Wilson etal., 1996).
The binding of coactivators to steroid receptors is also likely to be a ligand 
regulated process. The nuclear proteins ERAP 160 (Halachmi et al., 1994) 
and RIP 140 (Cavailles etal., 1995) will only bind a conformationally active 
ER LBD in a reaction which is dependent on oestrogens and is destabilised 
by antioestrogens. These nuclear proteins are found in most tissues, which 
suggests they play a generic role in transcription. Several additional 
factors which interact with nuclear hormone receptors have also been 
described, which may form a large family of related proteins. Examples 
include SRC-1, which enhances the transcriptional activity of GR, ER TR 
and RXR in vivo (Onate et al., 1995). It also interacts with agonist, but not 
antagonist occupied hPR (Onate et al., 1995). GRIP-1, of the same family as 
SRC-1 is a coactivator of steroid receptor LBDs in yeast (Hong et al., 1996). 
There are a whole host of other factors which bind either specifically (e.g. 
ARA7 0 : Yeh and Chang, 1996) or promiscuously (RAP4 6 : Zeiner and 
Gehring, 1995) to steroid hormone receptors. The CBP response element,
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which is often found in association with GREs, is bound and coactivated by 
the cAMP response element binding protein, CBP. Fibroblasts microinjected 
with anti-CBP antibodies are unable to support GR regulated transcription, 
demonstrating the involvement of CBP in glucocorticoid signalling in vivo 
(Hanstein et al., 1996). CBP could act as a cointegrator, coordinating the 
transcriptional effects of signals eminating both from cell membrane and 
nuclear receptors. The end result may be the integration of multiple, 
possibly conflicting signals which might impinge on a promoter.
This procession of recently discovered molecular interactions between 
steroid receptors and other nuclear proteins serves to illustrate the diverse 
molecular interactions which contribute to the transcriptional regulatory 
process. They also introduce a mechanistic complexity in which subtle 
differences in receptor steroid binding or protein sequence might be 
translated into different responses at the level of gene regulation. These 
additional regulatory layers might explain the heterogeneity of hormone 
responses seen in different tissues.
ii.) Synergism between the glucocorticoid and prolactin signalling pathways 
The modulatory capacity of GR has already been used in an experimental 
approach to the assay of receptor function. In recent studies by Stocklin et 
al., (1996) the glucocorticoid receptor has been shown to act as a 
coactivator for the transcription factor STAT5, enhancing STAT5-dependent 
transcription. STAT5 is a signal transducer and activator of transcription, 
one of a family of related transcription factors mediating the final stages of 
signal transduction through JAK/STAT pathways. These pathways are 
activated by cytokines, hormones and growth factors following binding to 
specific transmembrane receptors on the outside of the cell. The resultant 
activation of Janus protein tyrosine kinases (JAKs) leads to tyrosine 
phosphorylation of their associated STAT proteins and STAT dimerisation, 
conferring the ability to bind STAT-response elements in the DNA (Darnell 
etal., 1994).
Although the glucocorticoid and JAK/STAT pathways are apparently 
unrelated, synergism between glucocorticoid and prolactin hormone action
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in mammary epithelial cells is well documented (Doppler et al., 1989). 
Prolactin is a lactogenic hormone (others include hydrocortisone and 
insulin) which, via the prolactin receptor, mediates prolactin-dependent 
induction of milk protein ((3-casein) synthesis in terminally differentiated 
mammary epithelial cells through specific activation of STAT5. The 
coexpression of the prolactin receptor, STAT5 and GR in COS cells, in which 
only trace amounts of GR are normally expressed similarly results in 
synergistic activation of a cotransfected p-casein gene prom oter (Stocklin 
eta/., 1996).
The direct relevance of the interaction between GR and STAT5 to the 
experimental focus of this thesis is discussed further in chapter 7.
Because cytokines can mediate inhibition of glucocorticoid-induced 
apoptosis of lymphocytes (LaVoie and Witorsch, 1995), it may be that STAT- 
GR mediated suppression of gene induction in vivo is responsible for this 
anti-apoptotic effect. It has also been proposed that the glucocorticoid 
receptor acts differently in its role as a negative transcriptional regulator 
in its interactions with AP-1 (Teurich and Angel, 1995) and NFkB (Cato and 
Wade, 1996). As anti-inflammatory agents, the transcriptional repression of 
several cytokines and adhesion molecules relevant to inflamm atory 
processes are repressed by glucocortiocids (vanderBerg et al., 1997). For 
example, the expression of intracellular adhesion molecule-1 (ICAM-1), an 
integrin which plays an essential role in the recruitm ent and migration of 
leukocytes to sites of inflammation, is repressed by opposing effects on the 
NFkB/RelA family member, RelA. This repression does not require GR 
binding to NFkB elements in the DNA, rather, GR interacts with the RelA 
protein. Of the family of steroid receptors, this effect is almost exclusive to 
GR, indicating a m echanism by which glucocortiocids specifically, 
function as anti-inflammatory agents. Few genes that are repressed by GR 
have GRE or nGRE sequences in their promoters, which suggests that DNA 
binding is probably not critical for all aspects of GR m ediated gene 
repression (Truss and Beato, 1993).
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1.9.) Detailed structure of the glucocorticoid receptor: localisation of 
functional domains
The glucocorticoid receptor (GR) was the first mammalian transcription 
factor to be isolated and studied in detail (Muller and Renkawitz, 1991). 
Cloning and sequencing of GR cDNAs from mouse, rat and man (Hollenberg 
et al., 1985; Meisfield et al., 1986; Muller and Renkawitz, 1991) has played a 
pivotal role in the structural and functional characterisation of this 
complex molecule.
The rat glucocorticoid receptor (rGR) at the molecular level displays 
properties characteristic of the steroid receptor superfamily of DNA- 
sequence specific transcription factors. The full length molecule comprises 
795 amino acids (Miesfeld et al., 1986) and divides into several autonomous 
domains showing cooperative molecular interactions. This interpretation is 
based on experimental evidence that discrete proteolytic fragments of GR 
possess some, but not all of the functional properties of the intact molecule 
(Vedeckis et al., 1983). Residues 440-500 make contact with DNA through Zn- 
finger motifs, and present a nuclear localisation signal; the region from 
595-614 interacts with heat shock protein 90 (HSP90), and the domain from 
524-795 binds ligand and exposes a second nuclear localisation signal. The 
domains involved in transactivation of glucocorticoid-regulated genes are 
less well defined and several regions of GR show evidence of regulatory 
properties (McEwan et al., 1997).
1.9.1.) Hormone binding domain (HBD)
Steroid hormone binding is the first step in a series of events which 
translate the structural inform ation of the steroid into a biological 
response. Hydrophobic carboxyl-terminal residues in the HBD fold to 
accommodate the steroid binding pocket, which binds a single steroid 
molecule. Following hormone binding, steroid receptors undergo a 
structural (allosteric) alteration, or 'transformation', which for GR enables 
receptor dimerisation, translocation to the nucleus and finally, DNA 
binding (Garges and Adhya, 1985). The major (overlapping) sequences of
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the HBD responsible for these events are shown in Figure 1.9. The entire C- 
terminal region of GR shows 96% amino-acid sequence identity between 
human, rat and mouse receptors. Homology of the same region between 
other members of the steroid receptor superfam ily is less but still 
extensive, which probably reflects the structural differences between 
their hormone ligands (Evans, 1988). This homology may explain why 
virtually every steroid hormone appears to interact with more than one 
receptor subtype (Teustch et al., 1988).
Many mutations directed to the steroid binding domain of GR cause a 
reduction or loss in steroid binding activity, measured by ability to induce 
an MMTV-CAT reporter gene (Rusconi and Yamamoto, 1987). In contrast, 
amino-term inal m utations reduce the ability of GR to transactivate. 
(Giguere et al., 1986; Hollenberg and Evans, 1988, Dahlman-Wright and 
McEwan, 1996). Mutations occuring naturally in the steroid binding domain 
of GR (e.g., in familial glucocorticoid resistance; see section 1.13.) have a 
similar effect to directed mutations, in reducing steroid binding. There are 
exceptions; mutation C656G of rat GR results not only in increased affinity, 
but also in an enhanced specificity of steroid binding creating a 'super­
recep to r' (Chackraborti e t al., 1991). This supports the view that the 
hormone binding domain, at least in GR, contains a transcriptional 
inactivating function, possibly mediated through HSP90, which is known to 
bind to this region. The complete deletion of the carboxyl-terminus from 
hum an, ra t and mouse GRs also produces constitutive (hormone 
independent) transcriptional activators (Danielsen etal., 1987; Godowski et 
al., 1987; Hollenberg etal., 1987).
1.9.2.) DNA binding domain
The DNA binding domain of steroid receptors is comprised of a highly 
conserved 66-68 amino acid sequence, showing 42-94% homology between 
family members (Evans, 1988). It is the DNA binding domain which 
mediates specific recognition of the cognate steroid hormone response 
element (HRE). Each shows a clustering of basic residues, likely to interact 
with DNA (Umesono and Evans, 1989).
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The critical DNA binding sequence contains nine conserved cysteines, 
eight of which are thought to form two zinc fingers. Each finger (both of 
around 25 amino acids: Giguere et al., 1986) contains four cysteines 
coordinated with one atom of zinc (Evans and Hollenberg, 1987), forming 
motifs which in teract with half turns of the DNA helix (Fig. 1.7.). The 
amino-terminal finger makes sequence specific DNA contacts. Two amino 
acids located at the beginning of the alpha helix, which directly interacts 
with the DNA, are critical in determining binding specificity of GR and ER 
(Danielsen et al., 1989). Mutational analysis of the second finger indicates 
that this region is also required for efficient DNA binding (Hollenberg e t 
al., 1987).
Proof of function of the central nucleic acid binding region from different 
receptors has been aided by 'finger swap' experiments, used to characterise 
receptor domains. For example, substituting the DNA binding domain from 
the human oestrogen receptor (hER) with that from hGR produced a hybrid 
molecule activated by oestrogen, but with the DNA binding specificity of 
hGR (Green and Chambon, 1987).
1.9.3.) Modula tory domain
The am ino-term inal (m odulatory) dom ain of stero id  receptors is 
hypervariable in size and shows very little conservation between family 
members. However, this domain is still important for function. Deletions in 
this region of hGR can reduce transcriptional activity by 10- to 20-fold 
(Hollenberg eta l., 1987; Danielsen etal., 1987). Additionally, NT* (nuclear 
transfer increased) glucocorticoid receptor m utants with a truncated 
amino-terminus, can still bind hormone but are transcriptionally inactive 
(Dieken and Miesfeld, 1992). Mutants are retained in the cell nucleus more 
efficiently than wild type receptors, but fail to activate transcription. As 
well as a trans-activation function, receptors also appear to lose signals 
required for the efficient recirculation to the cytoplasm (Andreasen and 
Gehring, 1981; Westphal et al., 1984; Dieken and Miesfeld, 1992). Similarly, 
an oestrogen receptor with an amino-term inal deletion can normally 
regulate the vitellogenin prom oter, bu t is 10-fold less effective in
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regulating the expression of the oestrogen responsive prom oter, p52 
(Kumar et al., 1987). Structural differences in the amino-terminus may 
therefore influence the functional differences between receptors. The 
functional properties of this domain may involve interaction with general 
and promoter-specific transcription factors, modulation of DNA binding 
and responses to hormonal ligand by exerting an allosteric influence over 
the remainder of the activated receptor (Dellweg etal., 1982).
1.9.4.) Trans-activation domains
W einberger e t al., (1985) using insertional m utants, were able to 
demonstrate the existence of additional sequences, separate from DNA and 
steroid-binding domains with potent transcriptional activating properties. 
The trans-activation functions of the rat and hum an GRs have been 
localised to three distinct regions (McEwan et al., 1997). The strongest 
transactivating region in human GR is xl, located in the amino-terminal 
dom ain. The homologous region in rat GR is enh2, and is delimited by 
residues 108 and 318 (Godowski et al., 1988). Evidence that these regions 
contain transcrip tionally  active surfaces comes from  studies using 
chimeric proteins of both the human and rat GR amino-termini fused to 
unrelated DNA binding domains such as lexA (rat; Godowski et al., 1988) or 
GAL4 (human; Hollenberg and Evans, 1988). Each is capable of promoting 
activation of a reporter gene (e.g. chloramphenicol acetyl transferase; 
CAT) containing the appropriate DNA binding elements. Domains xl and 
enh2, coincide with the major immunogenic domain of their respective GRs 
and therefore are likely to appear on the external surface of the molecule 
(Weinberger et al., 1985). Weaker transactivating surfaces have been 
identified in the rGR protein: en h l co-localises with the DNA binding 
domain (between residues 440-525), and is functionally equivalent to a 
similar region in hGR, x2 (residues 526-556, human receptor sequence. See 
Fig. 1.9.). The x2 domain of human GR (which, unlike xl is also present in 
smaller steroid hormone receptors largely devoid of a modulatory domain, 
such as ER) represents a trans-activator dom ain in its own right, 
functioning in a position and orien tation-independent m anner. Its 
activity, like that of x l, is also increased when multimerised, or when
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expressed in unison with xl. When fused to the yeast transcriptional 
activators GAL4 or GCN4 as part of the ligand binding domain, x2 generates 
a hormone-inducible activator (Hollenberg and Evans, 1988). The location 
of x2, between DNA and hormone binding domains, suggests that it may act 
as a 'hinge' linking the two (Giguere et al., 1986). Mutations in this region 
could therefore block the allosteric transformation necessary for receptor 
activation. McBroom et al., (1995) have recently shown that a similar non­
conserved 'hinge' region of the ROR receptor (a newly described orphan 
member of the steroid-thyroid-retinoid receptor superfamily) is required 
for maximal and efficient DNA bending. A third transcriptionally active 
region of GR locates to the C-terminus and is highly conserved between 
different steroid receptors (Danielian et al., 1992).
i.) Detailed structure o f the glucocorticoid receptor transactivation domains, 
enh2 and xl
The experiments in this thesis are based largely on structure-function 
relationships of rat GR. An understanding of the mechanisms by which 
mutation of amino acid residues in the rGR amino term inus may alter 
molecular function depends on a detailed knowledge of the type and 
distribution of residues, their charge properties and likely contribution to 
specific molecular interactions.
The most detailed dissection of a transactivation domain of GR has been 
carried out in the amino-terminal xl region of hGR (Hollenberg and Evans, 
1988). xl is the homologue of rat enh2 and contains a potent site of 
transcriptional activation in a core sequence located between residues 1 ST- 
244. Recent studies have shown that the xl core sequence (Fig. 1.10.) is 
ordered into three a-helices (HRI, HRII and HRIII) with a defined loop 
structure separating HRI and HRII (Almlof et al., 1997). A sequence 
homologous to the xl core is also found in enh2 spanning residues 210-261. 
These core sequence polypeptides show 83% sequence homology, in which 
the residues key to receptor function are conserved (Almlof et al., 1997; 
Iniguez-Lluhi etal., 1997).
Charge properties, such as those resulting from acidity are known to 
influence the activity of many transcription factors (reviewed by Ptashne,
1988). However, the analysis of a series of xl mutants in hGR (TAs 1-8), each
30
of which encodes a small cluster of m utations affecting transcriptional 
activation (Almlof etal., 1995), has indicated that the acidity of individual 
residues is not critical for function. All of the corresponding residues are 
conserved in the aligned rat GR sequence (see Fig. 1.10.). For example TA1, 
in closest proximity to the amino terminal end of xl (and only 16 residues C- 
terminal to a polyglutamine tract in the corresponding position in rat GR), 
defines the effects of mutation of acidic residues; GIU9 2 , G IU 9 4  and Aspioi- 
The neutralisation of these residues produces a receptor protein with 
reduced transactivation activity (80% of wild type). Mutation of other acidic 
residues (predominantly glu, asp) throughout the majority of the xl domain 
also causes variable small changes in transcriptional activation function.
Three amino acid substitutions in the rat core peptide (E219 to K219, F220 to 
L220 and W234 to R234) selectively disrupt the activation, but not the 
repression function of the receptor amino-terminus. This supports the 
theory that specific residues of GR have defined functional roles (Iniguez- 
Lluhi et al., 1997). Each of these residues occurs within a 16 amino acid 
sequence which aligns with the corresponding region of the xl core of 
human GR (Fig. 1.10.). Residues E219 and F220 (rGR) correspond to residues 
in helical region I (HRI) of the xl core sequence. Similarly, residue W234 of 
rat GR is homologous to residue W213, a critical residue of the xl core loop 
sequence. Mutation of W213 to G213 reduces hGR transactivating activity to 
42% of wild type. It has been proposed (Almlof e t al., 1997) that the 
structural components of the xl core are likely to present an array of 
discrete surfaces for interaction with other transcription factors.
The functional complexities of transactivating surfaces are currently 
being defined. The charge properties of different types of residues are 
important: the significance of acidic residues has already been discussed. 
Hydrophobic residues, as well as charged residues, also appear to provide 
im p o rta n t fu n c tio n a l c h a rac te ris tic s , c o n tr ib u tin g  pa tches of 
hydrophobicity which may influence transactivation (Almlof et al., 1995). 
The structural influences these residues induce in the xl core sequence 
suggest an activity mechanism which is more complex than that predicted 
for an acidic blob-like activator domain (Dahlman-Wright et al., 1995) and 
has im portant implications for rGR function. Sequence alignments show 
that, as well as the 'core' sequence, a very high proportion of the acidic 
(Glu, Asp, phosphorylated Ser) and hydrophobic (Phe, lie, Leu) residues are 
conserved between rat and hum an receptors. This homology extends
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GR e n h 2 / T  1 :
r 39>thr val lvs val ser ala ser ser pro ser val ala ala ala ser gin ala asp ser lvs gin gin arq
h 38>thr val lys val ser ala ser ser pro ser leu ala val ala ser gin ser asp ser lys gin arg arg
thr leu ala cys gly ser leu glu glu asp
r 62>ile leu leu asp phe ser lvs qlv ser thr ser ala val gin gin arg
h 61>leu leu val asp phe pro lys gly ser val ser asn ala      
gin gin gin gin gin gin gin
gly val arg tyr gly
r 85>gln gin gin gin gin gin gin gin gin gin gin glr
h — >          gin gin
pro gly leu ser lvs ala val ser leu ser met
pro asp leu  s e r  l y s  a la  v a l  s e r  leu  s e r  met 
r!08>a l v  leu  t v r  met a l v  a lu  th r  a lu  th r  l v s  v a l  met a l v  asn asp  lu e  a l v  t y r
h 87> g ly  leu tyr met g l y  g lu th r  g lu th r  l y s val met gly asn asp leu gly phe p ro gin gin  g l y  g in
92 94 101
rl31> leu a l v  leu s e r  s e r  a l v  a lu th r  asp  phe arg leu leu alu alu s e r i l e  a la asn leu asn arg s e r
hllO> i l e s e r leu s e r s e r g l y  g lu th r asp leu lys leu leu glu glu s e r i l e ala asn leu asn arg s e r
116 118 123 124
rl54> th r  s e r  va l pro alu asn pro l v s s e r s e r th r s e r a la th r  g l y  cys a la th r pro th r a lu l v s a lu
hl33> th r s e r va l p ro glu asn p ro l y s s e r s e r a la s e r th r a la va l s e r a la a la p ro th r glu l y s g lu
137 153 155
rl77>phe pro l v s th r  h i s s e r asp a la s e r s e r  a lu aln aln asn ara  l v s s e r a ln th r  a l v th r  asn a l v
hl56>phe pro l y s th r h i s s e r asp va l s e r s e r g lu gin gin h i s leu l y s g l y  g in th r  g l y th r asn gly
162 166 HRI
r200 > a lv s e r va l l v s leu t v r pro th r asp aln ser th r  phe asp leu  leu l y s [gjuj Iphe ala
hl79> g ly asn va l l y s leu t y r th r th r asp gin ser th r  phe asp i l e leu gin asp le u gTu pHe s e r s e r
LO O P 187 192 1 Q6 1 QR HRII
r223 > a ly s e r pro s e r l v s asp th r asn alu s e r pro ara ser asp asp leu leu i l e asp alu asn
h202>gly s e r p ro  g l y  l y s g lu th r asn g lu s e r p ro t r p arg ser asp le u leu i l e asp glu asn cy s
201 21 n 216 HRIII 220 221
r246»Jeu leu s e r pro leu a la a l v  alu asp asp nrn nhe leu leu a lu a l v asn th r asn alu asp C V S l v s
h224^l e u leu s e r p ro leu a la g l y  g lu asp asp s e r phe leu leu g lu g l y a s n s e r asn glu asp cys l y s
231 232 233 238 243 244
r269>Dro lu e i l e leu pro asp th r l v s  pro l v s i l e l v s asp th r a l v  asp th r i l e leu ser ser pro s e r
h247>pro lu e i l e leu p ro asp th r l y s  p ro l y s i l e l y s asp asn g l y  asp leu val leu ser ser pro ser
259 262
r291>ser val ala leu pro aIn val l v s th r  a lu l y s asp  asp phe ile glu lys CVS th r pro
h270>asn val thr leu pro gin val lys thr glu ile glu leu lys glu asp phe ile glu leu cys thr pro
r311>a l v  va l i l e l y s gin alu l v s leu<318
h293>gly val ile leu gly glu lys leu<299
Fig. 1.10. A lig n m en t of the m ajor tran s a c t iv a t io n  dom ain s  ( t 1 and enh2) of the  
hum an and rat GRs. Open boxed residues in the am ino term inus of the rat sequence (in black) 
denote those residues m utated in rat GRs constructed  in this thesis. R esidues above in green 
represent the corresponding am ino acid m utations. Residues underlined represent sequences of 
hom ology between rat and human GR (shown in red). Am ino acid coord inates w ith in the human 
sequence m ark acid ic residues, w hich w hen m utated, bring about small a lte ra tions in receptor 
transac tiva tion  activ ity  (A lm lo f e t a l . ,  1995). D ashed lines loca te  res idues  m iss ing  in the 
co rrespond ing  sequence. R esidues in ita lics  m ark the m a jo r am ino -te rm ina l transactiva tion  
dom ains; x1 (human: residues 77-262) and e n h l (rat: residues 108-318). Shaded boxes localise 
those residues which make up the three helical regions of the hGR tau 1 core sequence (A lm lof 
et a l . ,  1997). Hom ology in these regions between human and rat GRs are: 83%  (HRI), 82%  (HRII) 
and 83%  (HRIII). C irc les identify residues of the rat GR w hich are known to se lective ly  disrupt 
transactivation function (see text for details).
beyond the perceived amino-terminal boundaries of enh2 and xl and into 
sequences which precede the polyglutamine tract of rat GR (see Figs. 1.9. 
and 1.10.).
Despite these advances in our understanding of the critical structural 
components of enh2 and xl the precise functional limits of these domains 
remain undefined. Most of the focus to date regarding GR amino terminal 
transactivation function has been centred around residues which comprise 
the 'core' polypeptide sequence. In addition, the identification of 
functionally im portant residues has been based largely on those which 
e ither significantly reduce, or com pletely abolish transcrip tional 
activation activity of GR (Godowski etal., 1987; Godowski etal., 1988).
ii.) Polyglutamine tract
Protein sequences rich in basic residues such as glutamine and proline are 
also known to affect transcription. Many proteins have now been described 
which possess homopolymeric stretches of these amino acids (Ross et al., 
1993; Gerber et al., 1994). Transactivation is shown to be affected when 
tracts of polyglutamine or polyproline are covalently inserted between the 
yeast GAL4 DNA-binding moeity and the transcriptional activation domain 
of herpes sim plex-derived VP16 p ro te in , ind icating  th a t these 
homopolymeric tracts could influence transcription (Gerber et al., 1994). 
No such evidence exists for GR. Whilst in the rat, the length of the 
polyglutamine tract varies between 7 and 23 CAG repeats, the mouse and 
human receptors are constant, with 9 and 2 repeats respectively (Danielsen 
et al., 1986, Hollenberg et al., 1985). At the molecular level, no gross 
differences in transactivation function have been reported  between 
human (2 repeats) and rat (21 repeats) GR cDNA clones (Miesfeld et al., 
1987). However, predisposition to prostatic cancer is positively associated 
with shorter CAG tracts in the human androgen receptor (hAR). Deletion of 
the CAG tract in rat or human AR is reported to enhance the activity of 
reporter elements, and long repeats reduce transcription to a degree 
(Mhatre et al., 1993; Chamberlain et al., 1994). In these reports it is difficult 
to exclude the possibility that two-fold differences in transactivation might 
be due, in part, to differences in protein stability. In a case of androgen 
insensitivity, a reduction of polyglutamine repeat length in hAR was
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associated with increased lability of the receptor in tissue culture when 
associated with the mutation T761C in the steroid binding domain (McPhaul 
etal., 1991).
The exact functional role of polyglutamine tracts is unclear, although by 
their very nature they are predicted to lie on the surface of proteins 
where, under non-pathological circumstances, could provide discrete 
surfaces which prom ote p ro te in -p ro te in  in teractions. Perutz and 
coworkers, (1994) have shown that synthetic polymers of glutamine 
residues are capable of forming regular beta-barrel structures, strongly 
held together by hydrogen bonds. These motifs may function as polar 
zippers, providing a means for the interaction of trans-acting factors even 
when bound to separate DNA segments. For example, the glutamine 
activation domains of Sp-1 (Courey and Tjian, 1988) and the POU (proline 
and glutamine-rich) domains of Oct-1 can specifically bind TBP in vitro. 
TBP mutants have now been identified which are defective in activated, but 
not basal transcription. A num ber of TAFs have been shown to bind 
specificaly to particular types of activation domains, e.g., dTAFHO which 
binds to the glutamine-rich domains of Sp-1 (see Triezenberg, 1995).
Interactions between polyglutamine tracts and other proteins has also 
been suggested as a molecular basis of the microsatellite expansion diseases 
such as Huntingtons disease (HD; Myers et al., 1993) spinocerebellar ataxia 
type 1 (SCA 1; Orr et al., 1993) spinal and bulbar muscular atrophy (SBMA; 
LaSpada et al., 1992) and dentatorubral pallidolusian atrophy (DRPLA; Koide 
et al., 1994). Of the gene mutations known to be involved in these diseases, 
only that causing SBMA is known to reside in a transcription factor (AR) 
and it is possible that altered transactivation function may lead to aberrent 
gene regulation. Alternatively, homopolymeric expansion may lead to 
progressive aggregation and co-precipitation of other cellular factors 
(Perutz et al., 1994), although confirm atory evidence of cellular 
precipitates has not been reported.
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Given the m olecular com plexities by which GR can m odulate 
transcriptional activity; GR can even act as a corepressor through 
interaction with other transcription factors such as AP-1 (Pearce and 
Yamamoto, 1993; Diamond et al., 1990), the potential for effects of 
polyglutamine sequences on interactions between GR and these other 
factors, or w ithin GR hom odim ers becomes more apparent. Such 
interactions could have far reaching consequences metabolically or in a 
tissue or developmental stage specific fashion. GR has also been shown to 
form dimers with MR (Trapp et al., 1995), which have an enhanced 
cooperativity in DNA binding and with AR (Chen et a l, 1997), which also 
carries an N-terminal polyglutamine tract in both rats and man. These 
interactions offer yet other ways of modulating glucocorticoid activity in 
tissues which express different combinations of these receptor types.
Part 2
Glucocorticoids and mechanisms of blood pressure control
1.10.) Corticosteroid receptor designation
Classically, corticosteroids are thought to exert their biological effects by 
differential binding to and activation of MR and GR. However, this 
distinction is possibly naive. There seems to be a clear lack of selectivity 
for natural mineralocorticoid and glucocorticoid hormones between these 
receptors. MR has a similar affinity (Kd, around 1 nM) for both aldosterone 
and glucocorticoids (cortisol/corticosterone) and is activated by both of 
these hormones in vitro (Krozowski and Funder, 1983). GR has only a 
slightly higher affinity for glucocorticoids (Kd, 10-50 nM) than for 
aldosterone (Kd, 50-100 nM) (Arriza et al., 1987).
Given that total circulating levels of glucocorticoids are usually several 
orders of magnitude (100-1000-fold) higher than those of aldosterone, 
despite the fact that glucocorticoids are heavily bound to plasma proteins,
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such as CBG (see section 1.3.) while aldosterone is mostly free, how is a 
mineralocorticoid response to aldosterone possible? Figure 1.11. outlines 
the basic mechanism. Primary sequence homology of hMR and hGR is high 
(DNA-binding domains, 94%; hormone binding domains, 57%. Respectively, 
59% and 76 % in the rat). Thus, tissue-specific differences in aldosterone 
and  glucocorticoid activation of m ineralocorticoid (type I) receptors 
cannot be explained purely by receptor differences.
GlucocorticoidMineralocorticoid
Cortisol
(ACTIVE)Distal nephron
SD2 Cortisol 
(ACTIVE)
C o rt is o n e ^
(INACTIVE)
Cortisone
(INACTIVE)
Brain
Liver
TYPE I TYPE
Dex
Na+ Retention
K+ Excretion A
Blood Pressure
Metabolism  
Vasoconstriction  
Blood Pressure
Fig. 1.11. The basic  m echanism  of a ld ostero n e  s e le c tiv ity  in target tissu es .
Glucocorticoids (cortisol/cortocosterone) have a roughly sim ilar a ffin ity for type I and type II 
corticosteroid receptors. In classical aldosterone responsive tissues, however, glucocorticoids 
are norm ally  p revented from  b inding to m inera locortico id  (type I) receptors by 11(3- 
hydroxysteroid dehydrogenase (11 (3-HSD) which rapidly m etabolises these compounds. The 
glucocorticoid metabolites (cortisone and 11-deoxycortcosterone, respectively) have a much 
lower affinity for the m ineralocorticoid (type I) receptor, thus allowing unhindered aldosterone 
binding. The reciprocal reactivation of cortisone and 11-deoxycortcosterone back to the active 
steroids occurs in other tissues, mainly the liver.
Clearly, a protection function preventing unwanted glucocorticoid access 
to type I receptors is necessary in tissues which are required to respond 
almost exclusively to aldosterone. This is achieved by the enzyme ll-(3 
hydroxysteroid dehydrogenase (11(3-HSD) (Monder and White, 1993). This
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enzyme has at least two isoforms (isozymes), the products of two distinct 
genes (Seckl, 1993). ll-pHSD2 (Albiston, et al., 1994; Brown et al., 1996), 
functioning as a reductase, converts cortisol and corticosterone to their 
respective inactive metabolites cortisone and 11-dehydrocorticosterone in 
aldosterone responsive tissues.
The other 11-pHSD isozyme, 11-(3HSD1, is proposed to be an NADP(H) 
dependent enzyme (Agarwal et al., 1989) which reactivates these 
glucocorticoid m etabolites in glucocorticoid responsive tissues. In 
transport epithelia, particularly the distal nephron of the kidney, MR co- 
localises with the ll-pHSD2 isoform (Albiston, et al., 1994; Brown et al., 
1996), which inactivates cortisol/corticosterone allowing aldosterone 
preferential access to the receptor. In brain and hippocampus, the 11 p- 
HSD1 isoform predom inates. In conclusion, the overall effects of 
corticosteroids on blood pressure are the composite result of activating 
more than one type of receptor.
1.11.) Glucocorticoid regulation of vascular tone: mechanisms of 
blood pressure control
Several components determine physiological blood pressure. These include 
cardiac output, resistance of the blood vessels, blood volume and viscosity. 
Total peripheral resistance is inversely proportional to vessel diameter, a 
function of vascular muscle tone and elasicity (Kenyon and Fraser, 1992). 
Each of these components is controlled by num erous neuronal and 
endocrine influences. The central nervous system control of cardiac 
function and total peripheral resistance is a critical factor in blood 
pressure regulation. Resultant effects are m ediated through various 
neurotransm itters such as norepinephrine and acetycholine and their 
receptors (Axelrod and Reisine, 1984). Properties of resistance vessels, 
including structure, basal tone and sensitivity to various pressor agents 
also depends on short and long term influences of systemic and local tissue 
derived hormones (Benjamin and Vallance, 1991). The synthesis, action and
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metabolism of many of these compounds are modulated by glucocorticoids 
and mineralocorticoids (reviewed by Walker and Williams, 1992).
All categories of adrenal steroids; glucocorticoids, mineralocorticoids, 
androgens and oestrogens are capable of influencing blood pressure but, 
glucocorticoids and mineralocorticoids are the major regulators (Sleight, 
1986). The mechanisms by which steroids raise blood pressure differ. In the 
case of aldosterone, the exact nature and functions of all of the induced 
proteins have not been fully identified. In the kidney and in other 
transport epithelia, aldosterone-induced proteins (AIPs) are thought to 
increase cell permeability to sodium, increase the rate of ATP synthesis and 
stimulate the activity of the Na+-K+-ATPase (Horisberger and Rossier, 
1992).
Despite their pronounced effect on blood pressure, mineralocorticoids and 
glucocorticoids do not effect smooth muscle contraction directly. Pressor 
effects of steroids can result from either the potentiation or stimulation of 
secretion of vasoconstrictors, or decrease in the effectiveness of 
vasodilators. The following two sections outline the principal modulatory 
effects of glucocorticoids on chosen examples of vasoactive molecules (see 
Table 1.2.).
1.11.1.) Vasoconstrictors
1.11.1a.) Catecholamines and adrenergic receptor interaction 
The vasoconstrictor properties of glucocorticoids are based predominantly 
on their modulation of vascular smooth muscle sensitivity to noradrenaline 
(NA) (Yagil et al., 1986; Frohlich, 1987; Darlington et al., 1989; Sudhir et al.,
1989). Changes in vascular s truc tu re , second m essenger events, 
adrenoceptor binding characteristics and the activity of enzymes which 
metabolise catecholamines are all known to be involved (Axelrod and 
Reisine, 1984).
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Sites of modulation Glucocorticoid effect Reference
V a so c o n s tr ic to rs
a-ad ren ocep tors In VSMCs of the rat, reduced high 
affinity a-adrenoceptor numbers are 
restored by dexamethasone
Haigh and 
Jones, (1990)
* ANP G lucoco rtico id s su p p re ss  ANP 
production in vivo and ANP activity 
in tissue culture
Kenyon e ta l, 
(1990)
*ACE G lucocorticoids induce ACE in 
endothelial cells
Medelsohn etal., 
(1982)
* A n g io te n s in o g en Circulating levels of angiotensinogen 
are increased by glucocorticoids
Ben-Ari etal., 
(1989)
* R e n in In contrast to m ineralocorticoids, 
glucocorticoids are rep o rted  to 
increase renin gene transcription
Morris etal., 
(1984)
V asodila  tors
(3-adrenoceptors Rat aortic vascular smooth muscle 
cells show increased numbers of (3- 
adrenergic receptors at physiological 
concentrations of dexamethasone
Jazayeri and
Meyer
(1988)
*V asop ressin Glucocorticoids secondarily down 
regulate vasopressin synthesis via 
ANP in response to vascular volume 
expansion
(Kenyon and 
Jardine, 1989)
* ANP G lu co co rtico id s in c re a se  ANP 
synthesis in response to surges in 
vascular volume
Kenyon etal., 
(1990)
Phospholipase A2 Glucocorticoids reduce the production 
of vasorelaxant eicosinoids PGE1 and 
prostacyclin  by down regulating 
phospholipase A2 gene transcription
Flower (1988); 
Axelrod, (1983)
*N O -synthase The inducible form of NO-synthase, 
identified in macrophages and VSMCs 
is inhibited by glucocorticoids
DiRosa etal., 
(1990)
Table 1.2. Vasoactive molecules modulated by glucocorticoids. Abbreviations: VSMC, 
vascular smooth muscle cell; PG E1, prostaglandin E1; Gi, G-protein inhibitory subunit; Gs, G- 
protein stimulatory subunit; IP3, inositol triphosphate; DG, diacyl glycerol; NA, noradrenalin; 
ANP, atrial natriuretic peptide; ACE, angiotensin converting enzyme; NO, nitric oxide. Those 
molecules primarily involved in blood pressure control are marked in bold. Those molecules 
controlled at the genetic level by glucocorticoids are marked with an asterisk.
For example, dexamethasone has been shown to increase the number and 
affinity of aortic binding sites for the specific a i-adrenoceptor ligand, 
prazosin, in adrenalectomized rats (Haigh and Jones, 1990). This effect is 
not produced by aldosterone (Yagil and Krakoff, 1988). Similarly, increased
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numbers of (3-adrenergic receptors in various tissues, including human 
lymphocytes and granulocytes, ra t liver and ra t lung (Davies and 
Lefkowitz, 1980) have been observed.
Although the activity of adrenoceptors is modified in a post-translational 
manner by glucocorticoids (Haigh and Jones, 1990), there are a number of 
molecules with vasoconstrictor properties, which are regulated at the level 
of the genome. Examples include angiotensinogen and angiotensin 
converting enzyme (ACE) (Mendelsohn et al., 1982), both im portant 
molecules of the renin-angiotensin system.
1.11.1b.) Renin-angiotensin aldosterone system
The influence of adrenocortical horm ones over the renin-angiotensin 
system occurs at several levels. Renin, an aspartyl protease, important in 
the regulation of blood pressure and electrolyte balance is expressed in a 
variety of mammalian tissues, predominantly in the afferent arterioles of 
the kidney, but also in the adrenals and vascular smooth muscle cells 
(Makried et al., 1988). The physiological effects of aldosterone suppress the 
renin-angiotensin  system (section 1.3). M ineralocorticoid induced 
hypertension in rats (DOCA treatm ent, or high salt [1%] diet) causes 
suppression of renal renin gene expression, which is thought to be 
mediated by MR. Glucocorticoids oppose the effects of aldosterone and are 
reported to increase renin activity by activating renin gene transcription 
(Glorioso et al., 1989). Possible GREs in the prom oter of the renin gene 
(Dzau et al., 1988) supports this proposal. M ineralocorticoid-induced 
increases in blood pressure are associated with increased vascular 
reactivity to angiotensin. Evidence of angiotensinogen gene regulationn 
by glucocorticoids is widely accepted and is likely to be im portant in 
conditions of glucocorticoid deficiency (Riftina etal., 1995).
ACE is localised to the luminal surface of vascular endothelial cells, the 
major site of angiotensin I conversion in vivo (Caldwell et al., 1976). Other 
prom inent sites of ACE activity include the kidney, brain and small 
intestine. Cultured endothelial cells from bovine aorta and intact rat lung
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in vivo show a net increase (6-7 fold) in ACE production in response to 
dexamethasone (100 nM). DOC and aldosterone are much less effective, 
stimulating only a 2-3 fold increase in ACE activity at 1 concentration 
(Mendelsohn e ta l., 1982). Local levels of vasoactive pepetides, angiotensin 
II and bradykinin are likely to be influenced by glucocorticoids, with 
resultant effects on vascular tone. ACE normally inactivates bradykinin, a 
potent vasodilator (Erdos, 1977), but activates angiotensin II.
Recent studies have also demonstrated that type 1 angiotensin II receptors 
(ATI) are up-regulated by glucocorticoids in the ra t hypothalam ic 
paraventricular nucleus (PVN). ATI receptor mRNA levels and All binding 
were reduced by approximately 20%, following adrenalectomy. This effect 
was prevented by corticosterone administration in the drinking water, or 
dexamethasone injection (100 mg, s.c., daily). Conversely, dexamethasone 
injection into intact rats caused a 20% increase in ATI receptor mRNA. 
Again, this up-regulation would potentiate the vasoconstrictor effects of 
the renin-angiotensin system (Aguilera etal., 1995).
1.11.2.) Vasodilators
Vascular tone is the balance between the action of vasoconstrictor and 
vasodilators m echanisms (Walker and Williams, 1992). Inhibition of 
vasodilation seems most relevant to glucocorticoid induced hypertension. 
The major vasodilators, atrial natriuretic peptide (ANP/ANH) (Kenyon et 
al., 1990), prostaglandins (Bailey, 1991) and the endothelium  derived 
relaxing factor, nitric oxide (DiRosa et al., 1990) are all regulated by 
glucocorticoids.
1.11.2a.) ANP
ANP has direct vasodilatory properties, separate from its natriuretic effect. 
Physiological concentrations of glucocorticoids are required for the 
normal expression of ANP, but glucocorticoids may inhibit ANP synthesis 
and secretion, either by reducing plasma volume, or by regulating ANP
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gene expression (Tonolo et al., 1988). Glucocorticoids may also inhibit the 
responsiveness of vascular tissues to ANP by interfering with ANP signal 
response coupling. For example, renal vascular smooth muscle cells 
(VSMCs) treated with dexamethasone produce less cyclic GMP (cGMP) in 
response to ANP than untreated cells (Yasunari et al., 1990). cGMP is the 
second messenger for a number of vasodilatory processes. Decreased ANP 
and cGMP levels will both tend to prevent vasodilation.
1.11.2b.) Nitric oxide (NO)
Synthesis of nitric oxide in endothelial tissues is controlled by two types of 
NO synthase, one constitutive and Ca^+-dependent and the other inducible 
and Ca^+-independent (Rees etal., 1989). Glucocorticoids block the activity 
of the inducible form of NO synthase (Radomski et al., 1990), limiting nitric 
oxide induced vasodilation. The effect of increase in blood pressure 
following inhibition of nitric oxide synthesis is well established (Haynes et 
al., 1993). Similar effects of glucocorticoids have also been demonstrated in 
macrophages (DiRosa et al., 1990) and have implications regarding the 
anti-inflammatory and immunosuppressive effects of glucocorticoids.
1.12.) Pathophysiological effects resulting from abnormal glucocorticoid 
signalling
Since corticosteroids exert powerful influences over interm ediary 
metabolism, blood pressure control and electrolyte homeostasis, it follows 
that any deviation from their normal rates of production and metabolic 
clearance (Kaplan, 1983), will have profound consequences on receptor 
mediated responses. The effects of abnormal steroid production, and of 
abnormal receptor and catabolising enzyme activities are well documented.
The best known example of clinical glucocorticoid excess is seen in patients 
with Cushing's syndrome, in which primary hyperactivity of the adrenal 
cortex (low ACTH, high cortisol) or of the anterior pituitary (high ACTH, 
high cortisol) causes increased cortisol secretions (For reviews see: Fraser
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et al., 1989; Connell and Fraser, 1991). A characteristic phenotype is 
observed; centralised body fat distribution, degeneration of muscle and 
connective tissue, growth im pairm ent and osteoporosis. Patients may 
develop hypertension, sexual dysfunction and reduced resistance to 
infection. Synthetic glucocorticoids, or ACTH adm inistered over a long 
period produces similar effects (Kenyon and Fraser, 1992). Excess 
a ld o ste ro n e  or 11-deoxycorticosterone (DOC) sec re tio n  causes 
m ineralocortico id-induced  hypertension . M ineralocorticoid  excess 
(resulting in hyperaldosteronism ) typically arises from adrenocortical 
adenom a or carcinoma (Conn and Mich 1955) and is characterised 
biochem ically by suppressed  plasm a ren in  and ang io tensin  II 
concentrations, together with Na+ retention, K+ loss and a metabolic 
alkalosis. The hypertension which ensues, is therefore an indirect 
consequence of changes in sodium levels and plasma volumes. As discussed 
in section 1.10., lip-HSD type I and II regulate the access of cortisol to MR 
and GR. Suppressed llp-HSD2 activity also leads to symptoms of 
hyperaldosteronism  in the absence of aldosterone excess. Two clinical 
situations are known in which the activity of this enzyme is reduced; 
congenital apparent mineralocorticoid excess (AME), in which enzyme 
activity is deficient (Stewart et al., 1988; Mune et al., 1995) and acquired 
AME, which is caused by intoxication with inhibitors of llp-HSD2 activity, 
such as glycerritinic acid, found in liquorice, or its derivative 
carbenoxalone (Stewart etal., 1987).
Reduced adrenocortical activity (eg. in patients with Addisons disease, 
resulting from pathological destruction of adrenal tissue or ACTH 
deficiency) is normally associated with hypotension, hypoglycaemia, 
weight loss, fluid and electrolyte disturbances and abnormal development 
of secondary sexual characteristics (Brosnan and Gowing, 1996).
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1.13.) Corticosteroid receptor mutations
The incidence of mutant corticosteroid receptors in humans is relatively 
rare. Studies of GR in patients with familial glucocorticoid resistance 
syndrome (FGR) has indicated that hypertension is a possible phenotypic 
consequence (Hurley et al., 1991). Sequencing of human GR cDNAs from a 
kindred with FGR revealed a single point mutation in the hormone binding 
domain (V641D) which resulted in a 3-fold reduction in affinity for 
dexam ethasone. The resu ltan t hypertension  was characteristic  of 
mineralocorticoid excess. The m utant GR was unable to switch off ACTH 
synthesis from the anterior pituitary, resulting in elevated levels of plasma 
cortisol. These higher cortisol concentrations presumably overstep the 
capacity of 11-PHSD2 to p ro tec t MR from  over-stim ulation  by 
glucocorticoids. A similar phenotype is encountered in patients with 
prim ary cortisol resistance, which is classified as a glucocorticoid 
receptor-mediated disease, resulting from a reduced affinity of the receptor 
for its horm one ligand (Bamberger et al., 1996). Other forms of 
glucocorticoid insensitivity have also been described. Werner et al., (1992) 
dem onstrated instances of receptor therm olability in association with 
increased rates of GR gene transcription. A novel form of natural 
glucocorticoid resistance is found in the guinea pig GR, in which the 
ligand binding domain contains several novel amino acid substitutions 
(Keightley and Fuller, 1994). This altered GR structure directs constitutive 
transcrip tional activity which is unsuppressed by RU38486 (l^iM). 
Uncontrolled receptor activity in these cases may result from loss of 
interaction with HSP90. M utant GR which do not bind HSP90 are 
transcriptionally active in the absence of hormone (Bronnegard et al., 
1991). Further abnormalities of GR function might be anticipated from 
mutations in the promoter region of the GR gene. As yet, no prom oter 
effects on GR mRNA levels have been dem onstrated. However, their 
identification may depend on promoter usage and the availability of tissue- 
specific transcription factors (Nobukuni etal., 1995).
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Glucocorticoid as well as progesterone, oestrogen and androgen receptors 
have been shown to be constitutively activated by loss of a portion of the 
ligand binding domain (e.g., Carson etal., 1987; Godowski etal., 1987; Brown 
et al., 1988). Resultant proteins are still able to bind DNA, but are no longer 
regulated by steroids. hGRa and hGR(3 are two isoforms of the human GR 
which result from alternate receptor mRNA splicing (Hollenberg et al., 
1985). hGRa is the biologically active isoform. The hGRp isoform is carboxy- 
terminally truncated, has no reported intrinsic activity, but has been 
shown to interfere in hGRa steroid binding studies. The relative levels of 
these GR isoforms may affect GR function, either globally or in a tissue- 
specific fashion. Studies by Bamberger et al., (1995), suggest that 
attenuation of transcriptional regulation by hGRa is brought about by 
competition by the truncated non-steroid responsive hGRp for GRE binding 
sites in the DNA. In the rat, no obvious GR splice variants have been 
observed. However, lower molecular weight hepatic GR isoforms have been 
reported, which possibly result from alternate use of translation initiation 
codons in the GR mRNA (Miesfeld etal., 1986).
Patients with depressive illness, characterised by excessive secretion of 
corticotropin releasing factor and cortoisol, due to hyperactivity of the 
HPA-axis also provide evidence of abnormal patterns of GR expression 
(Pepin and Barden, 1991). This observation derives from the action of anti­
depressants which modulate the GR mRNA content of neuronal cells 
involved in the negative feedback control of HPA-axis function. Similar 
observations have been made by Lamberts eta l., (1994) who described 
female patients with reduced GR expression, overproduction of adrenal 
steroids and pathology resulting from excessive adrenal androgenic 
activity. In support of a consequential loss of GR activity, the directed 
knockout of type II glucocorticoid receptors in mice carrying an antisense 
GR RNA transgene (Pepin etal., 1992) also generates increased activity of 
the HPA-axis, resulting in elevated corticosterone and ACTH levels, 
suggesting a general ineffectiveness of GR in feedback inhibition of 
glucocorticoid secretion.
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The effectivity of the glucocorticoid signal may be reduced by means other 
than interference of steroid binding to GR. Accessibility of activated GR to 
DNA, a vital component of the glucocorticoid signal pathway may also be 
affected. In steroid resistant (SR) asthmatics, (Barnes and Adcock, 1995) 
this condition seems to result from increased binding of GR to AP-1, 
presumably sequestering GR away from other modulatory roles concerning 
the anti-inflammatory actions of glucocorticoids .
1.14.) Essential hypertension in man
Although in man, specific abnormalities of glucocorticoid function have 
been shown to result in cardiovascular disease, in most cases, the cause of 
hypertension is not known. Essential hypertension, of unknown origin, 
represents a major public health issue due to its common occurrence 
(affecting 20-30% of the population) and its long-term complications. As a 
quantitative trait, blood pressure varies continuously in the whole 
population. Its regulation is controlled by a variety of mechanisms 
involving, probably several genetic loci and environm ental and other 
factors such as diet, body weight, stress and physical exercise (Camussi and 
Bianchi, 1988; Corvol etal., 1990; Guyton, 1991).
1.14a.) A role for glucocorticoids?
Several studies have implicated abnormal steroid hormone activity as a 
contributory factor in the aetiology of cardiovascular disease. For example, 
a well defined subgroup of patients have been described with low-renin 
hypertension (Gormez-Sanchez et al., 1985). Since this effect is typical of 
excessive mineralocorticoid activity, but in the absence of a measurable 
m inera loco rtico id  excess, suggestions of novel s te ro id s w ith 
mineralocorticoid properteis, reduced 11|3-HSD2 activity, or abnormal GR 
function have been proposed.
Data from several groups support the conclusion that llp-HSD is impaired 
in some hypertensive patients (Walker, 1993; Soro et al., 1995). In certain
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sample populations, however, neither mineralocorticoid or glucocorticoid 
levels are found to be sufficiently elevated to explain the rise in blood 
pressure. Abnormally high sensitivity to glucocorticoids might provide an 
explanation; firstly, dexamethasone treatm ent produces a paradoxical fall 
in blood pressure in a subgroup of hypertensives, possibly implicating the 
involvement of cortisol or another ACTH-dependent steroid (Whitworth et 
al., 1989). In essential hypertension, in which cortisol levels remain 
normal, sensitivity to this steroid, as judged by dermal blanching following 
topical administration, is increased (Walker et al., 1995). Again, the authors 
propose the possibility of defective cortisol inactivation by llp-HSD, or 
abnormality of glucocorticoid receptor action.
1.14b.) Genetic evidence for the involvement o f GR
Studies from a number of families have shown that essential hypertension 
is inherited as a polygenic trait (Higgins et al., 1980). However, only 30% of 
the blood pressure elevation has a genetic basis. The search for the 
causative genes in humans has encountered several complex problems 
including; adequate phenotype definition, the availability of informative 
families for genetic studies, the apparent heterogeneity of the disease 
(Lindpaintner et al., 1992a) and the confounding effects of environmental 
factors (listed above). Environmental factors can act over extremely long 
timespans affecting the genotype/phenotype relationship individually, 
within a family and regionally (Watt etal., 1992).
Two main approaches have been used to identify the genes involved in 
hypertension. One approach, which is largely restricted to animal models, 
is to map a series of polymorphic genetic m arkers (simple sequence 
repeats; SSRs) distributed throughout the genome to establish a link 
between increased blood pressure and specific gene loci (Jacob et al., 1991; 
Hilbert et al., 1991; Jacob et al., 1995; Pravenec et al., 1995). The other 
approach is to study candidate genes that are known to participate in blood 
pressure regulation, such as those which encode horm onal factors 
(catecholamines, vasopressin and components of the renin-angiotensin 
system, inlcuding renin: Barley etal., 1991 and ACE; Jeunmaitre etal., 1992),
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mediators of hormonal responses in target cells of heart and blood vessels 
(corticosteroid, catecholamine and other receptors, such as GR: Heeley e t 
al., 1996b; angiotensin II receptor, Koike et al., 1995) and membrane 
components of the distal nephron of the kidney, which critically control 
sodium balance (Na+ transporter: Husted etal., 1997; Na-K-Cl cotransporter: 
AlvarezGuerra, etal., 1997).
Neither of these approaches is without problems. For example, linkage 
mapping may be useful in identifying gene loci showing a significant 
linkage with blood pressure, but the precise identity of the genes involved 
remains unknown. There are also differences of opinion in what are 
considered to be candidate genes. The result is that a great many 
'candidates' get studied, only some of which may be completely relevant to 
the disease phenotype. Candidate genes can also be shown to segregates 
with blood pressure. This could be due to either genetic variation within 
the gene of interest or in a closely linked gene with very different 
properties.
On the basis of differences in glucocorticoid-dependent physiological 
variables, epidemiological studies by Watt et al., (1992) have suggested the 
association of Grl with high blood pressure in humans. The phenotypic and 
genotypic correlates of a predisposition to hypertension were investigated 
by comparing offspring with and without a family history of this disorder. 
Four groups were chosen on the basis of extremes of personal blood 
pressure and of their parents blood pressure. For those individuals selected, 
linkages between high blood pressure and a large num ber of other 
biochemical and physiological variables and various candidate genes were 
sought. Genetic linkage analysis was restricted to the extreme phenotypic 
groups (i.e. those with high blood pressure and those with low blood 
pressure) where an underlying genetic component would most likely be 
found. Only a few of the chosen variables showed a genetic link. Plasma 
concentrations of cortisol, 18-hydroxycorticosterone, and angiotensin II, 
were higher in those with a genetic predisposition to developing high
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blood pressure. Most importantly, plasma levels of the renin substrate 
angiotensinogen were also raised.
RFLP analysis revealed two hGR haplotypes, A and a, which were identified 
following Bel 1 digestion of genomic DNA and probing with a full length 
hGR cDNA probe. Homozygosity for the AA genotype occured in 50% of 
those with high blood pressure whose parents had raised blood pressure, as 
compared with 36% of those whose personal and parental blood pressures 
were low. Comparisons of individuals homozygous for either AA or aa 
genotypes showed a significantly higher association of the AA genotype 
with higher blood pressure scores. Quite possibly, the raised plasma cortisol 
concentrations, increased renin-angiotensin activity and the genotypic 
differences in the glucocorticoid receptor could represent the genetic basis 
for at least a proportion of the glucocorticoid associated hypertension. In 
contrast, markers associated with several other blood pressure-relevant 
genes, including ANP, renin and ACE were uninformative.
Although these data relate to blood pressure distribution within a young 
normotensive population, it is possible that the alleles of Grl which 
associate with high blood pressure contribute to the development of 
hypertension in later life. The more recent studies of Walker et al., (1995), 
in using the same population also identified abnorm al sensitivity to 
glucocorticoids, which predicted predisposition to hypertension.
Of particu lar in terest from these studies, is that elevated adrenal 
corticosteroid levels and a trend towards increased receptor affinity for 
dexamethasone binding (also see Panarelli and Fraser, 1994) were found 
associated with a specific Grl genotype (AA). It has been suggested that 
functionally unaccountable m utations of GR m ight be of general 
importance in contributing to the more common forms of hypertension 
(Lamberts etai., 1994; Werner eta/., 1992).
Essential hypertension in man is complex because several genes are 
involved, as in cardiovascular control mechanisms (Kreutz et al., 1992).
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Analyses, are complicated still further by heterogeneity of individual 
genetic background and differences in environm ental exposure. 
Epidemiological considerations, a vital aspect of human studies, requires a 
large populus in order to provide meaningful data. Difficulties with 
population size becomes more apparent when relatively rare disease loci 
are to be isolated and studied in detail. Finally, the availability of human 
biopsy m aterial is also very limited and the ease of investigations in 
hospitalised patients are hampered by ethical considerations. Well defined 
experimental animal model systems which provide more reliable genetic 
homogeneity are therefore a very useful alternative.
1.15.) Rat genetic models of hypertension and abnormalities of steroid 
metabolism
Several rat genetic models of hypertension have been developed over 
recent years, with phenotypes that include abnormal steroid action, as well 
as elevated blood pressure. These model strains include: the spontaneously 
hypertensive ra t (SHR), its stroke-prone derivative SHRSP and their 
normotensive control strain, Wistar Kyoto (WKY); the Dahl salt-sensitive 
and salt-resistant; the Milan hypertensive (MHS) and normo tensive (MNS); 
the Lyon strains (LH, LN, LL) and the New Zealand strains. Inbred strains 
displaying a particular phenotype are obtained by selective breeding. Once 
the trait of interest has become sufficiently well established, brother-sister 
matings are performed to achieve genetic homogeneity by theoretically 
fixing all genes of a given strain in the homozygous state. This determines 
a predisposition to the selected phenotype.
The following list summarises, for chosen ra t strains, phenotypic 
characteristics which are thought to result from abnormalities of steroid 
metabolism. Many of these strains provide evidence of abnorm al 
glucocorticoid activity. Included are those strains which are of specific 
relevance to the work of this thesis; SHR, Zucker obese and MHS.
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i.) SHR
Of the available rat models of genetic hypertension, the SHR strain has 
been the most intensely studied. Several abnormalities in the HPA-axis 
have been reported, including elevated plasma corticosterone levels 
(reviewed by Panarelli, 1994). The adrenal cortex shows hypertrophy 
compared with WKY and adrenalectomy prevents blood pressure increase, 
reversible by the administration of aldosterone (Kenyon et al., 1984). The 
development of hypertension is therefore dependent on an intact adrenal. 
Recent indication of slower rates of GR steroid binding depletion in SHR 
compared with WKY at elevated tem peratures (Panarelli e t al., 1995) 
provides evidence of a thermostable GR heterocomplex. Receptor stability 
in SHR is concomitant with an increased affinity for dexamethasone 
(Panarelli, 1994).
ii.) Dahl salt-sensitive and salt-resistant
These strains are characterised by abnormal steriod 11- and 18-hydroxylase 
activity. Part of the salt-dependent increase in blood pressure (SS-strain) is 
due to altered 11 (3-hydroxylase activity, producing an increased ratio of 18- 
hydroxy-DOC:corticosterone in vivo and in vitro. Breeding studies have 
shown that the preferential conversion of DOC to 18-hydroxy-DOC rather 
than corticosterone, which characterises the salt-dependent rats, accounts 
for at least 16% of the increase in blood pressure (Rapp and Dahl, 1972). The 
salt resistant (SR) and salt sensitive (SS) rats possess specific homozygous 
alleles of the 11 (3-hydroxylase gene, which differ by five amino acid 
substitutions. The salt-resistant allele, by coding for an enzyme which 
synthesises proportionally less 18-hydroxy-DOC, is thought to protect the 
SR strain from salt-induced hypertension (Matsukawa etal., 1993).
iii.) Lyon strains
Development of the hypertensive phenotype in Lyon hypertensive (LH), 
compared with the normo tensive (LN) and low (LL) blood pressure strains, 
is characterised by elevated deoxycorticosterone (DOC) and reduced 
corticosterone levels (suggesting a lowering of 11 (3-hydroxylase activity). 
Levels of 18-hydroxy-DOC and aldosterone are unchanged. These
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observations were made in young rats 5-weeks old (Vincent et al., 1989). 
DOC levels normalise on reaching maturity (at 20-weeks). However, this 
normalisation is accompanied by a reciprocal increase in corticosterone 
and a lowering of 18-hydroxy-DOC. W hether these changes represent 
altered steroid secretion or metabolism is uncertain.
iv.) Zucker obese
Although this strain represents a genetic model of obesity, it shares many 
interesting abnormalities of steroid metabolism common to hypertensive 
strains, including mild hypertension and is presented here for comparison.
Zucker obese rats, compared with lean controls, like SHR and MHS display 
adrenal hypertrophy with elevated plasma ACTH and corticosterone 
concentrations. In addition, hepatic GR from this strain have a lower 
affinity for glucocorticoids (White and Martin, 1990). Body weight gain is 
normalised following adrenalectomy.
v.) MHS
Details of the MHS phenotype are given in chapter 5, and will only be 
considered briefly at the end of this section in relation to hypertension 
gene candidates.
Varying degrees of progress towards defining the genes responsible for 
genetic hypertension has been made with the above rat models. Recent 
studies involving numerous microsatellite markers have been carried out 
using the stroke-prone SHR derivative (SHR-SP), crossed with its 
normotensive control strain, WKY. These large scale breeding studies have 
identified several loci showing linkage with the hypertensive phenotype 
in SHR-SP, although the precise identity of the genes involved remains 
unclear (Hilbert et al., 1991; Jacob e ta l, 1991). From the mapping study of 
Jacob et al., (1991), two 'interesting' loci were identified, one of which 
contained the growth hormone gene, GH. W hether the rat GH gene, or 
another closely linked gene was responsible for the linkage with blood 
pressure was not determined in this study. Another gene in close linkage
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with GH in the rat and perhaps of more relevance to blood pressure control, 
is the gene encoding angiotensin converting enzyme (ACE). The possibility 
of a direct association between ACE gene polymorphisms and increased 
blood pressure is still unclear. Segregating markers have identified other 
loci on chromosome 18 and on the X chromosome as being significantly 
associated with blood pressure. In the rat, GR is also localised to 
chromosome 18.
The highest rate of successful genotype-phenotype associations in 
hypertension have been a ttribu ted  to the candidate gene approach 
(Lindpaintner, 1992b). For example, the significant contribution of 
abnormal steriod 11(3- and 18-hydroxylase activity to the development of 
hypertension in the Dahl salt-sensitive rat has been known since 1972 
(Rapp and Dahl, 1972). In 1993, Matsukawa et al., reported variation in the 
gene encoding the llp-hydroxylase enzyme between salt resistant and salt 
sensitive strains. In the same year, linkage of llp -hydroxylase  
polymorphisms with altered steroid biosynthesis and blood pressure was 
confirmed (Cicila eta/., 1993).
In addition, comparison of the salt-resistant and salt-sensitive variants of 
Dahl rats has revealed differences in renin gene structure. The renin gene 
locus (i.e. the renin gene, or another closely linked gene) has been found 
to be linked to hypertension in the Dahl strain of sodium-sensitive rat 
(Rapp et al., 1989). In the Okamoto SHR strain, breeding studies suggest that 
between four and six independent loci contribute to high blood pressure 
(Jacob et al., 1991; Koike et al, 1995). Allelic variation has also been 
reported in the renin gene of SHR when compared to WKY, although inter­
strain genetic variation in controls makes realistic interpretation difficult 
(Samani etal., 1989).
Of particular interest and relevance during the course of this thesis has 
been the excitement regarding possible association between adducin genes 
and hypertension, both in humans and the Milan hypertensive strain of 
rat, MHS. Adducin is a heterodim eric membrane cytoskeletal protein, 
consisting of separately encoded a- and p- subunits. Adducin interacts with
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other membrane skeleton proteins affecting ion transport accross the cell 
membrane. Initial genetic studies have demonstrated that a point mutation 
within the a- subunit of adducin in MHS increases Na-K-ATPase activity 
when transfected into rat renal epithelial cells (Tripodi et al., 1996). In 
vivo, this mutation affects blood pressure, accounting for 40-50% of the 
blood pressure difference between MHS and MNS, when interacting with a 
mutated (3-adducin subunit (Bianchi et al., 1994). The effect of adducin on 
blood pressure is thought to be m ediated by changes in cell signal 
transduction mechanisms, through effects on the polymerisation of actin 
filaments. Recent studies in independent sample populations have now 
confirmed significant linkage of the a-adducin locus with hypertension in 
humans (Cusi et al., 1997).
The possibility that an abnormality of GR function could account for part of 
the remaining difference in blood pressure and /o r provide the basis for 
other phenotypic differences between MHS and MNS is the subject of 
further investigation presented in this thesis.
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Chapter 2 
Materials and Methods
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2.1.) Materials
2.1.1.) Reagents
All reagents were of analytical or molecular biology grade, purchased from 
either: Sigma Chemical Company Ltd. (Pool, Dorset, U.K.) or the BDH (Merck) 
Chemical Company (Lutterworth, Leicestershire, U.K.) unless otherwise 
stated.
2.1.2.) Animals
Rats of strains MHS and MNS were obtained from the Field Laboratories, 
University of Sheffield, U.K.. SHR, WKY and Zucker lean and obese rats were 
obtained from Harlan Olac (Bicester, Oxfordshire, U.K.).
2.1.3.) Tissue and DNA samples
English wild ra t liver samples were obtained from Central Science 
Laboratory, Ministry of Agriculture Fisheries and Food, Slough, Berkshire, 
U.K.. Scottish wild rat carcasses were donated by regional pest control 
departm ents of Scottish District Councils (Stirling, Glasgow and Fife). 
Carcasses were stored at -20°C prior to dissection and removal of the liver.
Inbred ra t liver samples from strains SHR-SPcia and WKYcia (Glasgow 
strains) and SD were obtained from The M.R.C. Blood Pressure Unit, Western 
Infirmary, Glasgow.
Inbred strain and substrain liver genomic DNA samples were obtained from 
The Departm ent of Laboratory Animal Science, Faculty of Veterinary 
Medicine, University of Utrecht, The Netherlands.
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The following sub-headings list specific materials, followed by the supplier 
for:
2.1.4.) Genomic DNA extraction
Proteinase K (Sigma).
Phenol (TE saturated): Obtained pre-equilibrated with TE (pH 8.0) (Fisons, 
Loughborough, U.K.).
2.1.5.) Polymerase chain reaction (PCR)
PCR prim er oligonucleotides (as well as single stranded complementary 
oligonucleotides and oligonucleotide probes) were obtained from Oswel 
(Oswel DNA service lab 5005, University of Southampton, Southampton, 
U.K.).
General PCR components, such as Taq DNA polymerase (from Therm us 
Aquaticus, compatible with reaction buffer B), lOx reaction buffer B, dNTPs, 
magnesium  chloride (25 mM) acetylated BSA (10 m g/ml) (Promega, 
Southampton, U.K.). Mineral oil (light white: Sigma).
VentR DNA polymerase (from Thermococcus literalis), lOx Vent polymerase 
buffer, magnesium sulphate (100 mM) and purified BSA (non-acetylated) 
(New England Biolabs, Hitchin, Hertfordshire, U.K.).
2.1.6.) Gel electrophoresis
Ethidium bromide (Sigma).
Agarose (GIBCO BRL [Life Technologies], Paisley, Scotland, U.K.).
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M etaphor agarose and low gelling tem perature (LMP) agarose (FMC 
Bioproducts, Rockland, U.S.A.).
1 Kb DNA ladder (GIBCO-BRL).
2.1.7.) Southern blotting
Sonicated salmon sperm DNA solution (10 mg/ml) (Pharmacia Biotech, Herts, 
U.K.).
H y b o n d - N + nylon  m em brane (A m ersham  In te rn a tio n a l pic, 
Buckinghamshire, U.K.).
Autoradiographic film (Hybond-MP) and intensifying screens (Amersham).
2.1.8.) 32p_iabening of DNA
T4 polynucleotide kinase (PNK) and lOx PNK reaction buffer (Promega). 
Sephadex G50 (Sigma).
2.1.9.) Sequencing
Sequenase version 2.0 kits"™ for plasmid sequencing (United States 
Biochemicals, Cambridge Bioscience, Cambridge, U.K.). Sequenase version
2.0 kitsTM for direct sequencing of PCR products (Amersham).
D y n a b e a d s T M  (Dynal Ltd., Merseyside, U.K).
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2.1.10.) RNA extraction
RNAzolTM b (Biogenesis Ltd., Bournemouth, U.K.).
2.1.11.) Tissue culture
All tissue culture components were obtained from GIBCO-BRL, unless 
otherwise stated.
Cell lines: COS-7 and CV-1 (European Collection of animal cell cultures 
Wiltshire, U.K.), EDR3 (G. Firestone, University of California, Berkeley, 
U.S.A.), 2s-Fasa and HEK293 (University of Edinburgh).
Calf thymus DNA (Sigma).
DMSO (Sigma).
DOTAP (Boehringer Mannheim, U.K.).
2.1.12.) DNA cloning
Restriction enzymes were obtained from Promega, except: Avail, Kpnl and 
Sfil (GIBCO-BRL).
Klenow fragment (5-10 U / | li 1) and lOx Klenow reaction buffer (Promega).
Random hexamer primers (3 jLxg/p.1 in 3 mM Tris-HCl [pH 7 .0 ], 0 .2  mM EDTA) 
(GIBCO-BRL).
Calf intestinal phosphatase (CIP) supplied at a concentration of 20-30 U/ja.1 
(GIBCO-BRL).
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DNA ligase and lOx Ligase buffer (Promega).
2.1.13.) Bacterial growth, colony screening and solutions for 
plasmid DNA extraction
Bacto-tryptone, yeast extract and agar (GIBCO-BRL).
Antibiotics: ampicillin, tetracycline, streptamycin and kanamycin (Sigma).
X-gal and IPTG (Sigma).
Lysozyme (Sigma).
2.1.14.) Reverse transcription of RNA
Random hexamer primers (as describerd in section 2.1.12.).
Molony Murine Leukaemia Virus (MMLV) Reverse Transcriptase, lOx MMLV 
reacton buffer and 0.75 M DTT (Stratagene Ltd., Cambridge, U.K.).
RNAsin (20 U/jo. 1) (Promega).
2.1.15.) Western blotting
Glucocorticoid receptor monoclonal antibody MAb 250 (also referred to as 
antibody No. 7) was a gift from Dr. A-C Wikstrom, Department of Medical 
Nutrition, Huddinge University Hospital, Huddinge, Sweden.
High molecular weight protein markers (GIBCO-BRL).
ECL Western blotting kit and PVDF membrane (Amersham).
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2.1.16.) Radiochemicals
All radioisotopes (nucleotides and ligands) were obtained from Amersham: 
[a32p]-dCTP: Supplied at S.A., 3000 Ci/mmole 
[y32p]-ATP: Supplied at S.A., 3000 Ci/mmole 
[a^^S]-dATP: Supplied at S.A., 1250 Ci/mmole 
[l,2,4,6,7-^H]-Dexamethasone: Supplied at S.A., 86.0 Ci/mmole
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2.2.) Methods
2.2.1.) Animal maintenance
Prior to sacrifice all animals were m aintained in house under standard 
living conditions (12 h light, 12 h dark), with free access to food and water 
in a temperature controlled environment.
2.2.2.) Extraction of genomic DNA
The protocol for the extraction of genomic DNA was taken from methods 
described by Sternberg et al., (1990). Essentially, 100-200 mg of tissue was 
homogenised on ice in 5 ml PBS (phosphate buffered saline: 1 Sigma PBS 
tablet dissolved in 200 ml ddH20) and centrifuged at 2000 rpm, 10 mins at 4°C. 
Pellets were washed twice by resuspension in 2 ml PBS and finally 
resuspended in 1 ml lysis buffer (50 mM Tris-HCl (pH 7.5), 0.1 M NaCl, 0.15 M 
EDTA, 1% SDS and 1 mg/ml proteinase K). The resulting mixture was 
incubated at 60°C for lh  to digest unwanted proteins. Vigorous pipetting was 
avoided to minimise shearing of the DNA.
DNA was recovered by increasing incubation volumes to 4.5 ml with TE (10 
mM Tris-HCl, 1 mM EDTA [pH 8.0]), adding 0.5 ml 3M sodium acetate (pH 5.2) 
and precipitating with 3 volumes 100% ethanol. Precipitated DNA was 
transferred to 1.5 ml microfuge tubes, washed with 0.5 ml 100% ethanol, 
briefly air dried and redissolved in 0.5-1 ml TE (pH 8.0) at 4°C over a period 
of at least 2 days.
Where DNA was expected to be of a lower integrity (from degraded tissue 
samples), proteinase K digests were protein extracted by combining with an 
equal volume of TE-equilibrated phenol, mixing gently and spinning at 5000 
rpm, 10 mins at 4°C. Taking care to avoid the interface, the supernatant was 
transferred to a fresh tube. Recovered supernatants were combined with an 
equal volume of chloroform/isoamyl alcohol (24:1 mixture), again mixed
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gently and spun at 5000 rpm, 10 mins at 4°C. Supernatants were recovered 
as previously described, transferred to a fresh tube, mixed with 1/10 
volumes of 3M sodium acetate (pH 5.2) and DNA precipitated with 3 volumes 
100% ethanol. Resulting DNA pellets were washed with 100% ethanol, 
briefly air-dried and redissolved in TE (pH 8.0) at 4°C.
2.2.3.) Polymerase chain reaction (PCR) amplification of nucleic acids 
General PCR strategy
Amplifications were performed using an Omnigene Thermal Cycler (Hybaid 
Ltd., U.K.) in 25^1 reaction volumes by combining 10-100 ng of genomic DNA 
or 1-10 ng of plasmid DNA with 20 pmoles of each primer and 2U Taq DNA 
polymerase in a standard reaction mixture containing; lx  Taq polymerase 
buffer, 125 jxM dNTPs, 1.5 mM Mg^+ and 0.01 mg/ml acetylated BSA. Reaction 
mixes were overlaid with 1-drop of mineral oil (approximately 25 |al) and 
heated to 95-97°C for 5-7 mins prior to PCR. In general, cycle profiles of: 
95°C, 1 min (step 1), followed by: X°C, 30s, 72°C, 30s and 95°C, 30s (step 2), 
continued for 30 cycles and finally: X°C, 30s, 72°C, 5 mins final extension 
(step 3) were used, where X°C = Primer annealing tem perature (normally 
about 5°C below the average of the primer Tm s) and was typically in the 
range of 56-60°C.
These conditions were optimal for the majority of PCR primers listed in 
Appendix 1 and were effective in the amplification of up to 2.5-3.0 kb of 
target sequence using Taq DNA polymerase. PCR reactions found to be 
inefficient under these conditions were further optimised, as described in 
chapter 3.
32p-pcr
PCR products were ’ 2p-la.belled by incorporating a single 32p end-labelled 
prim er (see section 2.2.7.) in subsequent PCR reactions. PCRs were 
perform ed as described previously, except DNA templates were initially 
denatu red  at 95°C for 5 mins prior to the addition of both Taq DNA
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polymerase and 32p_iabelled primer. In pilot experiments, the 32p_iabeueci 
prim er was added in a volume of 2.0 pi labelling reaction mixture 
(corresponding to 10-20 pmoles).
RT-PCR
A liquots of reverse tran sc rip tio n  reactions (2 pi: pu rified  by
phenol/chloroform extraction) were PCR-amplified in 25 pi volumes using 
previously described methods. RNA/cDNA templates were initially denatured 
for 2 mins at 94-95 °C prior to PCR.
2.2.4.) Preparation and electrophoresis through agarose and 
polyacrylamide gels
Various percentage agarose gels and their application:
Percent agarose
0.8% Low gelling 
temperature (LMP) 
agarose
Typical application
Isolation of DNA fragments for 3 2 p_iabehing or 
column purification (section 2.2.10.) prior to 
cloning
0.8% Normal agarose Analysis of plasmid clones and genomic DNA
1.5% Normal Analysis of restriction fragments and PCR products
larger than around 200 bp. Isolation of large DNA 
fragments for purification by dialysis (section
2.2.10.) prior to cloning
2-3% Normal Analysis of restriction fragments and PCR products
generally  sm aller th an  200 bp, carrying 
polymorphisms down to about 10 bp
4% Metaphor agarose Analysis of PCR products down to 100 bp with
resolution of polymorphisms down to 1-3 bp
The compositions of all electrophoresis and gel loading buffers were exactly 
as described by Sambrook et al., (1989).
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Agarose gels
Standard agarose gels at the appropriate percentages (depending on 
application, see above) were prepared as described by Sambrook et al., 
(1989). Metaphor agarose gels were prepared as recommended by FCM 
Bioproducts, Rockland, U.S.A..
DNA samples were mixed with 0.5-1 volumes of lx  sucrose gel loading buffer 
(Sambrook et al., 1989) prior to gel loading and electrophoresed in lx  TAE 
buffer, or 0.5x TAE for Metaphor gels to improve resolution. Normally, gels 
were run at 150-200 v, 40 mA. LMP gels were run at lower voltages (50-100 v, 
20 mA), to prevent excessive heating and possible melting of the gel. DNA 
bands were visualised using an ultraviolet (UV) transilluminator, following 
staining with ethidium bromide at 0.5-1.0 ^ g/ml.
Polyacrylamide gels
6% Polyacrylamide gels for sequencing and m icrosatellite typing were 
prepared by mixing 100 jliI  APS (25% w/v APS in ddH20) and 100 jrl TEMED 
with 100 ml gel solution: 15 ml 40% acrylamide solution (195 g acrylamide 
and 5 g bis-acrylamide in 500 ml ddH20), 15 ml 5x TBS and 50 g urea, made up 
to 100 ml with ddH20. Gels were cast by standard methods. DNA samples were 
mixed with 0.66 volumes of lx  formamide gel loading buffer (sequencing 
samples) or 0.165 volumes (PCR amplified microsatellites) prior to loading 
onto pre-heated (50-60°C) gels. Gels were run at 2000 v, 58 mA, 110 W for 1.5- 
2 h, or until the xylene cyanol dye front had reached about half way down 
the gel. DNA bands were visualised by transferring the gel to Whatman 3 
mm paper, drying using a BioRad model 583 gel dryer (BioRad), at 80°C for 2 
h and exposing to Hyperfilm-MP for 4-16 h, at -80°C with an intensifying 
screen. ^^S-containing gels were exposed at room temperature for 24-48 h.
2.2.5.) Measurement of nucleic acid concentrations
The concentrations of nucleic acid solutions (double stranded DNA, 
oligonucleotides longer than the average PCR primer length [21 mer] and
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RNA) were measured spectrophotometrically at 260 nm (concentration 
alone), or at a ratio of 260/280 nm (to estimate for purity). Nucleic acid 
concentrations were deduced as described by Sambrook et al., (1989).
The concentration of DNA bands in gels was estimated by comparing their 
fluorescent intensity with that of a band of sim ilar size in a known 
concentration of marker ladder.
2.2.6.) Restriction endonuclease digestion of DNA
For routine restriction analysis (20 pi standard volume), 0.2-0.5 p.g of DNA 
solution (PCR product, or potential recom binant plasmid clone from 
miniprep) was digested with 2-3 enzyme units/pg of DNA in a final volume 
of 20 jliI  containing lx  restriction enzyme reaction buffer. Incubations were 
routinely carried out at 37°C for 1-2 h, unless otherwise stated. 10 pi of the 
resulting digests were checked for restriction patterns on 1.5% agarose gels.
For generation of cloning fragments and Southern probes, 5-10 ng of DNA 
solution (plasmid clone) was digested with 1-2 enzyme units/pg of DNA in a 
final volume of 4 0  pi (Southern probe), or 8 0  pi (cloning fragments). 1 jlxI of 
resulting digests were checked on 1.5% gels for completeness of digestion. 
Reaction conditions were as previously described.
2.2.7.) 32p_iabelling of double and single stranded DNA 
32p end-labelling of single stranded oligonucleotides
PCR primers and single stranded oligonucleotide probes used in Southern 
blotting were 32p_iabelled at the 5'-end with [y 32p]_ATP (3000 Ci/mmole) 
using T4 polynucleotide kinase (Promega). Diluted prim er (lOpl, 10-20 
pmoles/pl) or oligonucleotide probe (lOpl, 70-80 ng/pl) was combined with 
5pl lOx polynucleotide kinase (PNK) buffer (700mM Tris-HCl [pH 7.6], lOOmM 
MgCl2 and 50 mM DTT) and 29 pi water, boiled for 2 mins and rapidly cooled 
on ice. 5pl [y 32p]_ATP (diluted to -500 cpm in water for the labelling of PCR
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primers) and lp l polynucleotide kinase were then added and the mixture 
incubated for 45 mins at 37°C.
Random primer labelling of Southern probes
cDNA fragments from plasmid digests were band excised from LMP agarose 
gel and melted at 70 °C. A 20 pi sample of molten DNA-agarose solution 
(approximately 100-200 ng DNA) was boiled for 5-10 mins, rapidly cooled on 
ice and combined with dATP, dGTP and dTTP (each at 0.0625 mM), 10-20 ng 
random hexamer primers, 5 p.1 [a^2p]-dCTP (3000 Ci/mmole) and 1 pi Klenow 
fragment and incubated in lx  Klenow buffer (50 mM Tris-HCl, 5 mM MgCl2,1 
mM DTT and 0.2 mM HEPES [pH 7.5]), at 37°C for 1 h. The reaction was stopped 
by the addition of 200 pi of Sephadex G50 column elution buffer (10 mM Tris- 
HCl [pH 8.0], 100 mM NaCl, 1 mM EDTA [pH 8.0] and 0.5% SDS).
Probe purification and measurement of specific activity
The 32p_iabeued probe DNA was separated from unincorporated radioactive 
nucleotides through a Sephadex G50 column (see Sambrook et al., 1989). 
Labelled probe DNA was eluted from the column using elution buffer (as 
described above) and fractions of peak activity collected and pooled.
Probe specific activity was determined by mixing an aliquot of purified 
probe with 3 ml of a toluene-based scintillant, Cocktail T (666 ml toluene, 332 
ml Triton X-100, 5 g 2,5-Diphenyloxazole [PPO] and 0.15 g l,4-Di-2-(5 
phenyoxazoyl) benzene [POP]) and counting cpm using a B4430 Tricarb 
scintillation counter (Packard, U.K.). Specific activities of 10^-10® cpm/pg 
were routinely obtained.
2.2.8.) Southern blot analysis
Alkali Southern blotting of PCR products from agarose gels
PCR products were separated and visualised in ethidium bromide stained 
agarose gels against 1 kb DNA markers. DNA samples were depurinated,
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denatured and transferred to Hybond-N+ nylon membrane using the 
methods described by Sambrook et al., (1989).
Southern blotting of PCR products from polyacrylamide gels
Unlabelled PCR products resolved on standard 6% polyacrylamide gels were 
transferred to nylon membrane using the basic methods of Southern. The 
region of the gel predicted to contain the PCR products was overlaid with 
Hybond-N+ nylon membrane (normally around 10x20 cm, exceeding the PCR 
'product window' by at least 2-3 cm on upper and lower margins) and wetted 
with 2x SSC. Any bubbles were carefully removed and the membrane 
overlaid with two pieces of Whatman 3 mm blotting paper and a stack of 
absorbent paper towels. With the application of sufficient pressure, the PCR 
product DNA was allowed to transfer onto the nylon membrane for 6-16 h.
2.2.9.) Hybridisation of radiolabelled DNA probes to Southern filters 
Using probes generated from random primer labelling
Prior to hybridisation with labelled probe, membranes were 'blocked' for 1 
h in 25 ml prehybridisation buffer (5x SSC [Sambrook et al., 1989], 5x 
Denhardt's solution [Sambrook et al., 1989] and 0.5% SDS) containing 20 
jug/ml of sonicated salmon sperm DNA. The salmon sperm DNA was denatured 
at 100°C for 5 mins before adding to the hot (65°C) prehybridisation buffer. 
After blocking of the membrane, 20 ml of prehybridisation buffer was 
removed and 100 |d (equivalent to roughly 20-50 ng) ^^P-labelled DNA probe 
solution added, following denaturation at 100°C for 5-10 mins. Hybridisations 
were carried out in 8 cm diameter hybridisation cylinders mounted in a 
rotating oven (Hybaid Ltd, U.K.) at 65°C for 16-18 h.
Hybridised filters were washed twice in 2x SSC, 0.1% (w/v) SDS for 10 mins at 
room temperature, once in lx  SSC, 0.1% (w/v) SDS for 15-30 mins at 65°C and 
if significant background counts still remained, once in O.lx SSC, 0.1% (w/v) 
SDS for 10 mins at 65°C. The washed filter was wrapped in clingfilm to retain
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moisture and exposed to autoradiographic film (Hybond-MP) for 2-3 h at 
-80°C with an intensifying screen.
Using single stranded oligonucleotide probes
Prior to hybridisation with labelled probe, membranes were 'blocked' for 1 
h in 50 ml 3% casein prehybridisation buffer (1.5 g milk powder dissolved 
in 50 ml 2x SSC). Hybridisations were carried out (either immediately or 
after several days storage of filters at 4°C) at 60°C for 8-10 h in 10 ml 2x SSC 
(containing 2% w/v milk powder) supplemented with 25 jxl ^P-la-loelleci 
oligonucleotide probe (equivalent to 30-40 ng DNA solution of specific 
activity: 10^-10^ cpm/^ig). Hybridised filters were washed twice in 2x SSC, 
0.1% SDS for 30 mins at 60°C, wrapped in clingfilm and exposed to 
autoradiographic film as described above.
2.2.10.) DNA cloning techniques 
Purification of DNA fragments
For cloning purposes, DNA fragments from restriction enzyme digestion of 
plasmid DNA were recovered from agarose gels by electroelution into 
dialysis tubing as described by Sambrook etal., (1989).
PCR products for sequencing (up to -2 kb) and cloning (up to -500 bp) were 
efficiently purified using QIAGEN PCR purification columns (QIAGEN, 
Dorking, Surrey, U.K.) according to the manufacturers recommendations.
Phenol/chloroform extraction of nucleic acids
All nucleic acid solutions were purified after proteinaceous digestions, as 
described by Sambrook etal., (1989).
Ligation of DNA fragments
For the directional cloning of DNA fragments carrying different cohesive 
termini, the appropriate ratio of molecular ends for an efficient ligation
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had to be optimised. For single fragment ligations, vector : insert ratios of 
1:1 and 1:3 (and occasionally 3:1) were routinely tested. The mass ratio of 
vector : insert(s) was dependent on the size (in bp) of fragments to be 
ligated. For multiple fragment ligations, similar ratios of vector to insert 
were used, with mass ratios decreasing with decreasing size of insert 
fragment. In general, 20-30 ng of linearised vector DNA was ligated with X 
ng of insert DNA fragment(s) [depending on their size, in bp] in one of the 
ratios described above, by combining 1 1^ lOx ligase buffer (300 mM Tris-HCl 
(pH 7.8), 100 mM MgCl2, 100 mM DTT and 5 mM ATP), 0.5 jlxI  (1.5-2 weiss units) 
T4 DNA ligase, X |rl DNA solution (for each DNA fragment, dependent on 
num ber of fragments and their size and concentration) and Y jil ddH20 
(dependent on X) in a final volume of 10 jil. The DNA ligase was added last 
and the reaction components gently mixed by stirring with a pipette tip. 
Ligation reactions were incubated at 16°C for 16 h and then stored at 4°C 
until required for transformation.
Dephosphorylation of linearised plasmid DNA
Purified linear plasmid DNA for cloning was dephosphorylated using calf 
intestinal phosphatase (CIP) at a concentration of 0.01 U/pmole of 51 
protruding DNA ends (where 1 pmole of DNA ends represents the number of 
ends generated from the linerisation of 1 |ug of a 4.3 kb plasmid). Reactions 
were incubated at 37°C for 30 mins and terminated by heating to 70°C for 30 
mins. Inactivated CIP was removed by phenol/chloroform extraction.
CIP was diluted to a concentration of 0.2 U/^il using CIP dilution buffer (30 
mM triethanolamine [pH 7.6], 3 mM NaCl, 1 mM MgCl2 and 0.1 mM ZnCl2, 
supplied with the enzyme) prior to use.
Klenow fill-in of protruding 51 ends
The filling in of 5' protruding termini with unlabelled dNTPs was achieved 
as follows: 1-4 |iig of DNA (in a volume of 20 jliI )  was digested to completion 
with a suitable restriction enzyme generating 5' overhangs. The digested 
DNA was then phenol/chloroform  extracted, ethanol precipitated and 
resuspended in 20 [d ddH20. The DNA solution was combined with 40 mM
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dNTPs, 20 ng/ml acetylated BSA and 1 U of Klenow/jxg of DNA. Reactions were 
incubated in 1 x Klenow buffer (50 mM Tris-HCl [pH 7.2], 10 mM MgS04 and 
0.1 mM DTT) at room temperature for 1 h and terminated by heating for 10 
mins at 70°C. Denatured Klenow was removed by phenol/chloroform  
extraction.
T-vector (pT7Blue) cloning of PCR products
For a standard ligation reaction, 50 ng (0.03 pmole) of pT7Blue T-vector 
(AMS Biotechnology, Oxford, U.K.) was ligated with 10-50 ng of amplified 
PCR product in a volume of 10 |d as recommended by the supplier. Ligation 
reactions were incubated at 16°C for 2-16 h. Normally, PCR product DNA was 
recovered by precipitation using 2 M ammonium acetate and 2 volumes of 
100% ethanol on ice to minimise the precipitation of lower molecular 
weight material such as unincorporated PCR primers.
2.2.11.) Bacterial transformation and colony screening
All bacterial growth media and related solutions were sterilized by 
autoclaving unless otherwise stated.
Preparation of competent bacterial cells
Bacterial cells of E. coli strain DS941 (obtained from Glasgow University 
Department of Genetics) were made competent with rubidium  chloride 
(RbCl) using a method obtained from Glasgow University Department of 
Genetics, originally described by Hanahan, (1983).
Transformation of bacterial strains with plasmid DNA
NovaBlue E. coli competent cells from the T-vector DNA cloning kit (AMS 
Biotechnology, Oxford, U.K.) were transfo rm ed  with T-vector as 
recommended by the supplier.
For E.coli strain DS941, the transformation procedure was similar to that 
described for NovaBlue cells, with the following modifications: 50 j l x I  of
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competent cells were mixed with 2-5 pil ligation mixture. Cells were heat 
shocked for exactly 2-mins at 42°C and transferred to ice for a further 2 
mins prior to the addition of 250 1^ 2x YT medium. Cultures were shaken at 
180-200 rpm in an orbital shaker for 1 h at 37°C prior to plating.
Rapid screening of bacterial transformants
Following transformation of competent bacterial cells, resulting colonies 
were screened for recombinants by one of the following methods:
Blue/white colony screening: following T-vector transformation, bacterial 
cells carrying a disrupted lacZ gene were selected as white colonies 
following staining with X-gal.
PCR (boil) method: colonies to be analysed were retained/duplicated on a 
second independent LB-agar plate (reference plate) containing 50 jig/ml 
ampicillin, by touching the chosen colony with the end of a sterile yellow 
pipette tip and then crossing the surface of the agar on the reference plate. 
Bacterial colony duplicates were grown for 16-18 h at 37°C and stored at 4°C. 
The remainder of the colony was lifted into 1 ml LB medium supplemented 
with 50 ng/ml ampicillin and grown for 6-16 h, with shaking (200 rpm) at 
37°C. 10 |il of bacterial culture was transferred to a 1.5 ml microfuge tube, 
diluted with 90 nl ddH20 and boiled for 10 mins. The bacterial lysate was spun 
at 14,000 rpm, for 5 mins at room temperature to pellet cell debris. The 
resulting supernatant was used directly in PCRs. PCR products were verified 
against a positive control PCR amplified from the original template DNA run 
in parallel
SCOP analysis (S. Rusconi personal communication) was routinely used for 
the rapid initial sizing of potential recombinants which were not pre­
selected by any other means (such as blue/w hite colony screening). 
Typically, 100-200 colonies could easily be analysed in one day by this 
method.
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Bacterial colonies were retained for further reference as described in the 
PCR-boil method. The remainder of each colony was mixed with 20 jul LETR- 
buffer (2 mg lysozyme lOOmM EDTA (pH 8.0), 50 mM Tris-HCl (pH 8.0) and 0.1 
mg/ml RNaseA) in a 1.5 ml microfuge tube and incubated on ice for 15-20 
mins. 2-drops of TE (pH 8.0) equilibrated phenol were then added to each 
incubation. Samples were vortexed briefly and spun at 14,000 rpm, for 5 
mins at room temperature. 10 i^l of the resulting supernatant was mixed with 
agarose gel loading buffer and run on a 1.5% agarose gel against a plasmid 
clone of known size, acting as a size marker. Colonies carrying recombinant 
plasmids of the correct size were identified from the reference plate and 
analysed further (e.g. miniprep, followed by restriction analysis).
Storage of bacterial transformants
All bacterial clones and subclones were stored as recom mended by 
Sambrook et al., (1989).
2.2.12.) Preparation of plasmid DNA
All bacterial plasmids were prepared by the alkaline lysis method described 
by Sambrook et al., 1989.
Minipreparations
These were adjusted to 5 ml to generate enough plasmid DNA (3-5 [ig/ml of 
original culture volume for a high copy num ber plasmid) for rapid 
restriction analysis or sequencing.
Midipreparation (100 ml)
For reasons of speed and expected product purity, plasmid midipreparations 
were also carried out using the QIAGEN midi-prep kit and accompanying 
protocol (QIAGEN). Using the corresponding QIAGEN tip lure recommended 
for this culture volume, plasmid DNA yields of 300-500 g were achieved.
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Maxipreparation (500 ml)
Large scale preparations of plasmid DNA were used in conjunction with a 
subsequent purificaton step (equilibrium centrifugation in cesium chloride 
[CsCl]-ethidium bromide gradients) designed to produce high quality 
supercoiled DNA suitable for transfection of mammalian cells.
The basic protocol for maxipreparation of plasmid DNA was the same as that 
described by Sambrook etal., (1989).
Nucleic acids were recovered at 10-12,000 rpm for 30 mins in a Beckman JC 
M2 centrifuge (JA20 rotor). Supernatants were decanted off and resulting 
pellets washed with 0.5 ml 100% ethanol. Tubes were inverted to drain and 
briefly dry nucleic acid pellets (5-10 mins, room tem perature) before 
dissolving in 3 ml TE buffer (pH 8.0).
Cesium chloride density gradient centrifugation
Cesium gradients were prepared by mixing crude plasmid DNA solutions 
with 2.6-2.8 g of solid CsCl and 100 ^1 of a 10 ng/ml solution of ethidium 
bromide. Filled ultracentrifuge tubes were adjusted to a weight of 5.9-6.0 g 
(to ensure buoyant plasmid bands were retained in the middle of tubes 
following centrifugation) using a solution of CsCl in TE (pH 8.0) [2g/ml]. 
Plasmid DNA was banded at 70,000 rpm for 16 h at 4°C, or at 100,000 rpm for 4 
h at 4°C in an O p t i m a ^ M  t l x  ultracentrifuge (Beckman, U.K.). Banded 
supercoiled DNA was recovered from gradients and ethidium  bromide 
removed as described by Sambrook etal., (1989).
The purified DNA was pooled and concentrated by ethanol precipitation and 
centrifugation at 10-12,000 rpm for 30 mins at 4°C in a Beckman JC M2 
centrifuge. Where yields were sufficiently high (usually for high 
molecular weight, high copy number plasmids), the precipitated DNA could 
be physically transferred to a microfuge tube and pelleted at 14,000 rpm for 
10 mins at room temperature. DNA pellets were washed in 0.5 ml 100% 
ethanol, air dried for about 10 mins and resuspended in 1-2 ml TE (pH 8.0).
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Plasmid DNA prepared in this way was successfully stored at 4°C with no 
compromise to its integrity.
2.2.13.) Dideoxy chain termination sequencing of DNA
The sequencing of double or single stranded DNA was based on the dideoxy 
chain termination method in conjunction with the Sequenase version 2.0 
DNA sequencing kit (United States Biochemicals, Cambridge Bioscience, 
Cambridge, U.K.), or an appropriately modified version.
Sequencing double stranded plasmid DNA
Typically, 18 i^l of plasmid DNA solution (2-10 \ig, depending on the source of 
DNA) were denatured in a 1.5 ml microfuge tube using 2 i^l of denaturation 
buffer (2 M NaOH, 1 mM EDTA) for 5 mins at room temperature. Denatured, 
single stranded DNA was recovered by precipitation with one tenth the 
volume of 3M sodium acetate (pH 5.2) and 3-volumes of 100% ethanol at -80°C 
for 1 h. DNA was then pelleted in a microfuge at 14,000 rpm for 10 mins at 
room tem perature. The pellet was washed with 200 jliI  of 100% ethanol, 
briefly air dried and sequenced as described in the Sequenase version 2 .0 ^ ^  
protocol. Sequenced products were separated on 6% polyacrylamide 8M urea 
sequencing gels. Prior to gel loading, product samples from each 
terminating nucleotide were denatured for 2 mins at 80-85°C and rapidly 
cooled on ice.
Sequencing of PCR products
Using Dynabeads: PCR products were im m obilised onto magnetic 
Dynabeads^ M 280 streptavidin, denatured and sequenced as recommended 
by the supplier. All manipulation and wash steps required a magnetic 
particle concentrator (MPC, Promega) to pellet the magnetic beads.
By direct method: double stranded PCR products were sequenced directly, 
without the need to remove complementary DNA strands, using a Sequenase 
version 2 .QTM kit specifically designed for this purpose (Amersham). Prior
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to sequencing, PCR products (non-purified) were trea ted  with the 
hydrolytic enzymes, Exonuclease I and Shrimp Alkaline Phoshpatase to 
remove unincorporated dNTPs, primers and spurious single stranded 
products. Purified DNA templates were sequenced and electrophoresed as 
recommended by the supplier.
2.2.14.) RNA extraction
Total RNA was extracted using RNAzol B under conditions recommended by 
the supplier. Resulting RNA pellets were washed in 200 1^ of 100% ethanol, 
dried briefly at room temperature and resuspended in a suitable volume of 
ddH20 (DEPC-treated as described by Sambrook et al., 1989), supplemented 
with DEPC-treated EDTA (pH 7.6) to a final concentration of 1 mM. RNA 
samples were adjusted to a final concentration of 1-2 ^ig/ml and stored at 
-80°C in one tenth the volume of DEPC-treated 3M sodium acetate (pH 5.2) 
and 3x the final volume of 100% ethanol.
2.2.15.) Reverse transcription of RNA
Total RNA was reverse transcribed into RNA/cDNA hybrids for RT-PCR by 
combining the following in a 1.5 ml microfuge tube: 0.01 M DTT, 0.2 U, 
RNAsin, 4 mM dNTPs, 5-10 jmg Total RNA, 5-10 pmoles gene specific primer or 
random hexamer primers, 20 U MMLV-RTase and 32.75 jil, ddH20 in a total 
volume of 50 jil. Reaction components were incubated in lx  RT Buffer at 37- 
42°C for 50-70 mins, depending on the length of the required transcript. 
Completed reactions were terminated by phenol/chloroform  extraction and 
stored frozen at -20°C prior to RT-PCR.
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2.2.16.) Tissue culture
Growth and maintenance of tissue culture cells
Both COS-7 and CV-1 cells were grown in DMEM (with 0.11 g/1 Na-pyruvate), 
supplem ented with 1% penicillin-streptomycin solution, 1% L-glutamine 
solution, FCS (10% for COS-7 and 2.5% for CV-1 and HEK293) and NBCS, 2.5% 
(for CV-1 and HEK293). 2s-Fasa cells were grown in Mccoy's 5-A medium and 
EDR3 in a 50 : 50 mixture of Glasgow medium and DMEM. Both were 
supplem ented with 1 % penicillin-streptomycin solution, 1% L-glutamine 
solution and 10% FCS. All cells were grown routinely on 10 cm tissue culture 
dishes at 37°C, in a water-saturated 5% C02 atmosphere.
When passaging cells, medium was aspirated off and the cells rinsed in 5 ml 
of room temperature TBS (0.14 M NaCl, 0.0027 M KC1 and 0.025 M Tris-HCl [pH 
7.4]). The TBS was aspirated off and the cells treated with 2 ml of trypsin- 
EDTA solution. Following aspiration of the trypsin solution cell plates were 
incubated at 37°C for 2-5 mins until cells were dislodged from the plate 
(determined by gentle tapping). 4-8 ml of growth medium was then added 
and adherent cells and cell clumps disaggregated by several passages 
through a pipette (10 ml), whilst forcing the tip against the base of the 
tissue culture dish. Cells were normally replated at a density of 0.25-0.5x10^. 
In routine maintenance, surplus cells were discarded. For bulk cell growth 
for transfection experiments, lifted cells were distributed between further 
tissue culture dishes and the culture volume adjusted to the appropriate 
level (10 ml for a 10 cm dish, 5 ml for a 6 cm dish).
Freezing and resuscitation of tissue culture cells
Cells were frozen to -80°C at an approximate density of 0.1-0.2x10^/ml. Cells 
lifted from tissue culture plates were pelleted for 5 mins at 1000 rpm, 4°C. 
Pelleted cells were resuspended in freezing medium (FCS supplemented with 
10% DMSO), allowed to freeze slowly, overnight (16-18 h) at -80°C and then 
transferred to liquid nitrogen for indefinite long term storage.
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Cells were resussitated by thawing as quickly as possible at 37°C and plating 
in 10 ml of growth medium in a 10 cm culture dish. Cells were normally 
revived completely within 2-3 days.
2.2.17.) Transfection of tissue culture cells with plasmid DNA 
Densitometry of plasmid clones
The DNA concentrations of the GR clones used in all quantitative assays 
(pSTC series) were determined by densitometry. Plasmid DNAs (100 ng of 
each clone) were run on a 1% agarose gel. DNA was visualised using a DNA 
imager (Oncor, Appligene, Durham, U.K.) and the final image saved on a 
Macintosh compatible disc as a TIFF file. The file was then converted to a 
PICT file using the program: Graphic Converter (designed by: Thorsten 
Lemke, Peine, Germany) and scanned densitometrically using the program: 
Scan Analysis 68000 (Biosoft, Cambridge, U.K.). Peak heights (graphically) 
and peak areas (numerically), measured for each DNA band were compared 
for each clone analysed.
T ransient transfection  into COS-7 cells was carried  out using the 
transfection reagent DOTAP as recommended by the supplier. Cells were 
grown for a further 48 h prior to harvest.
For the CaP0 4  coprecipitation method, plasmid DNA of appropriate quantity 
(depending on dish size: 20 ng for a 10 cm dish, 10 ng for a 6 cm dish) was 
prepared as follows: for a 10 cm culture dish, a total of 20 ng of plasmid DNA 
was combined with 70 nl ddH20, 150 nl T.E. (pH 7.6), 250 nl Ca2+ (4x) solution 
(0.5 M CaCl2, 0.05 M HEPES [pH 7.0]) and 500 nl Pi (2x) solution (0.75 mM 
Na2HP04, 0.75 mM NaH2PC>4, 0.05 M HEPES [pH 7.0] and 0.28 M NaCl in ddH20). 
For a 6 cm culture dish, a total of 10 ng of plasmid DNA was combined with 35 
nl ddH20, 75 nl T.E. (pH 7.6), 125 nl Ca2 + (4x) solution and 250 nl Pi (2x) 
solution.
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All components, except 2x Pi solution were mixed and incubated for 5-60 
mins until equilibrated to room temperature. Pi solution was then added and 
reactions incubated for a further 5-15 mins (depending on the age of the Pi 
solution). CaP0 4 -DNA precipitates were added to cells plated at 80-90% 
confluence in DMEM containing 3% FCS. Optimum transfection was achieved 
with CaP0 4 -DNA crystals of a similar size to the nucleoli of the cell nucleus. 
Precipitates were incubated with cells for 12-16 h under standard conditions 
(37°C, 5% C02, ) and removed with x2 washes of TBS. Cells were harvested 
after a further 44-48 h growth in DMEM containing 3% FCS.
2.2.18.) Lac Z staining of tissue culture cells
Cells transfected with clones encoding lac Z (and therefore expressing p- 
galactosidase) were assayed 48 h after the removal of the transfection 
mixture for the presence of functional enzyme as follows: growth medium 
was aspirated off and cells rinsed twice with PBS (1 Sigma PBS tablet per 200 
ml ddH20 [pH 7.4]: 3 ml for a 6 cm dish, 5 ml for a 10 cm dish). Fixation 
solution (2% formaldehyde, 0.2% glutaraldehyde: 10.8 ml 37% formaldehyde 
and 0.8 ml 50% glutaraldehyde in 200 ml PBS) was then added (2 ml for a 6 
cm dish, 4 ml for a 10 cm dish) and cells incubated for 2-5 mins (max.) at 4°C. 
Fixative was removed and cells again rinsed twice with PBS (3 ml for a 6 cm 
dish, 5 ml for a 10 cm dish). Cells were stained in staining solution (37°C, lx 
staining solution [5 mM K3[Fe2(CN)6] and 5 mM K4[Fe3(CN)6] in lx  PBS] 
supplemented with 2 mM MgCl2 and X-gal at 1 mg/ml [dissolved in N,N- 
dimethylformamide]), (2 ml for a 6 cm dish, 4 ml for a 10 cm dish) by 
incubating 2-6 h at 37°C. The staining solution was shaken well before use. 
Once blue colouring was apparent in positive cells, the staining solution was 
replaced with PBS (3 ml for a 6 cm dish, 5 ml for a 10 cm dish) and plates 
stored at 4°C to enhance pigmentation. The fraction of cells expressing p- 
galactosidase were estimated by averaging numbers of blue stained cells per 
10 fields of view (magnification (4/0.1) for three transfection plates per 
clone. Cells were photographed using a Nikon microscope mounted with a 
Nikon FX 35A camera (Nikon, Kingston Upon Thames, Surrey, U.K.).
2.2.19.) p-galactosidase assay
From 6 cm tissue culture plates of CV-1 cells transfected with different GR 
clones, 50 |rg of cell extract (prepared by NP40 lysis as described in section 
2.2.22.) were mixed with 181 nl of 0.1 M sodium phosphate buffer (0.082 M 
Na2 HP0 4 , 0.018 M NaH2 PC>4 [pH 7.5]), 66 jLtl of lx  ONPG solution (4 mg/ml ONPG 
in 0.1 M sodium phosphate buffer [pH 7.5]) and 3 nl of lOOx Mg^+ solution 
(0.1 M MgCl2, 4.5 M 2-mercaptoethanol). Samples were vortexed briefly and 
incubated at 37°C for 30-60 mins until a yellow colour developed. Reactions 
were stopped by adding 500 nl of a 1M Na2 (C0 3 ) solution. Optical densities of 
terminated reactions were measured at 420 nm. Each assay was performed in 
triplicate and an average O.D. reading determined for each GR clone.
2.2.20.) Determination of protein concentrations in cell extracts
Protein concentrations in all tissue culture cell extracts and tissue 
homogenates were determined using the Bio-Rad (Bradford) protein assay 
kit as recommended by the supplier.
2.2.21.) Steroid binding assays 
Using liver cytosol extracts
Rat liver cytosol extracts were prepared from freshly sacrificed animals. 
Livers were perfused via the hepatic portal vein with 20 ml of saline (room 
tem perature) to remove blood. 1-2 g of tissue (on ice) was finely minced 
using a pair of scissors and homogenised in 3-volumes of ice cold molybdate 
extraction buffer (10 m M  Tris-HCl, 1 m M  EDTA, 2 m M  DTT, 50 m M  NaCl, 0.1 M  
Na-molybdate and 10 % glycerol [pH 7 .2 ]). Homogenates were spun at 10-
1 2 ,0 00  rpm for 20 mins at 4°C (Beckman JC M 2 centrifuge) to remove 
cellular and tissue debris, followed by ultracentrifugation at 5 0 ,000  rpm, for 
1 h a t4 °C  (Beckman optim a^M  XLX ultracentrifuge) to pellet microsomes and 
DNA. Protein concentrations were determined by Bradford assay.
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Using sonicated cell extracts
Both cytosolic and nuclear proteins were extracted from  cell lines 
expressing GR (either naturally or from transfected cDNAs). Cells (normally 
30-40x1 C)6) were harvested using trypsin-EDTA, pelleted and resuspended in 
ice cold molybdate buffer, supplemented with 10 mM DTT. Cells were 
sonicated on ice at an amplitude of 6 microns. Cell debris and DNA were 
pelleted by ultracentrifugation at 50,000 rpm, for 1 h at 4°C (Beckman 
o p t i m a " ™  t l x  ultracentrifuge) and protein concentration measured as 
described for liver cytosol.
Receptor steroid binding assays were performed by equilibrating 50 i^g
a liquo ts of cell ex tracts w ith ^ H - d e x a m e t h a s o n e  (L 5 nM final 
concentration) and increasing concentrations of unlabelled dexamethasone 
or corticosterone in ice cold molybdate buffer [final concentrations: 1580 
nM, 500 nM, 158 nM, 50.0 nM, 15.8 nM, 5.0 nM, 1.58 nM, 0.5 nM, 0.158 nM and 
0.05 nM]) and incubating for 24-48 h at 4°C. ^H-dexamethasone binding to 
receptor (GR) was determined by removing unbound steroid ligand using 
100 i^l of an ice cold solution of activated charcoal (5% w/v methanol washed 
activated charcoal [Sigma] and 0.1% w/v Dextran T70 [Pharmacia] in 
molybdate buffer) and spinning at 2,800 rpm for 15 mins at 4°C. 125 \il of 
recovered supernatant was mixed with 250 [il of scintillant (Optiphase 
Supermix: Wallac, Milton Keynes, U.K.) and cpm measured over a 5 minute 
period using a 1450 Microbeta plus liquid scintillation counter (Wallac).
Scatchard analysis
Calculations of dissociation constants (Kd) and receptor binding capacities 
(Bmax, also referred to as Rl) were made from homologous and heterologous 
competition curves (Scatchard analysis) using the curve fitting program, 
LIGAND (Munson and Rodbard, 1980).
Statistics
Raw data obtained from studies of linkage of GR and other genotypes with a 
number of physiological variables in different strains of rat were analysed 
by analysis of variance using Numann-Keul's correction test for multiple
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comparisons. Kd (dex), Kd (B) and R1 values generated from analysis of 
steroid binding by GR were compared by parametric and non-parametric 
statistics where appropriate.
2.2.22.) Immunodetection of membrane-bound proteins 
Dot blot analysis
Protein samples, serially diluted from 100 i^g down to 0.01 jug (i.e., 100, 10, 1, 
0.1 and 0.01 |ig total protein) in a volume of 50 1^ were spotted onto a strip of 
PVDF membrane and dried at room temperature for 30-60 mins. Filters were 
then blocked using a 3% casein solution (3%w/v milk powder, 0.1% Tween- 
20 in PBS]) for 1 h at room temperature. Filters were probed using specific 
monoclonal antibody (section 2.1.15.) at various concentrations. Specific 
primary antibody binding was detected using the ECL immunodetection kit.
Western blotting
For large num bers of sam ples (10-15), SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) and blotting was carried out using a 15x20 cm 
midigel system (separation using a vertical midi electrophoresis tank 
[GIBCO-BRL], and blotting using a PROTEAN II xi electroblotting system [BIO­
RAD]). For the rapid turnover of smaller num bers of samples (rapid 
analysis), a minigel system, comprised of a vertical minigel tank (Sigma) 
and the Mini PROTEAN II electroblotting system (BIO-RAD) was used. 
Samples were generally run on 8% gels alongside high molecular weight 
protein markers.
Sample preparation by NP40 lysis
Soluble proteins (from cytosol and nucleus) were recovered from tissue 
culture cells by NP40 lysis. Harvested cells were pelleted in 1.5 ml microfuge 
tubes (15 s, 14,000 rpm) washed in 1 ml ice cold PBS (pH 7.4), repelleted (15 s 
at 14,000 rpm) and lysed in 40-50 jliI NP40 lysis buffer (10 mM HEPES [pH 7.9], 
1.5 mM MgCl2, 50 mM KC1, 0.5 mM DTT and 0.1-0.5% NP40) for 15 mins at 4°C. 
Cell debris and cell nuclei were pelleted at 14, 000 rpm for 15-20 mins at 4°C.
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Nuclear proteins were extracted using TGEN-50. Nuclei from lysed cells were 
washed twice in ice cold PBS (pH 7.4) and resuspended in an estimated 4- 
times the volume of TGEN-50 (10 mM Tris-HCl [pH 8.0], 10% glycerol, 1 mM 
EDTA, 50 mM NaCl and 0.5 % NP-40). Nuclei were lysed at 4°C for 15 mins. 
Nuclear debris was removed at 14,000 rpm for 5 mins at 4°C. Protein 
concentrations were determined by Bradford assay.
Whole cell preparations (-lx lO ^-lx lO ^ /lo ad in g ) were analysed for GR 
expression by pelleting at 14,000 rpm for 15 s at room temperature, washing 
in 1 ml of ice cold PBS (pH 7.4), repelleting (14,000 rpm for 15 s) and lysing 
in 20 |il of gel loading buffer. Samples were denatured at 95-100°C for 5- 
mins, cooled to room temperature and DNA and cell debris spun out for 3-5 
min at 13,000 rpm and the supernatant loaded onto the gel.
SDS gel preparation, sample loading and electrophoresis
SDS-polyacrylamide gels were prepared as follows: for minigels, 14.8 ml of 
8% resolving gel solution (8% acrylamide solution, 0.375 M Tris-HCl [pH 8.8]) 
was polymerised using 50 jliI 10% APS and 25 jal TEMED. The gel solution was 
overlaid with 100% ethanol (about 1.5 cm depth) to encourage a flat 
polymerised gel surface.
The resolving gel was overlaid with 4.9 ml of 6.5% stacking gel solution 
(6.5% acrylamide solution, 0.15 M Tris-HCl [pH 6.8]), polymerised using 30 1^ 
10% APS and 15 p.1 TEMED. Midigels (15x20 cm) were prepared in much the 
same way, except the resolving gel (50 ml) was polymerised using 100 nl 10% 
APS and 50 n-1 TEMED, and the stacking gel (30 ml) was polymerised using 50 
1^ 10% APS and 30 pi TEMED.
Prior to gel loading, protein samples (10-20 i^g of liver cytosol extract or 20- 
30 [ig of tissue culture cell extract: each at 5-10 yl final volume) were mixed 
with twice their volume (10-20 jliI) of lx  SDS-gel loading buffer (0.0625 M 
Tris HC1 [pH 6.8], 0.5% w/v SDS, 0.7 M 2-Mercaptoethanol, 10% glycerol and 
0.001% w/v bromophenol blue), heated at 95-100°C for 5-mins to denature, 
cooled to room temperature and loaded onto a gel pre-run at 100 v, 20 mA
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(for about 30 mins). Both midi and mini gels were run at 100 v, 20 mA in lx 
Tris-glycine eletcrophoresis buffer (0.1 % w/v SDS, 0.025 M Tris-HCl and 
0.19 M glycine [pH 8.3]) until the bromophenol dye front was about half way 
down the gel. The voltage was then adjusted to 150 v and finally, to 200 v 
until the dye front had run off the bottom of the gel.
Electroblotting of proteins onto solid supports
Proteins separated on SDS-polyacrylamide gels were transferred onto PVDF 
membrane prior to probing with antibody. PVDF membrane cut to the exact 
dimensions of the gel was 'activated' by soaking in 100% methanol for one 
minute exactly and washing twice in ddH20 for 2 mins each. 'Activated' 
membrane was further soaked in lx  Tris-glycine electrophoretic transfer 
buffer (2.5 mM Tris-HCl, 19.2 mM glycine, 2% methanol [pH 8.3]) for a 
minimum of 10 mins along with x4 pieces of Whatman 3 mm blotting paper 
cut to the same dimensions as the gel sandwiching pads (part of the 
electroblotting apparatus, used to promote a tight contact between gel and 
membrane). Soaked PVDF membrane was placed on top of the gel and good 
contact between gel and membrane and exclusion of any bubbles achieved 
by gently rolling accross the surface of the overlaid membrane using a 
glass pipette. Gel plus membrane was sandwiched on either side with two 
pieces of the pre-soaked Whatman 3 mm blotting paper and one gel 
sandwiching pad, whilst submerged in transfer buffer. The entire gel 
sandwich was assembled in the blotting tank inside a transfer casette and 
submerged in lx  transfer buffer. Proteins were transferred from negative 
to positive at a constant current of 250 mA for 1 h-40 mins (mini gel), or 3-4 
h (midi gel) for efficient GR transfer, in ice cold conditions to prevent 
excessive heating.
ECL detection of proteins bound to solid supports
Membrane bound proteins were detected using the ECL immunodetection kit. 
Blotted membranes were blocked for 1 h in 3% casein blocking solution and 
probed with specific primary monoclonal antibody (10 jrl for a midi-sized 
membrane [1:500 dilution] and 5 (il for a mini-sized membrane [1:750 
dilution]) in a 5 ml volume of PBS-Tween. Incubation with secondary
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antibody and detection of specific membrane-bound proteins was carried 
out exactly as described in the ECL immunodetection protocol.
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Chapter 3 
Results 1
85
Codon variation in the glucocorticoid receptor in inbred 
strains of rat
3.1.) Introduction
A num ber of studies in man and rat have indicated that abnormal 
adrenocortical hormone activity may contribute to the development of 
hypertension and obesity. In this chapter, the possible involvement of 
altered GR function has been considered in several inbred rat strains. The 
phenotypic evidence that glucocorticoid hormone action is affected in rats 
with a genetic predisposition to developing hypertension and obesity is 
reviewed.
Under normal physiological conditions, the circulating levels and eventual 
activity of glucocorticoids fall under the regulatory control of GR. In 
conditions of natural glucocorticoid excess, the release of corticosteroids 
from the adrenal and transcription of the GR gene itself are feedback 
inhibited by GR (Fraser, 1992). With abnormal GR function (typically the 
resu lt of a m utated receptor protein) the feedback inhibition of 
corticosteroid release and GR down-regulation (which normally occurs in 
conditions of glucocorticoid excess) is compromised. This inability to 
feedback inhibit pituitary ACTH secretion results in an increase in the 
synthesis of glucocorticoid and mineralocorticoid hormones, which may 
affect corticosteroid related phenotypes such as blood pressure (Mantero et 
al., 1983; Bianchi e ta l., 1984; Fraser eta l., 1994). Abnormal glucocorticoid 
activity has also been proposed to play a role in the expression of obesity in 
Zucker rats. A detailed overview of the phenotypes of rat strains SHR and 
Zucker obese is given chapter 1 (MHS in chapter 5) and will only be 
considered fu rther in this chapter in the context of steroid binding 
affinity.
It has previously been shown (Kenyon et al., 1994; Panarelli et al., 1995) 
that the glucocorticoid receptor (GR) from MHS and SHR strains of rat show 
significant differences in their affinities for steroids (cortisol, aldosterone
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and dexamethasone and the glucocorticoid antagonist, RU486) compared 
with their normotensive controls (MNS and WKY, respectively). For the 
MHS/MNS model, the hypertensive strain MHS revealed consistently lower 
affinities for these steroids, producing higher Kd values. Measurements of 
rec ep to r-s te ro id  b inding  in liver cytosol ex tracts from  non- 
adrenalectomised animals produced Kd values 1.39, 2.19, 2.06 and 4.12-fold 
g reater for dexam ethasone, corticosterone, RU486 and aldosterone 
respectively, in MHS than in MNS. For SHR and WKY strains, GR steroid 
binding characteristics were essentially reversed, the hypertensive strain 
(SHR) having generally higher affinities for natural steroids: 1.16 and 
1.37-fold lower Kd values for corticosterone and aldosterone respectively 
than in WKY. Affinities for dexamethasone were not significantly different 
between strains. Similar studies in Zucker rats has yielded receptor 
affinities for corticosterone 100-fold lower in obese compared with lean 
rats, reduced to a difference of 2-3-fold following adrenalectomy (White 
and Martin, 1990; C. Kenyon, unpublished observations).
The total numbers of hepatic receptors between MHS and MNS and SHR and 
WKY rats were comparable under the chosen assay conditions and for the 
Milan strains, this was consistent with the observations made by Stewart et 
al., (1993), in which levels of GR mRNA from liver and kidney were not 
found to be significantly different between these strains. For Zucker rats, 
the obese strain showed a 40-50 % reduction in the num ber of hepatic 
receptors which was normalised following adrenalectom y (White and 
Martin, 1990; C. Kenyon, unpublished results). Although changes in 
glucocorticoid activity can result from regulatory gene mutations which 
may alter the turnover of GR transcripts or from post translational 
modifications affecting the level of functional protein, taken together, the 
findings described above for the rat models of hypertension were more 
suggestive of abnormalities resulting from changes in the primary GR 
sequence. It was therefore logical to consider a search for mutations in the 
structural genes for GR, since these are frequently associated with changes 
in affinity for ligand (Brown etal., 1990; Hurley etal., 1991; McPhaul etal., 
1991). The potential relationship between any gene and disease phenotype 
must also take into account the possibility of mutations elsewhere, other
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than  in the candidate gene itself, but in close linkage on the same 
chromosome arm. There is always the possibility that unknown mutations 
within the same locus of DNA are responsible for the observed disease 
phenotype.
The question of functional differences of GR can be addressed using 
different but com plem entary methods. Primary sequence information 
would allow for identification of sequence changes which might explain 
diffences in receptor function. Primary sequence data would also be useful 
in providing genetic markers for use in linkage studies.
The aims of this section of work were therefore focused in three main 
areas.
1.) To define a specific genetic marker for the rat glucocorticoid receptor 
locus (Grl). Such markers form the basis of rat breeding experiments in 
which genetic linkage with one or more physiological variables of the 
disease phenotype is sought (discussed fu rther in chapter 5). The 
requirem ent for a genetic marker for the rat Grl was aided by the prior 
knowledge of a polyglutamine encoding triplet (CAG)n repeat sequence 
(microsatellite) in the 5'-end of the GR coding sequence (identified from 
the cDNA sequence: Miesfeld et al., 1986). Trinucleotide repeat 
polymorphisms could themselves be considered as potential sources of 
differential GR function, either at the steroid binding or gene regulatory 
levels and were thus exploited early on in linkage studies.
2.) To determine whether there was variation between pairs of rat strains 
(MHS and MNS, SHR and WKY, Zucker lean and obese) in the codons for GR 
which may have provided an explanation for the observed differences in 
steroid binding affinity.
3.) To carry out a detailed analysis of the GR triplet (CAG)n repeat sequence 
from a large num ber of inbred rat strains. This was done to provide 
information on the extent of heterogeneity in the GR polyglutamine tract 
in inbred rats, which would be potentially  useful when choosing
appropriate rat strains for breeding, or GR alleles for experiments focusing 
on GR function.
Part 1
3.2.) Methods for resolving rat Grl triplet (CAG)n repeat 
polymorphisms
From nucleotide position n223 in exon 2, the rat GR contains a series of 
glutamine residues encoded by a CAG trinucleotide repeat. Because of the 
inherent polymorphic nature of simple sequence repeats, this region was 
chosen as the starting point in the search for a genetic marker of the rat 
glucocorticoid receptor locus for use in linkage studies (see chapter 5). A 
num ber of potential methods were available for resolving triplet (CAG)n 
repeats, only two of which (high percentage agarose gel electrophoresis 
and sequencing) were well established. A preliminary assessment of each 
method was made to find the one most suitable for routine typing of the rat 
GR. All methods were based on PCR, so an initial verification that amplified 
sequences were of rat GR origin was required.
3.2.1.) PCR amplification of rat Grl triplet repeats, Southern 
blotting and probing with a rat GR cDNA fragment
The rat GR polyglutamine tract was amplified from SHR (Spontaneously 
Hypertensive Rat) strain liver DNA. Reactions were performed in a 50 1^ 
volume using rGR gene specific PCR primers, pA and pG (Appendix 1) and 
1.5 mM Mg2 + . Primer annealing temperature was optimised at 60°C. For 
general PCR strategy see section 2.2.3. PCR products (395 bp) were resolved 
on a 1.5% agarose gel. Different DNA concentrations (50-500 ng) and cycle 
numbers (30-35 cycles) were used to help maximise the probability of PCR 
amplification (Fig. 3.1a.).
For verification of the specificity of primer annealing, amplified products 
were transferred  onto nylon membrane (Hybond-N+) using Southern
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Fig. 3.1. Rat Grl poiygiutam ine tract am plified from  strain SHR, using PCR prim ers pA and 
pG.
a.) PCR w as carried out for 30-cycles (lanes 2 and 3), or 35-cycles (lanes 6 and 7): from  50 ng 
(lanes 2 and 6) and 500 ng (lanes 3 and 7) tem plate  DNA. Lanes 4 and 8: negative (no DNA) 
contro ls . Lanes 1 and 5: 1 Kb DNA ladder.
b.) P reparation of 704 bp cDNA probe from  rat rGR clone pRBal117. A large scale Xba\/Bgl\\ 
digest (5 |ig ) of clone pRBal117 was band separated on a 1% agarose gel (lanes 2 and 3). The 704 
bp band w as excised and ^P -la b e lle d  using random  oligonucleotide prim ers. Lane 1:1 kb ladder.
c.) Southern blot of rat (SHR) am plified  Grl polyglutam ine tract. The hybrid ised filte r was probed 
using the  32P-label!ed 704 bp Xba\/Bgl\\ fragm ent of clone pRBal117. S pecific  bands of the 
expected  size (395 bp) were identified in lanes 2, 3, 6 and 7.
blotting methods as described in section 2.2.8. Blotted DNA fragments were 
probed using a 704 bp ^ 2p-ia.belleci (section 2.2.7.) cDNA fragment (Fig. 
3.1b.) spanning the extreme 5'-end of the ra t  GR coding sequence, 
including the triplet (CAG)n repeat. The probe was generated by Xbal/BgM  
digestion (section 2.2.6.) of rat GR cDNA clone pRBalll7  (Fig. 3.2.). The 
hybridised filter revealed single PCR product bands of the expected size 
(395 bp) and intensity, with respect to the number of PCR cycles (Fig. 3.1c.).
Hindlll 7 
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Sail 22 
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Nhel 5591 
Nael 5560 
Sphl 5401
Hindi 24 
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Hindlll 994
Hindlll 1269 
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EcoRI 2228 
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d ii once  i Xbal 2679Pvull 3066 V \ ^ n noo/i . BamHI 2834
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! Sad 2850  
Aval 2839 
EcoRI 2886
Fig. 3.2. Restriction map of rat GR cDNA clone, pRBal117 (M iesfeld et al., 1986). The
clone pR B all 17 is a 5.8 kb plasmid based on the bacterial c lon ing vector: pSP64 (Promega, 
U.K.). The entire rGR coding sequence, 360 nucleotides of the 3' UT and 24 nucleotides of 
the 5‘ UT are cloned into the Bam HI site of the vector polylinker in sense orientation.
3.2.2.) Analysis of Grl triplet (CAG)n repeats in ra t strains: SHR, 
WKY, MHS, MNS and SD, using high percentage agarose 
gels
Having dem onstra ted  the specificity (stringency) of annealing of PCR 
primers pA and pG in SHR, further analysis of GR polyglutamine tracts was
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carried out. Genomic DNA, prepared from the livers of parental rats of 
strains: SHR, WKY, MHS, MNS and Sprague Dawley (SD) was PCR amplified 
using primers pA and pG under exactly the same conditions as described in 
section 3.1.1. PCR products (5 jil sample volumes) were resolved on a 3% 
agarose gel, run at 150 v/100 mA, in 0.5 x TAE buffer (1 x in gel) to improve 
resolution.
3.2.3.) T-vector cloning and sequencing of amplified Grl triplet 
(CAG)n repeats from: SHR, WKY, MHS, MNS and SHR-SP
The T-vector, pT7Blue (AMS Biotechnology, U.K., Ltd.) is a 2887 bp cloning 
vector, specifically manipulated for cloning PCR products. The vector is 
linearised through an EcoRV site within the polylinker, part of the lac Z 
gene which encodes the a-subunit of p-galactosidase. The 5' T-overhang 
which is generated by this cleavage is ideally suited for the ligation of PCR 
products, which are normally terminated with 31 A-nucleotides by most of 
the commonly used thermostable DNA polymerases (e.g. Taq polymerase).
The T-vector cloning system relies on Lac-Z inactivation. Insertion of a 
cloned DNA fragment within the £coRV-cut Lac-Z region disrupts the open 
reading frame (ORF). Because the vector no longer encodes a functional p- 
galactosidase a-peptide (which norm ally com plem ents the LacZ co- 
fragment, expressed by the bacterial host-strain) the enzymic conversion 
of the chromogenic substrate X-gal to 5-bromo-4-chloro-3-indolyl and 
galactose, is prevented.
GR microsatellites from SHR, WKY, MHS, MNS and SHR-SP, amplified using 
PCR primers pA and pG, were cloned from single PCR reactions into the T- 
vector as described in (section 2.2.10.). Following 16-20 h ligation (16°C) 
and competent Novablue-E.coli transformation, (section 2.2.11.), cultured 
bacterial plates supplemented with ampicillin (50 ng/ml), tetracycline (20 
Hg/ml) X-gal (1.75 ng) and IPTG (0.08 mM), were subjected to blue/white 
colony selection. A number of white colonies were selected, representatives
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of each rat strain and preserved as 'potentially positive' recombinants by 
streaking onto LB-ampicillin agar plates. Colony streaks were grown for 
16-20 h (37°C) and stored at 4°C prior to further analysis.
Selected white colonies (Table 3.1.) carrying either full length pA/pG 
generated PCR product inserts or some other product of the PCR reaction, 
were further grown in 1 ml LB-ampicillin liquid cultures (see section 
2.2.11.). Each was analysed for the presence of the correctly sized insert 
(395 bp) by a second round of PCR amplification (in a consistent 50 jliI  
reaction volume), using the same primers as those used in the initial PCR 
(pA and pG). Diluted samples (1/10) were boiled for 5 min and 1 nl aliquots 
used directly in PCR (see section 2.2.11.). Amplified products were run on 
1.5% agarose gels against the 1 kb ladder. PCR reactions for each 
transform ation (per rat strain) included a no-culture negative control to 
monitor for cross contamination. These were usually found to be negative, 
but when contamination was identified, all PCR solutions were discarded 
and replaced. Clones producing a signal of the correct size (395 bp) were 
retained by streaking onto LB-ampicillin plates and storing at 4°C for 
further analysis by sequencing. Clones carrying full length inserts were 
innoculated into 100 ml LB-ampicillin medium (midiculture) and grown 16- 
20 h (37°C), with shaking. Bacterial plasmids were recovered according to 
the Qiagen midiprep protocol (see section 2.2.12.). Clone DNA was analysed 
on 1% agarose gels for quality (absence of nicking) and efficiency of 
removal of RNA. O.D.260 was measured at a 1/100 dilution and plasmid 
concentrations adjusted to 1 in T.E. (pH 8.0). Normally 4-6 ng of
plasm id tem plate DNA was re-precipitated  and denatured  prior to 
sequencing by the methods of Sanger from the reverse PCR primer, pG 
which doubled as a convenient sequencing primer. Three to four positive 
clones were sequenced per rat strain (see method for plasmid sequencing, 
section 2.2.13.).
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3.2.4.) Typing Grl triplet repeat lengths in a wider variety of 
rat strains using a 32p_based PCR approach
Due to the problems encountered in generating reliable sequence data 
from T-vector cloned GR poly glutamine tract (discussed in section 3.3.1b. of 
this chapter), a different typing strategy was adopted. This new approach 
combined directly the speed and efficiency of PCR with the high resolving 
powers of polyacrylamide gel electrophoresis, coupled to the added 
sensitivity of autoradiographic detection. Higher resolution was achieved 
by reducing the average size of PCR products, from 395 bp down to a range 
of about 100-120 bp. This required the design of a new set of universal PCR 
primers, flanking the poyglutamine tract as closely as possible. The new 
primers were designated: p9 (forward) and p l9  (reverse) (their positioning 
in the GR coding sequence is listed in Appendix 1). The incorporation of 
radioactivity into PCR products was achieved by end-labelling p9 using 
[y32p]-ATP as described in section 2.2.7.
Pilot typing experiments were carried out on parental rats from a small 
num ber of selected strains: SHR, WKY, MHS, MNS, WKYGia, SHR-SPoia  
(Glasgow strains) and Lyon strains: LL (low), LN (normal) and LH (high) 
blood pressure). Glucocorticoid receptor poyglutam ine tracts were 
amplified in 25 jliI  reaction volumes by combining 5-10 pmoles each of PCR 
primers: p9 (32p_iabelled) and p l9 , with 50-100 ng genomic D N A and 2 mM 
Mg2+ and PCR cycling for 30-cycles under the general conditions described 
in materials and methods (section 2.2.3.). Primer annealing temperature 
was 6 0 °C .
A further 61 inbred strains together with 29 of their substrains (Table 3.3.) 
(obtained from Prof. B. van Zutphen, University of U trecht, The 
Netherlands, [see section 2.1.3.]) were typed using an optimised 32phased  
PCR protocol. PCRs were optimised by reducing the concentration of DNA 
and Mg2+ used in each reaction down to about 20 ng/pl and 1.5 mM 
respectively. The labelled PCR primer (p9) was also prepared at a 3x higher 
specific activity, so that the quantity of prim er mixture added to each
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reaction was reduced making interference of PCR by labelling reaction 
components less likely.  ^2 p-iabelled PCR products were resolved on 6% 
polyacry lam ide , 8 M urea  gels and  respective  bands identified  
autoradiographically (section 2.2.4.).
3.2.5.) Development of a suitable marker for 32p_based 
microsatellite typing
A series of T-vector clones (Table 3.2.) containing rat GR polyglutamine 
tracts of known length and sequence (see section 3.2.1b. and Fig. 3.6.), were 
used as DNA markers to calibrate the sizes of PCR products of unknown 
length.
1 2 3 4 5
21-CAG 
20-CAG 
19-CAG 
18-CAG
Fig. 3.3. M icrosatellite markers.
3 2 P-PCR am plifications were performed from T-vector cloned rat GR polyglutam ine 
tracts. C lones: T3/3 C3, T1/2 C2, T3/2 C5 and T4/1 C14 (Table.3.3.) were amplified 
using PCR primers p9 (labelled with y-32P) and p19 (Appendix 1). PCR products of:
18, 19, 20 and 21 CAG-repeats were resolved either separately (lanes 1-4), or from a 
pooled m ixture of these PCR products, producing a banding ladder (lane 5) on a 
standard 6% polyacrylam ide 8M urea gel. Numbers on the right represent the length 
in (CAG)n repeats of the individual marker bands.
PCR products generated from these T-vector clones: T3/3 C3 (18-CAG), T l/2  
C2 (19-CAG), T3/2 C5 (20-CAG) and T4/1 C14 (21-CAG repeats), also amplified 
using p9 [3-P] and p l9 , were pooled to produce a composite DNA ladder with 
a resolution down to at least one codon spacing between bands (see Fig.
3.3.). The method used for determination of triplet (CAG)n repeat length is 
described in section 3.3.1b.
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3.2.6.) Resolving rat GR polyglutamine tract polymorphisms 
using 4% m etaphor gels
In addition to the high sensitivity and resolving powers of 3 2p gel typing 
systems described in section 3.2.4, consideration was also given to overall 
speed and efficiency and the possibility of minimising, or even avoiding 
the use of  ^2 p jn t^ e routine typing of rat GR polyglutamine tracts. 
Methodology for resolving microsatellite polymorphisms in simple or 
multiplex PCR systems using 4% metaphor agarose gels has been developed 
(Shiels e t a l ,  1995). Amplified polyglutamine tracts from strains: MHS (21- 
CAG repeats), MNS (20-CAG repeats), SHR (19-CAG repeats), a rat GR clone 
(18-CAG repeats; see chapter 6 for details) and BC (7-CAG repeats), were 
resolved on gels run in 0.5 x TAE (1 x in gel) and kept as cold as possible.
3.3.) Results
3.3.1.) Typing rat GR triplet (CAG)n repeat lengths by different 
methods (3.3.1a.-3.3.1d.)
3.3.1a.) Using high percentage agarose
1 2 3 4 5 6 7
Fig. 3.4. A search for genetic variation in rat GR polyglutam ine tracts. Polyglutam ine 
tracts were amplified from the GR of parental rats of strains: SHR (lane 2) W KY (lane 3) MHS 
(lane 4) MNS (lane 5) and SD (lane 6) using PCR primers, pA and pG. PCR products (395 
bp) were resolved on a 3% agarose gel. Lane 1: 1 kb DNA ladder. Lane 7: No DNA negative 
control.
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Only minor differences in the m igrational properties of pA and pG 
amplified GR polyglutamine tracts from rat strains: SHR, WKY, MHS, MNS 
and SD were identified using 3% agarose (Fig. 3.4.), indicating the need for 
a more sophisticated approach for typing rat GR alleles.
3.3.1b.) T-vector cloning and sequencing
Table 3.1. lists the number of blue and white colonies obtained following 
the transformation of NovaBlue E.coli with T-vectors ligated with pA/pG- 
generated PCR products from each of the rat strains. All clones, sequenced 
as described in section 3.2.3, contained PCR product inserts of rat GR origin 
(determ ined by the positive identification of flanking sequences). To 
conform to a previous report (Gearing et al., 1993), repeat lengths were 
calculated as the total number of CAG codons in respective polyglutamine 
tracts, interrupted by one alanine codon at the 5'-end. For the remainder of 
this thesis, CAG-repeat alleles will be referred to, where appropriate, in the 
following way: GrlGAGX, where X refers to the length of the (CAG)n repeat. 
As an example, Figure 3.5. below details the rGR 7-repeat allele, GrlGAG7-
Ser Thr Ser Asn Val Gin Gin Arg Gin Gin Gin Gin Gin Pro Gly Leu Ser Lys 
5' >TCC ACA AGC AAT GTG CAG CAG CGA CAG CAG CAG CAG CAG CCA GGC TTA TCC AAA< 3'
Fig. 3.5. The coding sequence of the 7-repeat rGR polyglutamine microsatellite 
(GrlCAG7).
The sense DNA strand nucleotide sequence of the CAG repeat (underlined), plus five 
flanking codons either side is shown. The respective amino acid sequence is given above in 
the three letter code.
Figure 3.6. and Table 3.2. show examples of the rat GR poly glutamine tract 
sequences identified, together with evidence of minor length variabilities. 
Sequences presented are of the antisense DNA strand. Glutamine polymers 
are therefore expressed as GTC-repeats [5'->3', see Fig. 3.6.] and not the 
conventional CAG-repeats, obtained  from the sense DNA strand. 
Unexpectedly, variation was identified, not only between different rat 
strains, but also between clones isolated from PCRs from the same strain. 
The assignment of a single polyglutamine tract length to a given rat strain 
glucocorticoid receptor was therefore unreliable.
Rat strain
m icr o sa te llite
c lo n ed
T ransform ation
Set
No. of colonies selected
(pool of 3 xlOcm plates) 
BLUE WHITE
SHR Tl/2 2 6
WKY T3/2 10 8
T4/3 5 12
MHS T4/2 15 24
MNS T4/1 8 24
SHR-SP T3/3 4 5
T4/4 14 12
T-vector positive 10 63
control insert
Table. 3.1. Blue/white colony selection following ligation of PCR amplified rat GR 
polyglutamine tracts into the T-vector.
Ligated vectors were used to transform competent Novablue E.coli. (AMS Biotechnology, 
U.K., Ltd.). Each transformation set was derived from a single PCR reaction from respective 
rat strain genomic DNAs. The numbers of blue and white colonies for each set were the 
proceeds from three 10 cm bacterial plates. Ligation efficiency was monitored using the T- 
vector kit (AMS Biotechnology, U.K., Ltd.) positive control insert.
These inconsistencies were considered to be caused by mutations arising 
during the PCR reaction, or during the growth of clones in E. coli prior to 
sequencing. The m ajority of m utations could be explained by the 
phenomenon of 'slippage' (Strand etal., 1993; Tautz and Schlotterer, 1994) a 
process in which a replicated DNA strand in the region of a polymeric tract 
of repeat sequence is aligned out of register with the template strand 
during DNA synthesis. This is an unavoidable process which can occur in 
v itro  or in vivo. In each set of transform ations, contamination was 
considered an unlikely explanation because of the implementation of a 
reliable negative control.
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A second observation from the sequencing of T-vector clones was the low 
frequency of polyglutamine tracts interrupted by a single point mutation 
(T -> C transitions, converting Gln90->Arg90), (Table 3.2., clones: T4/2 C2, 
T4/4 C3 and Fig. 3.6., sequence E).
Clone CAG repeat 
number
Rat strain 
(PCR template)
A Tl/2  Cl 20 SHR
C2 19 SHR
B T3/2 C5 20 WKY
C7 19 WKY
C15 19 WKY
C T3/3 C3 18 SHR-SP
D T4/1 C14 21 MNS
C18 21 MNS
C19 21 MNS
E T4/2 Cl 16 MHS
C2 5-CCG-14 MHS
C ll Nonsense MHS
C14 19 MHS
F T4/3 C2 20 WKY
C6 20 WKY
G T4/4 C3 5-CCG-14 SHR-SP
C5 18 SHR-SP
C7 19 SHR-SP
Table. 3.2. Variation in the number and composition of CAG repeats in the rat 
glucocorticoid receptor polyglutamine tract cloned into the T-vector (Cambridge 
Bioscience, U.K.).
Each of the letters A-G , represents a set of T-vector clones derived from one PCR  
amplification of a single rat genomic template.
The low frequency and sporadic occurrence of these mutations implied that 
they were artefacts incorporated during PCR and were analysed no further.
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GCC
Fig. 3.6. Sequencing of rat GR polyg lutam ine tracts from  T -vector clones.
Sequencing was carried out using the antisense primer: pG (Appendix 1). Sequences: 
A (C, T3/3 C3), B (A, T1/2 C2), C (B, T3/2 C5) and D (D T4/1 C14) (Tab le .3.3.) 
dem onstra te  va ria b ility  in p o lyg lu tam ine  trac t length . Po lym er lengths were 
determ ined by counting the numbers of GTC codons (including the single GCT) in the 
antisense DNA strand from top (green arrow) to bottom  (red arrow). Sequence E 
shows a probable PCR artifact in which a T->C transitional point mutation (nucleotides 
relative to antisense DNA strand: letters underlined) converts Glngo (GTC- antisense) 
of the polyglutam ine tract to Arggo (GCC-antisense). Letters above sequence lanes 
represent term inating nucleotides. In each case the antisense DNA strand is shown 
(5 ’ -> 3 ’, top to bottom). GR sequences flanking polyglutam ine tracts confirm s the 
stringency of PCR-primer annealing.
3.3 .1c . )  Typing  o f  Gr l  tr ip let  ( C A G ) n re peat  p o l y m o r p h i s m s  in the rat  m ode ls  
o f  essent ial  hypertens ion:  a.) M H S / M N S  an d  S H R / W K Y  an d  h.) SHR-  
S P c i a / W K Y c i a  anc  ^ Lyon s trains by ^ 2 P - P C R
a.)  In M H S / M N S  a n d  S H R / W K Y
T h e  m ig ra t i o n  o f  PC R  p r o d u c ts ,  i n d e p e n d e n t l y  a m p l i f i e d  f rom the D N A  of  
severa l  parental  rats o f  s t ra ins  M H S  (n=5) ,  M N S  (n=6) ,  S H R  (n=3 )  and W K Y  
(n = 3 ) ,  were  c o m p a r e d  on 6%  p o ly a c r y l a m i d e  gels.  A size d i f f e r enc e  of  3 bp 
was  ide n t i f ie d  b e tw e e n  M H S  and  M N S  and  S H R  and  W K Y .  T h e s e  resu lt s
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PCR
product
size (bp)
2 3 4 5 7 8 9 10 11 12 13
; V . § § r
21-CAG ■ 
20-CAG « 
19-CAG ■ 
18-CAG ■
b.) 1 2 3 4 5 6 7 8 PCR product 
size (bp)
21-CAG ■ 116 
20-CAG " 1 1 3  
19-CAG - 1 1 0  
18-CAG ■ 107
Fig. 3.7. Typing gel show ing polym orphism  of the GR polyglutam ine tract 
between rat strains: MHS, MNS and SHR, WKY.
a.) MHS and MNS. Lanes 2, 4, 7, 9, 10 and 12: MNS (21-CAG repeats). Lanes 3, 5, 8 
and 11: MHS (20 CAG-repeats). Lane 13: Sprague Dawly (20-CAG repeats). Lanes 
1, 6 and 14: Pooled m icrosatellite markers.
b.) Between strains SHR and WKY. Lanes 2-4: WKY (20-CAG repeats). Lanes 5-7: 
SHR (19-CAG repeats). Lanes 1 and 8: m icrosatellite markers.
116
113
110
107
PCR
product
size (bp)
PCR
product
b.) 1 2 3 4 5 6 7 8 Slze
Fig. 3.8. T yp in g  gels show ing an absence of p o lym orph ism  of the GR 
polyglutam ine tract between strains: SH R -SPcia and W KYoia and LL, LN , and 
LH
a.) SHR-SPoia and WKYcia (Glasgow strains). Lanes 2-4: WKY; A1641, A1661 and A
1662 (19-CAG repeats). Lanes 5-7: SHR-SP; C2128, C2129 and C 2134 (19-CAG 
repeats). Lanes 1 and 8: m icrosatellite markers.
b.) Lyon strains: LL (low) LN (normal) and LH (high) blood pressure. Lanes 2 and 3: 
LL. Lanes 4 and 5, LN. Lanes 6 and 7, LH (all 21-CAG repeats). Lanes 1 and 8: 
m icrosatellite markers.
suggested a polyglutamine tract which was shorter by one codon in MHS 
and SHR compared with their normotensive controls: MNS 21, MHS 20 and 
WKY 20, SHR 19-CAG repeats (Fig. 3.7a and b, respectively). PCR products 
from individuals of the strains MHS and MNS were loaded onto the gel in an 
alternate pattern to demonstrate the reproducibility of the polymorphism 
between PCR product bands (and hence, polyglutamine tracts. Fig. 3.7a.). 
Differences in the length of polyglutamine tracts (in codons) was 
determined by comparing the migrational distance of sample PCR products 
with that of reference bands of the size marker (Fig. 3.7a: lanes 1, 6 and 14 
and 3.7b: lanes 1 and 8) (refer also to section 3.2.5.). Because no examples of 
T-vector clones were found with changes in the arrangem ent of 
nucleotides in flanking sequences, any differences in the size of PCR 
products m ust have been a ttribu tab le  solely to m utations in the 
polyglutamine tract. The expected GR polyglutamine tract lengths predicted 
for each strain (MHS, MNS, SHR and WKY) by the typing of whole 32p_ 
labelled PCR products was confirmed by the direct sequencing of RT-PCR 
and genomic PCR products (see part 2 of this chapter).
b.) In SHR-SPGla/WKYQia and Lyon strains
Individuals of strains: SHR-SPoia> WKYcia and Lyon strains, LL (low), LN 
(norm al) and LH (high) blood pressure, were also typed. No GR 
polyglutamine tract polymorphisms were identified between strains (Fig. 
3.8.). For the SHR-SPda and WKYcia strains (Fig. 3.8a.) the CAG repeat 
number was 19. For the Lyon strains (Fig. 3.8b.) the CAG repeat number was 
2 1 .
3.3. Id.) Typing o f selected strains using 4% Metaphor gels 
Figure 3.9., reported  in Shiels et al., (1995), shows the successful 
fractionation of variant rat GR triplet (CAG)n repeat PCR products on high 
percentage metaphor agarose gel. Allelic variants of 21, 20, 19 and 18-CAG 
repeats (rGR T-vector clone, T 3/3 C3; section 3.2.5. and Table 3.2) and 7-CAG 
repeats (rat strain BC) were resolved successfully on 4% metaphor down to 
a resolution of 1-codon spacing from single or mixed sample gel loadings. 
Resolving capabilities were similar to that of 6-8% polyacrylamide.
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Despite the possible application of metaphor gels in microsatellite typing, 
these gels were not used routinely because of the extreme fragility of high 
percentage gels, becoming an increasing problem with the build up of heat 
in 'fast' gel runs. Gels were broken too easily resulting in the need for 
repetition.
a.) b.)
1 2 3 4 5 6 7 8 9  10 1 2 3
_  116
—  113
—  110 
—  107
—  75
Fig. 3.9. Rat GR triplet (CAG )n repeat variants resolved on a 4% m etaphor gel.
a.) GR alleles, cloned and sequenced from different rat strains and found to have the 
follow ing numbers of CAG repeats were resolved on a 4% metaphor gel: 20 (MHS, lane 
2), 21 (MNS, lane 3), 20 (MHS, lane 4), 19 (SHR, lane 5), 18 (GR clone [see text for 
details], lane 6) and 7 (BC, lane 8). Lanes 8 and 10 show m ixtures of 21, 20 and 7 
repeat variants. Lane 9 shows a m ixture of 21, 19 and 7 repeat variants. Lane 1: 1 kb 
ladder.
b.) Lanes 8-10 from a.), am plified to show the resolution of bands with two or one 
codon spacing. The numbers and arrows at the right hand side shows the length in bp 
of the five allelic PCR products.
The integrity of gels could be maintained by running much more slowly 
(2-4 h: 10 cm gel), which kept them cooler. However, even under these 
conditions, the resolution of bands in mixed sample loadings was not always 
clear. The use of 3 2p jn a polyacrylamide gel system was therefore 
preferred because of high sensitivity and resolution. In addition, 3-4 times 
as many samples could be assayed at any one time compared with the 
metaphor gel.
1 0 1
3.3.2.) Polymorphisms o f the rat glucococrticoid receptor polyglutamine 
tract in 61 inbred strains and substrains 
A total of 61 inbred strains and 29 of their substrains (Table 3.3.) were 
analysed using the method described in section 3.1.4.
Rat Strains and Sub-strains* Grl allele
A2/Colle; ALC/colle; BBWB/Mol; BDII/Han; GC/Kun; MNS/Gib; 
MW/Hsd; SPRD/Mol; SPRD-Cu3/Han; SR/*2; SS/Jrlpvc; WF/*4; 
WOK.1A/K
Grl CAG21
ACI/*2; AGUS/OlsHsd; AO/OlaHsd; AS/Ztm; AUG/OlaHsd; AVN/Orl; 
BN/*10; BN.lx/Cub; BP/lxCub; BS/Ztm; BUF/Han; CAP/Kuv; 
COP/OlaHsd; DA/Han; DZB/G; E3/Han; F344/Han; LE/Han; 
LEP/Cub; LEW/*12; MHS/Gib; OM/Han; PAR/Wsl;
PD/Cub; PVG/OlaHsdCpb; R/*3; SD/Rij; SHD/Ztm; SDL/Ipvc;
WAG/Rij; WIST/N; WKY/*2; WOK.1W/K
Qrl CAG20
LH/Ztu; OKA/Wsl; SHR/OlaHsd; SHR-SP/RmRiv Grl CAG19
Amorat/Wsl; Aristorat/Wsl; BH/Ztm; LOU/CHan Grl CAG17
BC/Cpbu; BDE/Han; BDIV/Ifz; BDVII/Cub; BDIX/Han; BDX/Cub; 
NAR/SaU; U/A
Grl CAG7
Table 3.3. CAG-repeat alleles o f the glucocorticoid receptor in 
inbred strains of Rattus norvegicus.
Asterisks indentify those strains or substrains which were obtained and 
tested from several different laboratories, this is noted by showing the 
'holder' as '/* ', followed by the num ber of different suppliers. Thus R 
( C A G ^ O )  Was obtained and tested from three separate laboratories (R/*3). A 
catalogue of all holders is given by Otsen, (1995).
Figure 3.10. shows a typical 32p_typing gel obtained for a sample of inbred 
strains and substrains. In general, the clarity of PCR product bands was
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better than previously seen for the typing of strains: MHS, MNS, SHR, WKY, 
SHR-SPoia, WKYcia, LL, LN and LH (Figs. 3.7. and 3.8.).
Fig. 3.10. Typical typing gel for GR polyglutam ine tract lengths in inbred strains 
and substrains.
Rat strains: MW (lane 2), AR ISTORAT (lane 3), SDH (lane 4), OM (lane 5), BDIX 
(lane 6) and LEW (lane 7). Lanes 1 and 8: Cloned m icrosatellite markers.
The majority of rat strains were reliably 'typed' by comparing PCR product 
migration with that from the cloned markers (lanes 1 and 8). The smallest 
PCR product, from rat strain BDIX (lane 3) revealed a novel PCR product size 
(74 bp) which could not be predicted by comparison with the markers. The 
length of this polyglutamine tract was determined by direct sequencing of 
the PCR product using pG (see Fig. 4.8.). Other 7-CAG repeat lengths (see 
Table 3.3.) were determ ined by comparison with similarly sized PCR 
products of previously determined sequence (results not shown). 98% of 
strains tested were found to be homozygous at the GR locus as expected, with 
polyglutamine tracts of: 7, 17, 19, 20 and 21 CAG repeats (Table 3.3. and Fig.
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a.)
MNS MHS 
SD BN 
SHR- WKY 
SP
SHR
LEW
AMO- BC 
RAT BDX
2 3
PCR
product
size (bp)
21-CAG ■ 116 
20-CAG - 1 1 3  
19-CAG " 1 1 0  
18-CAG i  107 
■ 104
(7-CAG) ■ 74
b.)
Number of 
GR alleles 
observed
120 
100  -  
80 -  
60 -  
40 
20 - I
17 18 19 20 21
Number of CAG repeats
Fig. 3.11. The range of triplet (CAG)n repeat variants in inbred rat strains.
a.) Polyacrylam ide typing gel show ing exam ples of GR alle les from d iffe ren t rat 
strains. Abbreviations above each lane cite strain and substrain exam ples with GR 
triplet (CAG)n (polyglutamine) tract lengths of: 21-CAG (lane 2) 20-CAG (lane 3) 19- 
CAG (lane 4) 17-CAG (lane 5) and 7-CAG (lane 6). Lanes 1 and 7: previously cloned 
and sequenced rat GR microsatellite markers. The length of each PCR product
(bp) is given to the right of the figure.
b.) H istogram showing a d iscontinuous distribution of GR alle le trip le t CAG repeat 
lengths.
3.11a.). Two substrains of ACI and LEW were apparently heterozygous for 20 
and 21 CAG repeat alleles. However, no breeding studies have been carried 
out to confirm heterozygosity.
An im portant observation made in the 'typing' of all rat strain GR triplet 
(C A G )n repeats by 32p_pcR was the appearence of shadow bands above and 
below the m ain PCR product band. This is a common feature of 
m icrosatellite typing by this technique (Jacob et al., 1991). These 
artefactual bands are understood to arise from stuttering during the PCR 
reaction (Tautz and Schlotterer, 1994) when newly synthesised DNA strands 
sit down out of register with the template strand in the region of the 
polymeric tract (see section 3.3.1b.).
3.4.) Distribution pattern of the different GR alleles found in 
inbred strains
The entire range of rat GR polyglutamine tract lengths identified in the 61 
inbred strains and substrains typed (section 3.3.2.) is shown in Figure 3.11a. 
The strain notations above each of the lanes 2-6, represent examples of rat 
strains and substrains with GR polyglutamine tracts of each of the 
respective lengths: MNS, SD and SHR-SP (21-CAG), MHS, BN and WKY (20- 
CAG), SHR and LEW (19-CAG), AMORAT (17-CAG) and BC and BDX (7-CAG 
repeats) (refer also to Table 3.3.). Seven of the strains were represented by 
more than one substrain, and these had consistent Grl CAG-genotypes.
Figure 3.11b., shows the incidence and distribution pattern of GR alleles 
with differing polyglutamine tract lengths. The rarest allele was the 17- 
CAG repeat allele, present in only 2% of individuals tested, whilst the most 
common was the 20-repeat allele present at 61%. No GR alleles with a 
polyglutamine tract length of between 8 and 16, or less than 7 or greater 
than 21 CAG-repeats were identified. This lead to a clear discontinuous 
allelic distribution.
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3.5.) Discussion of Grl triplet (CAG)n typing results
The primary aim of this section of work was to establish genetic markers 
for Grl for use in rat breeding experments and to optimise methods for 
genotyping. This was achieved by identifying polymorphism in the triplet 
(CAG)n repeat of the rGR coding sequence. The established markers were 
used by the groups of Bianchi (Milan rat model, Milan) and Samani 
(SHR/WKY model, Leicester) in studies of linkage between Grl and 
glucocorticoid related phenotypes in rat models of hypertension, discussed 
in chapter 5.
An analysis of the rat GR from other strains was also undertaken to 
determine the extent of heterogeneity in the polyglutamine repeat region. 
To date, CAG repeat lengths in the rat GR of 7, 17 and 21 have been reported 
in the literature, the result of a minimal analysis of Sprague Dawley and 
Wistar rat genomic DNAs obtained from a variety of sources (Gearing et al., 
1993). In the body of work reported here, 61 inbred strains and substrains 
(a total of 90 rats) were analysed for Grl triplet (CAG)n repeats identifying 
a clear discontinuous distribution between alleles.
Knowledge of the range of natural GR triplet repeat variants would be 
useful in selecting the structurally more interesting alleles for studies of 
GR function in tissue culture and in vivo and hence, in choosing the 
appropriate  ra t strains for breeding experiments. Differences in GR 
genotypes may be used as a basis for searching for positive associations 
between Grl and glucocorticoid related phenotypes. Based on the screening 
of rat strains for Grl triplet (CAG)n repeat lengths (section 3.3.), a marked 
difference between two of the strains, BC (7-CAG repeat allele) and Lewis 
(20-CAG repeat allele) was identified. These strains are of interest because 
of differences in cholesterol metabolism and immune responsiveness (the 
immune system in the Lewis rat is compromised because of a hyposensitive 
HPA-axis). The possibility that these phenotypes are associated with 
differences in GR genotype are currently under investigation (C. Kenyon, 
personal communication). Finally, the distribution and incidence of the
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different GR alleles may be useful as a basis for understanding the 
evolution of triplet (CAG)n  repeat sequence in rat Grl (see discussion to 
chapter 4).
Part 2
3.6.) Methods for determining variation in glucocorticoid 
receptor coding sequences
The coding sequence of the glucocorticoid receptor from inbred rat strains: 
MHS, MNS, SHR, WKY and Zucker, lean and obese were determ ined from 
mRNA using methods of RT-PCR coupled with direct sequencing of PCR 
products. The objective was to compare GR sequences between the strain 
pairs of each model, in order to identify mutations which might explain the 
differences in steroid binding affinity. Importantly, the Milan and Zucker 
lean and obese rats used for both steroid binding analysis (Kenyon et al., 
1994; Panarelli et al., 1995 and Kenyon, unpublished results, respectively) 
and primary sequence determination reported here were from the same 
colonies. Milan rats were obtained from stocks held in Sheffield, Zucker 
rats from Harlan Olac. SHR and WKY rats were from the same colony as 
those used by Samani in linkage studies, (see materials and methods and 
chapter 5 for further comment).
Total RNA was isolated from 100 mg samples of rat liver using RNAzol B, 
following the method outlined in section 2.2.14. The integrity of RNA 
routinely obtained is shown in Figure 3.13a. Approximately 5 ^g samples of 
total RNA were reverse transcribed into complementary DNA/RNA hybrid 
molecules using MMLV reverse transcriptase, as described in section 2.2.3. 
Figure 3.13b. shows the reproducibility, between reverse transcription 
reactions and between rat strains. Full length reverse transcripts of the 
rGR coding sequence (over 2.3 kb) were initiated from the rGR gene 
specific antisense primer rGRl (Appendix 1). The hybridisation site of rGRl 
is shown in Figure 3.12. Pools of smaller reverse transcripts of variable
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length (500 bp, up to around 1 kb), routinely used to verify small stretches 
of sequence, were initiated from random hexamer primers (GIBCO-BRL, 
U.K.) at multiple positions along the GR transcript (results not shown).
a.) 1 2  3 b.) 1 2 3 4 5 6 7
Fig. 3.13. Input and output of reverse transcription reactions.
a.) Examples of the integrity of RNA isolated from rat liver: lane 2, strain MHS; lane 3, 
strain MNS. In each case, 1-1.5 pg total RNA was loaded per lane. Lane 1, 1 kb DNA 
ladder.
b.) Duplicate reverse transcription reactions using total RNA from strains MHS (lanes 2 
and 3) and MNS (lanes 5 and 6). Lanes 4 and 7 are negative, no MMLV controls. In 
each case, 2 pi of RT-reactions (1 /25th) were loaded per lane. Lane 1, 1 kb DNA 
ladder.
PCR products for sequencing, derived from the reverse transcribed rGR 
message, were generated from a series of independent overlapping PCR 
primer pairs (Fig. 3.12.), which in combination covered the entire GR 
coding sequence. Examples of the product yield and specificity of typical 
RT-PCR reactions are shown in Figure 3.14.
Under conditions described in section 2.2.3., PCR products of 250-500 ng (see 
section 2.2.5.), were biotin labelled through the forward PCR primer. They 
were immobilised onto dynabeads through the 5' biotin label and denatured 
and  sequenced  from  m ultip le  positions  using specific p rim ers  
complementary to rGR cDNA, as described in section 2.2.13.
Sequencing of PCR amplifications from each primer set was carried out at 
least 2-3 times, each PCR template being derived from independent reverse 
transcription products. The reference notation (see Appendix 1) for each of 
the numbered PCR and sequencing primers described above are illustrated
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in Figure. 3.12. For comparative purposes, the rat GR cDNA clone, pRBalll7 
(A gift from R. Miesfeld, University of Arizona, Arizona, U.S.A. [See Fig.
3.2.]), containing a previously cloned and sequenced rat GR cDNA from rat
c . )
1 2 3 4 5 6 7
1047 bp
Fig. 3.14. Exam ples of RT-PCR products generated from  rat GR RNA/cDNA  
hybrid tem plates from strains MHS and MNS.
Gels show exam ples of consistent, but m oderate yields of high specific ity RT-PCR 
products generated using primer pairs:
a.) rGR19-BIO and rGR10 (1934 bp product).
b.) rGR31 -BIO and rGR10 (1165 bp product).
c.) rGR5-BIO and rGR2 (1047 bp product).
Product bands, each the proceeds of independent reverse transcrip tion and PCR 
reactions, represent loadings of 2 pi per 25 pi RT-PCR. Sam ples on each gel are 
loaded in pairs for each rat strain: MHS, lanes 2 and 3 (a., b. and c.); MNS, lanes 5 
and 6 (a. and b.); lanes 4 and 5 (c.). Lanes: 4, (a. and b.) and 6 (c.) MHS, no MMLV 
negative controls. Lanes: 7 (a., b. and c.) MNS, no MMLV negative controls (refer to 
text for details). Lanes: 1 (a., b. and c.), 1 kb DNA ladder.
hepatoma cell line 6.10.2 (Miesfeld et al., 1986), was re-sequenced using the 
same methods, PCR and sequencing primers as those used to sequence the 
GR from other rat strains.
1 0 8
Negative controls, the purpose of which were to monitor for the possibility 
of contam ination of RNA with DNA sequences were used in every set of 
reverse  tran sc rip tio n  reactions (for exam ples, see Fig. 3.14.). 
Contamination by DNA was considered to be from two possible sources; 
either genomic DNA from liver cells from the RNA preparation process 
(not usually  a problem  when sequencing across several spliced 
intron/exon boundaries from large multi-exon genes such as GR; roughly 
80 kb in human (Encio and Detera-Wadleigh, 1991) to over 100 kb in the rat 
(Jacobson, 1991), or from contaminating plasmid DNA containing cloned GR 
sequences. Controls routinely gave negative results in PCR. Where 
contam ination arose, all components, including the MMLV reverse 
transcriptase were replaced.
3.7.) Results
3.7.1.) Nucleotide sequence differences in the rat glucocorticoid 
receptor
Sequencing of the glucocorticoid receptor coding sequence from rat 
strains: MHS, MNS, SHR and WKY, identified two types of mutation.
a.) The polyglutamine repeat
The CAG repeat, n223-288 in the modulatory domain of rGR (nucleotide 
coordinates relative to m etl: taken from the published cDNA sequence of 
Miesfeld et al., 1986) showed length differences of one codon between MHS 
(20-CAG) and MNS (21-CAG) and SHR (19-CAG) and WKY (20-CAG) (Fig. 3.15.). 
No difference was found in the triplet (CAG)n repeat length between 
Zucker lean and obese strains.
b.) Nucleotide substitutions
In addition to differences in the length of the polyglutamine tract, 
comparison of nucleotide sequences between these rat strains and rat GR 
cDNA clone pRBalll7 revealed three silent transitional m utations at 
nucleotide positions: n 198 (TTC -> TTTlphegg, n 531 (TTT -> TTC)phei7 7  and n
109
711 (GAT -> GAC)Asp2 37- These three point mutations were found in the 
hypertensive strains, MHS and SHR (see Figs. 3.16., 3.17., 3.18. and 3.21.).
A C G T  A C G T  A B C D
i___________ I I--------------- 1 l__________ I
SHR W KY/MHS MNS
Zucker lean/
Zucker obese
Fig 3.15. Polym orphism s of the GR polyglutam ine tract between strains of the rat 
models of human essential hypertension: MHS/MNS and SHR/W KY.
Triplet (CAG)n repeat numbers identified were: 19 (SHR), 20 (WKY and MHS) and 21 
(M NS). Letters above each sequence lane represen t te rm ina ting  nucleo tides. 
Sequences shown are of the antisense DNA strand, reading 5 ’ -> 3 ’, top to bottom. 
Sequences were initiated from primer pG (Appendix 1).
None were present in MNS, which in turn was identical in sequence to the 
cloned rat GR cDNA of pRBalll7. Arbitrarily, the MNS GR sequence was 
taken as the base, or wild type sequence, against which all others were 
compared (Fig. 3.16). The strain WKY, was m utated only at the third 
nucleotide position: n 711 (Figs. 3.16. and 3.18.).
No coding sequences differences were identified between the Zucker lean 
and obese strains, which in turn were identical to that of the MNS strain 
(see Fig. 3.16.).
1 1 0
MNS 9 9 9 C t c a c a t t a a t  a t t t a c c a A T GGACTCCAAA 1 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ---------------------------------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ---------------------------------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
MNS GAATCCTTAG CTCCCCCTGG TAGAGACGAA GTCCCTGGCA GTTTGCTTGG CCAGGGGAGG GGGAGCGTAA TGGACTTTTA 9 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY --------------------- ----------- ----------- ----------- ----------- ----------- -----------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS TAAAAGCCTG AGGGGAGGAG CTACAGTCAA GGTTTCTGCA TCTTCG CCCT CAGTGGCTGC TGCTTCTCAG GCAGATTCCA 1 7 2
MHS --------------------- ----------- ----------- ----------- ----------- ----------- -----------
WKY ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ---------------------------------------------------
MNS AGCAGCAGAG GA TTCTCCTT GATTTCTCGA AAGGCTCCAC AAGCAATGTG CAGCAGCGAC AGCAGCAGCA GCAGCAGCAG 2 5 2
MHS --------------------------------------------  T ---------------------------------------- ------------------------- ---------------------------------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR --------------------------------------------  T ---------------------------------------- ------------------------- ------------------------- -------------------------
MNS CAGCAGCAGC AGCAGCAGCA GCAGCAGCAG CAGCAGCCAG ACTTATCCAA AGCCGTTTCA CTGTCCATGG GGCTGTATAT 3 3 2
MHS ---------------------- ------------------------- ------------------------- ---------  -------- ------------------------- ------------------------- ---------------------------------------------------
WKY ---------------------- ------------------------- ------------------------- ---------  -------- ------------------------- ------------------------- ---------------------------------------------------
SHR ----------------------  ---------------------- -------------------------  -------- -------------------------  ---------------------- ------------------------- -------------------------
MNS GGGAGAGACA GAAACAAAAG TGATGGGGAA TGACTTGGGC TACCCACAGC AGGGCCAACT TG GCCTTTCC TCTGGGGAAA 4 1 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ---- ---------------------------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS CAGACTTTCG GCTTCTGGAA GAAAGCATTG CAAACCTCAA TAGGTCGACC AGCGTTCCAG AGAACCCCAA GAGTTCAACG 4 9 2
MHS ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- -------------------------  ---------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY
SHR
MNS TCTGCAACTG GGTGTGCTAC CCCGACAGAG AAGGAGTTTC CCAAAACTCA CTCGGATGCA TCTTCAGAAC AGCAAAATCG 5 7 2
MHS ----------------------    C - ------------------------- ------------------------- ---------------------------------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ----------------------    C - ------------------------- -------------------------  ---------------------- -------------------------
MNS AAAAAGCCAG ACCGGCACCA ACGGAGGCAG TGTGAAATTG TATCCCACAG ACCAAAGCAC CTTTGACCTC TTGAAGGATT 6 5 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS TGGAGTTTTC CGCTGGGTCC CCAGGTAAAG ACACAAACGA GAGTCCCTGG AGATCAGATC TGTTGATAGA TGAAAACTTG 7 3 2
MHS ----------------------      C - ------------------------- -------------------------
WKY ----------------------      C - ------------------------- -------------------------
SHR ----------------------       C - ------------------------- -------------------------
MNS CT TT C T C C T T TGGCGGGAGA AGATGATCCA TTCCTTCTCG AAGGGGACAC GAATGAGGAT TGTAAGCCTC TTA TTTTACC 8 1 2
MHS ---------------------- ------------------------- -------------------------  ----------------------  ----------------------  ---------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS GGACACTAAA CCTAAAATTA AGGATACTGG AGATACAATC TTATCAAGTC CCAGCAGTGT GGCACTGCCC CAAGTGAAAA 8 9 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ---------------------- -------------------------
MNS CAGAAAAAGA TG ATTTCATT GAACTTTGCA CCCCCGGGGT AATTAAGCAA GAGAAACTGG GCCCAGTTTA TTGTCAGGCA 9 7 2
MHS ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
SHR ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS AGCTTTTCTG GGACAAATAT AATTGGTAAT AAAATGTCTG CCATTTCTG T TCATGGTGTG AGTACCTCTG GAGGACAGAT 1 0 5 2
MHS ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
SHR ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
MNS GTACCACTAT GACATGAATA CAGCATCCCT TTCTCAGCAG CAGGATCAGA AGCCTGTTTT TAATGTCATT CCACCAATTC 1 1 3 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
MNS CTGTTGGTTC TGAAAACTGG AATAGGTGCC AAGGCTCCGG AGAGGACAGC CTGACTTCCT TGGGGGCTCT GAACTTCCCA 1 2 1 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
MNS GGCCGGTCAG TG TTTTCTAA TGGGTACTCA AGCCCTGGAA TGAGACCAGA TGTAAGCTCT CCTCCATCCA GCTCGTCAGC 1 2 9 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
SHR ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS AGCCACGGGA CCACCTCCCA AGCTCTGCCT GGTGTGCTCC GATGAAGCTT CAGGATGTCA TTACGGGGTG CTGACATGTG 1 3 7 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ----------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS GAAGCTGCAA A G TA TTCTTT AAAAGAGCAG TGGAAGGACA GCACAATTAC CTTTGTGCTG GAAGAAACGA TTGCATCATT 1 4 5 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS GATAAAATTC GAAGGAAAAA CTGCCCAGCA TGCCGCTATC GGAAATGTCT TCAGGCTGGA ATGAACCTTG AAGCTCGAAA 1 5 3 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- -------------------------  ---------------------- ------------------------- -------------------------
SHR ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ----------------------------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS AACAAAGAAA AAAATCAAAG GGATTCAGCA AGCCACTGCA GGAGTCTCAC AAGACACTTC GGAAAATCCT AACAAAACAA 1 6 1 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS TAGTTCCTGC AGCATTACCA CAGCTCACCC CTACCTTGGT GTCACTGCTG GAGGTGATTG AACCCGAGGT GTTGTATGCA 1 6 9 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------  ---------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS GGATATGATA GCTCTGTTCC AGATTCAGCA TGGAGAATTA TGACCACACT CAACATGTTA GGTGGGCGTC AAGTGATTGC 1 7 7 2
MHS ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- -------------------------  ---------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WRY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS AGCAGTGAAA TGGGCAAAGG CGATACCAGG CCTGAGAAAC TTACACCTGG ATGACCAAAT GACCCTGCTA CAGTACTCAT 1 8 5 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS GGATGTTTCT CATGGCATTT GCCCTGGGTT GGAGATCATA CAGACAATCA AGTGGAAACC TG CTCTGCTT TGCTCCTGAT 1 9 3 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS CTGATTATTA ATGAGCAGAG AATGTCTCTA CCCTGCATGT ATGACCAATG TAAACACATG C TG TTTG TC T CCTCTGAATT 2 0 1 2
MHS --------------------- ----------- ----------- ----------- ----------- ----------- -----------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- -------------------------  ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS ACAAAGATTG CAGGTATCCT ATGAAGAGTA TCTCTGTATG AAAACCTTAC TGCTTCTCTC CTCAG TTCCT AAGGAAGGTC 2 0 9 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ---------------------------------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY -------------------- ----------------------- ----------------------- ----------------------- ----------------------- ----------------------- ----------------------- -----------------------
MNS TGAAGAGCCA AGAGTTATTT GATGAGATTC GAATGACTTA TATCAAAGAG CTAGGAAAAG CCATCGTCAA AAGGGAAGGG 2 1 7 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS AACTCCAGTC AGAACTGGCA ACGGTTTTAC CAACTGACAA AGCTTCTGGA CTCCATGCAT GAGGTGGTTG AGAATCTCCT 2 2 5 2
MHS ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY -------------------- ----------------------- -----------------------  -------------------- ----------------------- ----------------------- ----------------------- -----------------------
MNS TACCTACTGC TTCCAGACAT TTTTGGATAA GACCATGAGT ATTGAATTCC CAGAGATGTT AGCTGAAATC ATCACTAATC 2 3 3 2
MHS ---------------------- ------------------------- ------------------------- ------------------------- -------------------------  ---------------------- ------------------------- -------------------------
SHR ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ----------------------  ----------------------  ----------------------  ---------------------- -------------------------  ---------------------- ------------------------- -------------------------
MNS AGATACCAAA ATATTCAAAT GGAAATATCA AAAAGCTTCT GTTTCATCAA AAATGAc t a c  c t t a c t a a g a  a a g g t t g c c t  2 4 1 2
MHS ----------------------  ---------------------- ------------------------- -------------------------  ---------------------- ------------------------- ------------------------- -------------------------
SHR ----------------------  ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- -------------------------  ----------------------  ---------------------- ------------------------- ------------------------- ------------------------- -------------------------
MNS t a a a g a a a g t  2 4 2 2
MHS ---------------------- -------------------------  ----------------------  ---------------------- ------------------------- ------------------------- -------------------------
SHR ---------------------- ------------------------- ------------------------- ------------------------- ------------------------- ------------------------- -------------------------
WKY ---------------------- ------------------------- -------------------------  ---------------------- -------------------------  ---------------------- -------------------------
Fig. 3.16. Alignment of rat glucocorticoid receptor (GR) nucleotide sequences.
Coding sequences of GR derived from RNA/cDNA hybrids from strains: MHS, MNS, SHR 
and WKY are shown. The base GR sequence (2422 bp) is that of strain MNS, which was 
found to be identical to rat GR cDNA clone pRBal117 (Miesfeld e t al., 1986), in which a 
number of mistakes were identified (letters shown in bold type). Gaps (line 332) represent 
missing glutamine codons, resulting in a shortening of respective polyglutamine tracts and 
presumably translated GR protein. Upper case lettering in bold type identify the sites of 
silent point mutations. Lower case lettering in bold type: 5' and 3' untranslated sequences. 
Codons underlined show the major start and stop codons of the full length receptor 
protein. Numbers to the right hand side represent nucleotide positions in relation to the 
ATG start site (line 12).
MHS MNS
A C G T
n 198 
(TTC -> TTT)
n 531 
(TTT -> TTC)
A C G T
it*  jsss
A C G T A C G T
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n 711
(GAT -> GAC) # 7 3
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Fig. 3.17. N ucleotide  sequence d ifferences in the g luco co rtico id  receptor 
between rat strains: MHS and MNS.
Three silent point mutations were identified in the GR coding sequence of hypertensive 
rat strain MHS (sequences on the left) at nucleotide positions:
a.) n 198, b .) n 531 and c.) n 711. None of these m utations were present in the 
normotensive control strain MNS (sequences on the right).
SHR WKY
A C G T A C G T
n 198 
(TTC -> TTT)
n 531 
(TTT -> TTC)
.
A C G T
ttSB
A C G T
■mm*#*
A C G T
n 711 
(GAT -> GAC)
Fig. 3.18. N ucleotide  sequence d ifferences in the g lucocortico id  receptor 
between rat strains: SHR and WKY.
Three s ilen t po int m uta tions were iden tified  in the GR cod ing  sequence  of 
hypertensive rat strain SHR (sequences on the left) at nucleotide positions: 
a.) n 198, b.) n 531 and c.) n 711. One of these m utations (n 711) was found to be 
present in the normotensive control strain WKY (sequences on the right).
Sequencing across longer CAG repeats (e.g., from pG: Appendix 1) produced 
sequence which was often stuttered in appearance; compare upper blocks 
of sequence in Figs. 3.17. and 3.18. with Fig. 3.19a., derived from a GR 7- 
repeat allele (see section 3.2.5. and chapter 4 for further details of rats with 
QrlCAG/ alleles). Point mutations at nucleotide position n l9 8  (in MHS and 
SHR) were therefore verified by sequencing across the opposite (sense) 
DNA strand from p9, detailed in Appendix 1 (Fig. 3.19b.).
a-) A C G T  b ) A C G T
<wmi
mm
Fig. 3.19. Clarification of GR sequences.
a.) The clarification of sequence above the rGR trinucleotide repeat derived from a 
QrlCAG7 rat strain (see text for details).
b.) Varifica tion  of silent nucleotide substitu tion n 198, by sequencing of opposite  
(sense) DNA strand (orientation is 5 ’ -> 3 ’ , top to bottom). Top sequence set, strain 
MNS; bottom sequence set, strain MHS. Letters above each sequence lane represent 
term inating nucleotides.
c.) Errors in the Miesfeld sequence
Re-sequencing of pRBalll7 in duplicate revealed 10 nucleotide differences 
when compared to the published sequence (Miesfeld et al., 1986), which was 
also derived, in part, from pRBalll7. All of these differences were present
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in each ra t strain and were therefore regarded as genuine sequencing 
errors.
These errors may have arisen in the original sequence because of 
technological difficulties at the time sequencing was carried out (1985- 
1986). Sequencing was from M13 clones (S. Rusconi, personal 
communication) which require more complicated sequencing protocols 
than those currently available. The differences identified are listed in 
Table 3.4.
Five of the nucleotide differences identified in pRBalll7: n 293 (G -> A), n 
676 (A -> G), n 778 (A -> G), n 1799 (T -> C) and n 1804 (G -> C), predicted a 
change in amino acid at the corresponding position in the rGR protein. 
These were, respectively: Glygs -> Aspgs, Ser226 _> Gly226> Asn260 _> Asp260> 
Leu600 _> Pro6C)0 anc* Leu602 -> Phe6 0 2  (Figs. 3.20. and 3.21.).
Position (in nucleotides)
relative
to m etl
New codon sequence Change in amino acid
66 CAA -> CAG
293 GGC -> GAC Gly -> Asp
676 AGT -> GGT S er ->  Gly
778 AAC -> GAC Asn -> Asp
879 CTA -> CTG
1799 CTA -> CCA Leu -> Pro
1804 TTG -> TTC Leu -> Phe
1821 CTC -> CTG
1876 TTG -> CTG
1905 AGC -> AGT
Table 3.4. Errors identified in rat GR cDNA clone pRBal117. The rat GR cDNA of 
clone pRBal117 (Miesfeld et al., 1986) was re-sequenced in duplicate for the purpose 
of comparison with novel GR sequence obtained from rat strains: MHS, MNS, SHR and 
WKY. Inconsistencies with the published sequence were identified at 10 nucleotide 
positioins which are recorded relative to met 1 in the GR coding sequence.
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3.8.) Discussion of sequencing results
The reason for this section of work was to try to find an explanation for the 
apparen t differences in steroid binding affinities of GR between the 
strains of the rat models of hypertension: MHS/MNS and SHR/WKY, as 
reported by Kenyon et al., (1994) and Panarelli e t al., (1995). Structural 
mutations in GR would support its possible involvement (and hence, of the 
glucocorticoid receptor locus [GrI]) as a candidate gene in the development 
of the hypertensive phenotype. Glucocorticoid receptor coding sequences 
from inbred rat strains: MHS, MNS, SHR and WKY, which to my knowledge 
have not been reported elsewhere, identified three point mutations in the 
hypertensive strains MHS and SHR, which were absen t in the 
norm otensive controls (apart from m utation n 711 in strain  WKY). 
However, all point mutations were in the wobble codon position and were 
silent (Fig. 3.16.). Thus, from single nucleotide substitutions, no change in 
GR function would be predicted. These mutations were used as genetic 
markers for rat GR haplotype analysis, described in chapter 4.
Polymorphism was also found in the triplet (CAG)n repeat of the GR coding 
sequence, which could be of potential im portance for GR function. 
Polymeric tracts consisting of repeat codons for glutamine, or glutamine 
rich sequences are a common feature of several transcription factors (Ross 
et al., 1993; Gerber et al., 1994). Many belong to the steroid receptor 
superfamily, of which the rat glucocorticoid receptor (rGR) and human 
androgen receptor (hAR) have been most intensely studied. Both have a 
variable length polyglutamine tract in the amino terminal domain and 
repeat expansions in the androgen receptor are well established (LaSpada 
et al., 1992). The idea that relatively long polyglutamine tracts (20 residues 
or more) may be im plicated in the functioning of transcrip tional 
regulators is supported by earlier studies involving the transcription 
factors Spl and the human TATA binding protein TFIID (Courey and Tjian, 
1988; Kao eta/., 1990) for which a possible role in gene regulation has been 
assigned.
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Because of the potential functional significance of polyglutamine tracts, 
particularly at the level of gene transcription and also, in the case of GR, in 
the binding of hormone, further investigations of the possible effects of 
polyglutamine tract length on rGR function (steroid binding properties, 
detailed in chapter 6 and transcriptional regulatory properties) were 
considered. The coding sequence of GR from Zucker lean and obese rats was 
identical at all positions and the same as that of strain MNS. This suggests 
that differences in receptor activity in the Zucker strains in vivo must 
depend on influences other than on primary receptor sequence.
Re-sequencing of the ra t GR cDNA clone pR B alll7  identified ten 
sequencing errors when compared to the original report of Miesfeld et al., 
(1986). These differences were confirmed in reverse transcribed PCR 
amplified sequence from RNA of rat strains MHS, MNS, SHR, WKY and 
Zucker lean and obese. All novel rat GR sequences identified in this section 
of work have been submitted to the EMBL sequence databases under the 
accession number Y12264. These results lead to five coding changes in the 
published rGR sequence (Miesfeld et al., 1986), Glygs being amended to 
Aspgg, Ser2 2 6  to Gly2 2 6 > Asn2 6 0  to Asp2 6 0 > Leu6 0 0  to Pro6 0 0  and Leu6 0 2  to 
Phe602 (Fig- 3.16. and 3.21.). Two of these differences, Leu600 to Proeoo and 
Leu602 to Phe602 map within a part of the hormone binding domain that is 
conserved among all other members of the nuclear hormone receptor 
family, and is implicated in the binding of HSP90 (Danielsen, 1986: see Figs. 
3.20. and 3.21.). Amino acid insertions w ithin this subdom ain 
(corresponding to residues 595-614 in rat GR) disrupt hormone binding 
(Giguere et al., 1986). Deletion of this region results in a protease-sensitive 
receptor which associates only weakly with HSP90 and has some 
constitutive transcriptional activity (Housely et al., 1990). Figure 3.20. 
depicts the amino acid sequence of this domain as originally reported by 
Danielsen, (1986). These amendments lead to residues 595-614 of rat GR 
showing a complete conservation of amino acid sequence with GR of mouse 
and human, and a lower but still extensive homology with other members 
of the nuclear hormone receptor family, and confirms its functional 
significance.
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Chapter 4 
Results 2
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Typing of Grl triplet (CAG)n repeat lengths in wild rats and the 
determ ination of Grl haplotypes in selected wild rats and inbred 
strains
4.1.) Introduction
Through PCR analysis of the number of CAG codons, myself and others have 
found strain variation in the length of the polyglutamine tract of rat GR 
(Gearing et al., 1993; Heeley et al., 1996a). The data for inbred strains is 
presented in chapter 3 of this thesis. It was therefore of interest to 
determine whether the discontinuous distribution of GR CAG-repeat alleles 
seen in inbred rat strains was an accurate representation also found in 
unselected rats, or an artefact resulting from the chance fixation of GR 
alleles through random choice of strains for breeding. I therefore typed 
155 wild R. norvegicus from Scotland and England.
As there was no evidence of a structural mutation in the coding sequence 
of GR from MHS or other rat strains which might explain the suggested 
differences in glucocorticoid receptor activity or phenotype between 
strain pairs, the likelyhood of genetic variation elsewhere in Grl was 
considered. Part of this section of work was therefore based on a haplotype 
analysis centred on the genetic variation in and around the CAG repeat of 
rGR, both in the Milan strains (for which linakge analysis was available. 
See Chapter 5) and in a range of other inbred and wild rats.
4.2.) Methods for determination of Grl genotypes
4.2.1.) Typing of Grl triplet (CAG)n repeats
Tissue samples and preparation o f genomic DNA
English wild R. norvegicus liver samples were obtained from the Central 
Science Laboratory, Ministry of Agriculture Fisheries and Food (MAFF), 
Slough, Berkshire. Scottish wild R. norvegicus were collected from local
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regional pest control departments of Scottish district councils by periodic 
donation over a number of weeks.
The origin of each set of rat samples is shown in Figure 4.1. The following 
shorthand was adopted for reference to each location: St (Stirling); Fk 
(Falkirk); Fi (Fife); Gla (Glasgow); Be (Berkshire); Ha (Hampshire); Sh 
(Shropshire); Su (Sussex); Wi (Wiltshire); Ox (Oxfordshire); Es (Essex); Yo 
(Yorkshire); Do (Dorset). Numbers accompanying each notation in the 
remainder of this chapter refer to individual rats from the corresponding 
location. Genomic DNA was prepared from liver tissue using methods 
referenced in (section 2.2.2.). As much care as possible was taken to avoid 
unnecessary shearing and to generally m aintain the intactness of DNA 
from all locations. DNA samples in 0.5x TE (pH 7.6) were left to resuspend 
over 2-3 days at 4°C. Examples of the integrity of samples is shown in 
Figure 4.2. There was variability in the level of intactness of DNA from 
different locations in England. For example, DNA from Hampshire (Fig. 
4.2a., lanes 2-11) was generally more degraded than that from Dorset (Fig. 
4.2b., lanes 2-11). Some samples showed extreme degradation (e.g., Fig. 4.2a, 
lanes 3, 5 and 11) which were considered unsuitable because of likely effect 
on the efficiency of PCR amplification. Alternatively, some of these rat 
tissues may have contained contam inants which were ineffectively 
removed by phenol/chloroform extraction (see below). As a result, not all 
rats could be typed for Grl CAG repeats. Nine to ten rats were originally 
obtained for each site in England, a total of 94 animals, only 61 of which 
were typable. In contrast, all Scottish rats were typed successfully (see 
Table 4.1.). The degradation of genomic DNA was probably related to the 
time after death before which rat carcasses were collected. (E. Gill MAFF; 
personal communication). Many of the tissue samples obtained from MAFF 
came from rats which had been killed by Warfarin poisoning.
DNA loadings per lane (Fig. 4.2a. and b.) were of the order, 0.5-1.0 jig, 
m easured using a spectrophotom eter. A pparent differences in DNA 
loadings between lanes was most likely due to either: inconsistencies in 
spectrophotometer readings, resulting from differences in the degree of 
homogeneity of DNA samples, or more likely, because of differences in the
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Fig. 4.1. Origins of wild rats used for typing of Grl triplet (CAG)n repeat variants: 
A, from  Scotland; B, from England.
The county, or town (where known) of individual sample sites are shown: 1, Stirling; 2, 
Fife; 3, Falkirk; 4, G lasgow; 5, Yorkshire; 6, Shropshire; 7, Oxfordshire; 8, Berkshire; 
9, Essex; 10, W iltshire; 11, Fiampshire; 12, Dorset; 13, Sussex.
Fig. 4.2. Samples of wild rat genom ic DNA from different geographical locations  
resolved on 0.8% agarose gels.
a.) Fiampshire rat DNAs (lanes 2-11), 0.5-1 pg/lane.
b.) Dorset rat DNAs (lanes 2-11), 0.5-1 pg/lane.
c.) Random sample of G lasgow rat DNAs (lanes 2-7), 200-400 ng/lane.
See text for details of sample loadings per lane. Lanes 1 (a, b, c), 1 Kb DNA ladder 
(GIBCO-BRL). Lanes 12 (a and b), Hind\\\ DNA size markers.
intactness of DNA samples. For the extraction of Scottish rat DNAs, where 
carcasses were much fresher (in the majority of cases, no older than 1-2 
days prior to DNA extraction) the integrity of DNA samples was much 
higher. Fig. 4.2c. shows a random selection of DNAs prepared from Glasgow 
rats. DNA loaded per lane was of the order, 200-400 ng.
Typing o f  Grl triplet (CAG)n repeats
The conditions and PCR primers used for typing wild rat Grl triplet (CAG)n 
repeats were initially as described in chapter 3 for inbred strains.
1 2 3 4 5 6 7 8 9 10 11 12 13
21-CAG 
20-CAG 
19-CAG 
18-CAG
7-CAG
Fig 4.3. Pilot experim ent showing the typing of Grl triplet (CA G )n repeats in a sample of 
wild rats.
DNA samples were initially amplified using exactly the same conditions as those described in 
chapter 3 for inbred strains. Am plifications were as follows: lane 2, Do91; lane 3, Do92; lane 
4, Do94; lane 5, W i48; lane 6, Yo80; lane 7, Su32; lane 8, Gla2, lane 9, Gla21; lane 10, 
Gla42; lane 11, Gla7 (see table 4.1.). Lane 12, no DNA negative control. Lanes 1 and 13, 
m icrosatellite markers.
1 1 8
Figure 4.3. shows an example of a typing experiment for Grl (CAG)n repeats 
for aelection of rats from England and Scotland. In each case, there are 
ambigu sities in the form of additional PCR bands. Notably, many of the 
amplifications revealed bands much higher in the gel than that predicted 
from the size markers. These additional DNA bands could represent somatic 
m utation of Grl triplet (CAG)n repeats. Flowever, no such banding was 
observed in the typing of inbred strains, which suggested that these 
additional bands were artifacts, resulting from excess genomic DNA in PCR. 
Attempts were therefore made to optimise PCR conditions to take account of 
this problem. As a starting point, the samples used in the pilot experiment 
(Fig. 4.3) were diluted 10-fold. Prior to dilution, DNAs were left to resuspend 
for a further week at 4°C to ensure homogeneity and OD26O values were re­
determined.
1 2 3 4 5 6 7 8 9 10 11 12 13
21-CAG
20-CAG
19-CAG
18-CAG
Fig. 4.4. W ild rat PCR am plifications performed under optim ised conditions.
DNA per PCR reaction was in the range 2-5 ng. Gel loading was exactly as decribed in 
Fig. 4.3. (see table 4.1. for corresponding genotypes).
PCRs were performed using the diluted DNA samples exactly as in pilot 
experiments.
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Figure 4.4. shows the resulting increase in product specificity. PCRs were 
fu rther optimised by reducing cycle number from 30 to 28. Figure 4.5. 
below shows examples of the enhanced specificity achieved.
1 2 3 4 5
21-CAG
20-CAG
19-CAG 
18-CAG
*  m  7 ' CAG
Fig. 4.5. Typing of wild rat (CAG )n repeats under further optimised PCR 
conditions.
Lane 1, Do91; lane 2, Su39; lane 3, Do94; lane 4, Su41. Lane 5, 
m icrosatellite markers.
The spurious banding in Figure 4.5., lane 3 (Do94) is likely to be an artifact 
resulting from an excess of DNA used in PCR, since the magnitude of the 
specific 7-CAG repeat product band is elevated compared with those in 
other lanes. Similar spurious bands were occasionally seen for clone DNA 
amplifications (marker bands), for which somatic m utation  is not a 
consideration (results not shown). From this point, PCR conditions were 
considered optimal for the typing of the remaining wild rats.
Routine analysis of larger numbers of GR CAG repeat lengths was based on 
a Southern blotting approach, in which non-radioactive PCR products 
(amplified under optimised PCR conditions) were transferred  to nylon 
membrane (Hybond-N+, Amersham, U.K.) for 6-16h and then probed using
1 2 0
a  ^ 2 p-enci la b e l led  p o ly g lu ta m in e  o l ig o n u c le o t id e  p ro b e  (5' 
AGCAGCAGCAGCAGCAGGC 3': see Appendix 1 for coordinates in rGR cDNA) 
complementary to the 3' end of the rGR polyglutamine microsatellite (see 
section 2.2.7. for labelling conditions). Hybridisations were carried out at 
60°C for 8-1 Oh in 10ml 2x SSC containing 2% w/v milk powder. Hybridised 
filters were washed in 2x SSC, 0.1% SDS for 30 mins (or until the 
background  was suffic ien tly  reduced) a t 60°C and  exposed to 
autoradiographic film for 2-3h at -70°C. Microsatellite markers were the 
same as described in chapter 3.
4.2.2.) Grl Haplotype analysis
Determination of Grl haplotypes was based on the nucleotide sequence in 
and around the Grl triplet (CAG)n repeat.
a ) 1 2 3 4 b ) 1 2 3 4 5 6 7 8 9
1224 bp
1224 bp
c ) 1 2 3 4 5 6 7 8 9 10
1224 bp
Fig. 4.6. Am plification of rGR sequences for haplotype analysis.
PCR products of 1224 bp were am plified fo r 47 rat DNAs. A m p lifica tions were 
performed in duplicate follow ing optim isation to provide enough DNA for sequencing 
(See text for details).
a.) Pilot experiment: non-optim ised PCR with additional banding below the expected 
PCR band was perform ed using 1.5 mM M g2 + , 35 PCR-cycles and 58°C  primer 
annealing tem perature. Lanes 1 and 2, am plified BDE rat strain genom ic DNA (see 
Table 4.5.); lane 4, no DNA negative control.
b.) Selection of PCRs performed under optim ised conditions of 1.2 mM M g2+, 37 
PCR-cycles and 60°C  prim er annealing tem perature. Lane 2, Gla32; Iane3, Gla44; 
lane 4, Gla45; lane 5, Gla6; Iane6, Gla10; lane 7, Fi3; lane 8, Fi6. Lane 9, no DNA 
negative control.
1 2 1
c.) Amplification of selected rat DNAs under optimised PCR conditions. Lanes 1 and 2, 
BDE strain; lanes 4 and 5, St1; lanes 6 and 7, St2; lanes 8 and 9, St3 (see table 4.5.). 
Lane 10, no DNA negative control.
Lanes 1 (a, b, c), 1 kb DNA ladder (GIBCO-BRL, U.K.).
Data obtained up until this point for inbred and wild rats indicated a high 
degree of trip let repeat polymorphism , together with three silent 
nucleotide substitution sites identified in chapter 3. PCR products (1224 bp) 
containing all potential mutation sites were amplified using primers rGR19 
and rGR21 (Appendix 1).
4.2.3.) Sequencing
Novel triplet (CAG)n repeat lengths were sequenced from PCR products 
using the dynabead method described in section 2.13.
Duplicate PCR amplifications were performed for a total of 47 homozygous 
rat DNA templates (14 inbred rats, 33 wild rats; see table 4.5.). Pilot 
experiments were carried out in 25^1 of standard reaction mixture (see 
section 2.2.3.) by combining 50-100ng genomic DNA with 20 pmoles of each 
PCR primer, 1.5 mM Mg^+ and 0.01 mg/ml acetylated BSA. The PCR reaction 
profile described in section 2.2.3. was performed for 35-cycles, with an 
annealing tem perature of 58°C. PCR products were less specific than 
required for uninterrupted sequencing (see Fig. 4.6a.). The stringency of 
PCR reactions was therefore optimised by reducing Mg^ + concentration 
from 1.5 mM to 1.2 mM. Annealing temperature was also increased from 58 
to 60°C, requiring an additional x2 PCR cycles (37-cycles, total). Fig. 4.6b. 
and c. shows succesfully optimised PCRs.
Grl haplotypes were determined by direct sequencing of double stranded 
Exonuclease I  and Shrimp Alkaline Phosphatase-treated PCR products using 
a modification of the sequenase version-2 DNA sequencing kit (Amersham 
International, U.K.), described in section 2.2.13. Sequencing was initiated 
from three separate sites in the amplified DNA using primers: pG rGR22, 
rGR23 (Appendix 1). Gels were run exactly as described in chapter 3.
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4.3.) Results
4.3.1.) Grl triplet (CAG)n repeat variation in wild rats
The absence of CAG repeat lengths of 2-6, 8-16, and of more than 21 in Grl 
alleles of inbred strains may reflect that only a limited num ber of alleles 
were fixed when establishing laboratory strains from wild rat populations. 
CAG repeat lengths of wild caught rats from Scotland and England were 
therefore analysed.
Origin
(where
caught)
Total number 
of rats from 
each location
Number of rats with specific GR genotype
Stirling 12 St1-12 (7)
Falkirk 3 Fk1, 3 (7); Fk2 ( 7 ,21)
Fife 9 FI3, 6 (7); Fi5, 7, 9 (7, 22)] Fi2 (7, 23)] Fi1, 4, 8 
(18,22)
Glasgow 70 Gla2,10, 31, 43, 53 (7); Gla9, 21, 44, 65, 67,
70 (18)\ Gla32, 45, 50, 51 (20)] G la13,14 
(21)] Gla8, (22)] G la7,16, 26, 47, 62-64, 66
(23)] Gla 42, 46, 55, 58 (7, 18)] Gla6, 48, 52 
(7, 20)] Gla41 (7, 22)] Gla3, 19, 20, 23, 30, 33, 
(7,23)] Gla1, 12, 15, 17, 49 (18, 20)] Gla69 
( 18, 21)] Gla11 ,18 , 22, 25, 27, 34, 35, 37, 40, 54, 56, 
61, 68 (18, 23)] Gla4, 5 (19, 20)] Gla57 (20, 22)] 
Gla24, 28, 29, 36, 38, 39, 59, 60 (20, 23)
Berkshire 8 Bk27 (7); Bk2, 6 (7, 18)] Bk26 (7, 19)] Bk24 
(17, 19)] Bk22 (17, 20)] Bk20, 25 (19, 20)
Hampshire 9 Ha18 (7); Ha11,14(79); Ha9 (20)] Ha20, 12, 
15-17 (7,20)
Shropshire 6 Sh29 (7); Sh30, 89 (23)] Sh31, 88 (7, 23)] 
Sh90 (19,23)
Sussex 8 Su32, 36, 37 (7); Su41 (7, 77); Su34, 40 (7, 22)] 
Su39 (17, 18)] Su35 (20,21)
Wiltshire 7 Wi44 (18); Wi48-50 (20)] Wi45 (18, 20)] 
Wi42, 47 ( 19, 20)
Oxfordshire 7 0x59 (79); 0x61, 62, 66 (7, 20)] 0 x6 3  (7, 21)] 
0 x64  (20, 23)] 0 x65  (21, 22)
Essex 2 Es74 (7, 17)] Es75 (7,20)
Yorkshire 5 Yo84 (20); Yo77 (23)] Yo80 (7, 19)] Yo82 
(20, 22)] Yo81 (21, 23)
Dorset 9 Do91, 92, 94, 96, 98-100 (7); Do95 (7, 22)] Do93 
(19,21)
Table 4.1. Incidence of Grl genotypes found in Scottish and English wild rats.
Each rat genotype is prefixed by its origin, given in shorthand notation. References 
highlighted in bold type show homozygous animals (n = 67). Number of heterozygotes was 
found to be 88. Bracketed numbers in italics represent GR alleles.
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a)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23
21-CAG 
20-CAG 
19-CAG 
18-CAG
— 7-CAG
PCR
Product
Size
(bp)
119
116
113
110
107
104
74
b)
N um ber of GR 
alle les observed
■ 11 1 ■ M1
7 17 18 19 20 21 22 23
Num ber of CAG repeats
Fig. 4 .7 . The range of CAG repeat lengths in wild rats caught in Scotland and England.
a): 32P-labelled PCR products resolved on a denaturing polyacrylam ide gel, showing GR repeat 
length varia tion for 20 wild rats, selected to show the range of observed alle les: lane 2, G la t 4; 
lane 3, Fi2; lane 4, G la41; lane 5, Sh89; lane 6, Gla8; lane 7, S t1 ; lane 8, Fi 1; lane 9, Ha9; lane 
10, W i44; lane 11, Gla1; lane 12, Gla 42; lane 13, 0x64 ; lane 14, Gla68; lane 16, Bk2; lane 17, 
Do91; lane 18, Do95; lane 19, Sh88; lane 20, Su35; lane 21, Su39; lane 22, Su41. Lanes 1, 15 
and  23  c o n ta in  m ixe d  PC R  p ro d u c ts  a m p lif ie d  fro m  c lo n e d  a lle le s  Grl7’ 18'21 .
b): frequency distribution of CAG repeat alle les from Scottish and English wild rats.
Table 4.1. shows the GR genotypes of all wild rats typed. A representative 20 
samples successfully typed under optimised PCR conditions are shown in 
Figure 4.7.
Two novel allele lengths were identified with 22 and 23 CAG repeats (see 
Fig. 4.8. for entire range of GR alleles identified in inbred and wild rats).
Fig. 4.8. Sequences of naturally occuring GR triplet (CA G )n repeats found in wild 
and inbred rats.
Repeat lengths, determ ined as described in Figure 3.5. chapter 3, ranged from the 
sm allest at 7-CAG repeats (far left) to the longest at 23-CAG repeats (far right). The 
longest polymer tracts of 22 and 23-CAGs were found only in wild rats and not in any 
inbred stra ins tested. Sequencing was from the antisense strand using prim er pG 
(Appendix 1). The letters A, C, G, and T above sequence lanes represent term inating 
nucleo tides. Num bers above each sequence represent num bers of CAG repeats, 
respectively.
Of 155 rats, 67 (43%) were homozygous for any one of alleles GrlGAG7> 18-23 
Allele GrlGAG7 was the most common. GrlGAG1/ was least common; its 
presence in only five heterozygotes explained why no homozygotes were 
observed. Table 4.2. shows the totals of each Grl allele identified in wild rats. 
Tables 4.3. and 4.4. show the expected and observed homozygous alleles for 
Glasgow and all other sample locations in the U.K. respectively, with the
21
A C G T
22
A C G T
23
A C G T
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exception of Stirling, from which all rats were typed as homozygous for 
QrjCAG7 ancj therefore considered to bias the data. The possible implications 
of these results are discussed at the end of this chapter.
Location. No. of Numbers of GR alleles
(town or Rats GR-CAG repeat No.
county) typed 7 17 18 19 20 21 22 23
Stirling 12 24 0 0 0 0 0 0 0
Falkirk 3 5 0 0 0 0 1 0 0
Fife 9 8 0 3 0 0 0 6 1
Glasgow 70 24 0 35 2 27 5 4 43
Berkshire 8 5 2 2 4 3 0 0 0
Hampshire 9 7 0 0 4 7 0 0 0
Shropshire 6 4 0 0 1 0 0 0 7
Sussex 8 9 2 1 0 1 1 2 0
Wiltshire 7 0 0 3 2 9 0 0 0
Oxfordshire 7 4 0 0 2 4 2 1 1
Essex 2 2 1 0 0 1 0 0 0
Yorkshire 5 1 0 0 1 3 1 1 3
Dorset 9 15 0 0 1 0 1 1 0
Total 155 108 5 44 17 55 11 15 55
Homozygotes 34 0 4 3 9 2 1 11
Table. 4.2. Total numbers of each GR allele found in wild rats (English and Scottish).
Out of a total of 155 rats, 67 were found to be homozygous and 88, heterozygous for the 
corresponding GR alleles. Total homozygous animals are given for each allele.
4.3.2.) Grl haplotypes in wild and inbred rats
Wild rats (n=32) homozygous for CAG repeat alleles were typed by direct 
PCR sequencing for variation at the three silent nucleotide substitution 
sites (coordinates: n l98 , n531, n711 in published sequence of rGR cDNA). 
Most (n=29) rats typed as homozygotes: nl98C, n531T, n711C, with CAG repeat 
lengths of 7, 18, 20, and 23. The remaining three rats typed homozygous for 
flanking markers: nl98T, n531C, n711C, with CAG repeat lengths of 19, 20 
and 22, respectively (see Table 4.5).
The typing results for 14 inbred strains defined 6 haplo types, as shown in 
Table 4.6. The overall quality of sequencing and dem onstrations of 
homozygosity are given in Figure 4.8. Sequence sets were run side-by-side,
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bringing all nucleotide substitu tion sites into the same window of 
sequence, thus simplifying the interpretation.
Grl Allele Number
of
alleles
Allele
frequency
Frequency exp 
homozyg's
9Qbderved
homozyg's
Frequency obs 
homozyg's
7 24 0.17 0.029 5 0.07
18 35 0.25 0.063 6 0.09
19 2 0.01 0.0001 0 0
20 27 0.19 0.036 4 0.06
21 5 0.04 0.0016 2 0.03
22 4 0.03 0.0009 1 0.01
23 43 0.31 0.096 8 0.11
Total 140 0.23 26 0.37
Table 4.3. Frequency of Grl alleles in Glasgow rats.
Total alleles together with expected and observed frequency of homozygotes is given in bold 
at the foot of the table. Homozyg's = homozygotes.
Grl Allele Number
of
alleles
Allele
frequency
Frequency exp 
homozyg's
sQbderved
homozyg's
Frequency obs 
homozyg's
7 60 0.41 0.17 17 0.23
17 5 0.034 0.0012 0 0
18 9 0.061 0.0037 1 0.014
19 15 0.1 0.01 2 0.027
20 28 0.19 0.036 4 0.055
21 6 0.041 0.0017 0 0
22 11 0.075 0.0056 0 0
23 12 0.082 0.0067 3 0.041
Total 146 0.24 27 0.37
Table 4.4. Frequency of Grl alleles in wild rats from other locations.
The frequency of all other Grl alleles are given, with the exception of those from Glasgow 
and Stirling. Total alleles together with expected and observed frequency of homozygotes is 
given in bold at the foot of the table. Homozyg's = homozygotes.
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Strain/rat CAG-repeat Nucleotide at 
nl98
Nucleotide at 
n531
Nucleotide at 
n711
WILD RATS
Stl-3 7 C T C
Fi3&6 7 C T C
GlalO 7 c T C
Gla32 7 c T C
Gla53 7 c T C
Sh29 7 c T C
Su32 7 c T C
Su36 7 c T C
Do92 7 c T C
DolOO 7 c T C
Gla8 18 c T C
Gla26 18 c T C
Gla45 18 c T C
Gla65 18 c T C
Gla67 18 c T C
GlaO 18 c T C
0x59 19 T C C
Gla9 20 c T C
Gla51 20 c T C
Ha9 20 T C C
Su44 20 C T C
Yo84 20 C T C
Gla7 22 T C C
Gla2 23 C T c
Gla63 23 C T c
Gla64 23 C T c
Gla66 23 C T c
Sh30 23 C T c
Yo77 23 C T c
INBRED STRAINS
BC38 7 c T c
BDE123 7 c T c
U62 7 c T c
LH157 19 c T T
OKA108 19 T C c
SHR (NL) 19 T C c
SHR (UK) 19 T C c
SHR-SP 19 T C c
MHS 20 T C c
WKY 20 C T c
MNS 21 C T T
Zucker ob 21 C T T
Zucker lean 21 C T T
Table 4.5. Grl haplotypes in a selection of wild rats and inbred strains.
Wild rats are referred to by shorthand notation. Inbred strains are shown in bold type. 
Haplotypes shown in italics highlight the rarest haplotypes found in wild rats.
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Fig. 4.9. Examples of rat Grl haplotypes.
Nucleotide sequences of a l l e l e s G r / C A G 2 3  and G r l C A G 7  (a ancj b. respective ly) show 
exam ples of n198C, n531T, n711C haplotypes for which c lear hom ozygosity is detectable. 
G r / C A G 1 8  (c ) j shows an example of a rare n198T, n531C, n711C haplotype. Red arrows mark 
the positions of substituted nucleotides in the codon chages: TTC->TTT, TTT->TTC and GAT- 
>GAC, identified using seqencing primers pG, rGR22 and rGR23 respectively (prim ers are 
listed in Appendix 1). Letters A, C, G, T at the top of each sequence lane represent term inating 
nucleotides. Sequences are of the antisense DNA strand.
Haplotype
#
Strains Variation at Grl nucleotide position:
198 223-288' ' 531* 711*
1 BC; BDE; U C 7-CAG T C
2 WKY C 20-CAG T C
3 LH C 19-CAG T T
4 MNS; Zucker-obese; Zucker-lean C 21-CAG T T
5 OKA; SHR; SHR-SP T 19-CAG C C
6 MHS T 20-CAG C C
Table 4.6. Haplotypes of CAG repeat length and same-sense point mutations in the 
coding sequence of rat glucocorticoid receptor.
‘ nucleotide positions based on coordinates in the allele GrlCAG21. tencodes polyglutamine 
repeat in Grl°AG21- (All nucleotide positions relative to m etl).
4.4.) Discussion
In distinction to the hum an receptor, exon 2 of ra t GR contains a 
polymorphic microsatellite comprising a variable number of CAG repeats. 
Microsatellite repeats are a widespread source of genetic variation in 
mammals (Rubinsztein et al., 1995). They are a key tool for the mapping of 
phenotypic traits (see Jacob et al., 1995), and some microsatellites may 
directly influence phenotype e ither through variation  in pro tein  
structure (Ross et al., 1993; Perutz et al., 1994), or by less well defined 
influences over the expression of adjacent genes (Kashi et al., 1997). The 
present finding of a discontinuous distribution of CAG repeat lengths in the 
GR of inbred and wild rats raises fundamental questions about the genetic 
origin of this discontinuity and the endocrine significance of the observed 
variation in the length of the poly glutamine tract.
In the sample of 155 wild rats in this study, homozygotes were identified for 
each allele, with the exception of GrlCAG17, and indicates that the alleles 
are compatible with viable and competative phenotypes. The observed 
frequency of 45% homozygosity was high. Of the 67 homozygous rats, 12 
were trapped in Stirling (Central Region, Scotland) and were homozygous
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for GrlCAG7. The frequency of homozygosity was 37% for Glasgow (70 rats 
trapped; Table 4.3.), and 37% for all the other sites combined (73 rats; Table
4.4.). From the observed frequency of Grl alleles in the Glasgow population, 
an expected frequency of homozygosity was calculated at 23% on the 
assum ption of Hardy-Weinberg equilibrium. This is substantially lower 
than the observed frequency of 37%. This may indicate the existence of 
deem structures in rats with significant levels of inbreeding, similar to 
those reported in wild mouse populations, but further work is needed to 
relate capture sites to the local geography of rat populations.
There was a qualitatively similar distribution of CAG repeat lengths in the 
GR of inbred strains and wild rats. Neither set of animals had CAG repeat 
lengths of less than 7, or between 8 and 16, indicating that these alleles are 
either absent, or at least are significantly under-represented. The inbred 
strains analysed in this study originated from Europe, USA and Japan. It is 
therefore unlikely that the observed allelic discontinuity is due to 
sampling bias, although it is possible that other rat populations exhibit 
atypical allele lengths. Apart from genetic drift due to the effects of chance 
sampling, the observed rGR alleles may have a selective advantage through 
their function as transcription factors. The latter possibility has not been 
resolved.
The observed distribution of rGR alleles may reflect a non-random  
m echanism  by which trip let repeats expand and contract. Though 
discontinuous distributions are relatively uncommon for non-disease 
related alleles, they have been demonstrated for a small number of human 
loci, including HUMRENA4 (renin) and markers DSX 228 and DSX 426 
(properidin P; Coleman et al., 1991). The myotonic dystrophy (DM) locus has 
an unstable (CTG)n repeat in the 3'-untranslated region (3'-UTR) of a gene 
encoding a protein kinase family member (DMPK; Harris et al., 1996). This 
sequence is highly polymorphic in the normal population, presenting 
(CTG)n variants with between 5 and 36 copies (Brook et al., 1992; Zerylnick 
et al., 1995). In the studies of both Brook et al., (1992) and Zerylnick et al., 
(1995), significant numbers of normal individuals had a (CTG)s repeat
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allele. Repeat lengths of (CTG)6 - 9  were very rare and lengths of (CTG)io-15 
were also observed at high frequency. The under-representation of DM 
(CTG)6 - 9  and Grl (CAG)s-16 alleles may have a similar cause: namely that 
Grl (CAG) 7 and DM (CTG)5 repeat alleles may be too stable to create frequent 
length variants, but occasionally mutate through a multi-step process to a 
larger allele size, from which further diversification generates a typical 
series of microsatellite alleles, probably by replication slippage (Sinden 
and Wells, 1992). In primates, there is evidence to suggest that there is a 
general progression towards increased m icrosatellite lengths with 
evolutionary time (Rubinsztein et al., 1995).
The inbred samples analysed here included some closely related strains 
(Table 3.3). Amorat/Wsl and Aristorat/Wsl are congenic strains based on 
LOU/C (respectively: LOU/C.IgK-lb OKA and LOU/C.IgH-12b OKA; 
Greenhouse et al, 1990; Hedrich, 1990); all three have GrlCAG17, which was 
uncommon in the present wild populations. BD strains E, IV, VII, IX and X all 
have GrlCAG7, and originate from coat colour crosses of Druckrey 
(Greenhouse e t al., 1990), mainly from the founding lines BDI-III. The 
origin of strains BC and U (GrlGAG7) are not certain, but both arose in 
Utrecht. Allele GrlGAG7 was common in the wild rat populations sampled 
(Fig. 4.7 and Table 4.1.). Alleles GrlGAG22>23 were found in wild rats only, 
with the latter being relatively common. As expected, none of the 155 wild 
rats sampled exhibited very large allele sizes which might have been 
indicative of a trinucleotide expansion syndrome.
In addition to the expressed genetic variation within the CAG repeat, 
genetic variation was investigated in GR codons at nucleotide positions 198, 
531, and 711 which are silent in effect and do not lead to changes in amino 
acid sequence (these nucleotide coordinates are based on the GrlGAG21 
allele and extends over nucleotide positions 223-288). These four variable 
sites are very close together and constitute haplotypes within which 
recom bination is expected to be very rare. For haplotypes including 
GrlCAG211 four sites extend over a distance of 513 bp in rGR exon 2, 
corresponding to a recombination interval of about 5 x 10~4 cM (Jacob et
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al., 1995). For the range of CAG repeats from GrlCAG7~23, this distance 
corresponds to 471-519 bp, respectively. Laying aside the unlikely 
possib ility  th a t CAG rep ea t lengths of 7-23 are significantly  
recombinogenic, GR haplotypes will therefore on average only be expected 
to be disrupted by recombination once per 200,000 rat generations. Six 
different GR haplotypes were identified from the panel of inbred strains of 
ra t (Tables 4.5. and 4.6.). The synonymous nucleotide differences of 
haplotypes 2 and 6 show that the CAG repeats in these two haploypes have 
separate origins; this also applies to haplotypes 3 and 5 (CAG19). Haplotypes 
5 (CAG19) and 6 (CAG20) do not differ at the other three nucleotide 
positions; since both haplotypes are Wistar-derived, the possibility that 
both are directly related through a mutation in the CAG repeat number 
cannot be excluded. Strains SHR and SHR-SP are hypertensive strains 
derived from outbred Wistar-Kyoto stock and OKA is believed to be a subline 
of SHR (Greenhouse et al., 1990; Otsen, 1995). A close relationship between 
these strains is supported by the presence of GR haplotype 5 in all three 
strains (Table 4.6.). Strains MNS and MHS are Wistar-derived. They have GR 
haplotypes 4 and 6, respectively, which differ at all four sites (Table 4.6.). 
Although it is not known whether the differences in haplotypes arise as a 
result of recom bination or from point m utation events, the results 
presented here suggest that haplotypes 4 and 6 were separate for thousands 
of generations before fixation in the Milan selection lines (Bianchi et al.,
1984) and it is therefore likely that MNS and MHS will show other genetic 
variation in the genome flanking the GR locus. In support of this proposal, 
Figure 4.10. shows a dendrogram of the geneologic relationships between 
63 inbred laboratory rat strains and 124 of their substrains (taken from 
Canzian, 1997). The relatedness of strains was based on a total of 995 genetic 
and biochemical m arker typings and implies a significant degree of 
genetic divergence between strains MHS and MNS.
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Glucocorticoid receptor polymorphism: possible association 
with glucocorticoid based phenotypes in Milan rats
The majority of data in this chapter is not my own work, but resulted from a 
collaborative effort between myself my supervisors and the group of G. 
Bianchi, Department of Nephrology, S. Raffaele Hospital, Milan, Italy. The 
work was in itiated  following the characterisation of glucocorticoid 
receptor steroid binding affinity differences between MHS and MNS strains 
of rat (C. Kenyon and M. Panarelli) and identification of the triplet (CAG)n 
repeat polymorphism, the result of my own work (discussed in chapter 3). 
This polymorphism was used to screen for association between Grl and  
glucocorticoid related phenotypes in F2 rats of an MHS x MNS cross.
5.1.) Introduction
The Milan hypertensive strain of rat (MHS) presents altered renal function 
(Bianchi et al., 1986) and increased adrenocortical activity (Ferrari et ah,
1985) when compared to its norm otensive control strain  (MNS). A 
significant proportion of the MHS hypertension is sustained by the kidney 
(Bianchi e t al., 1984) as demonstrated by a long series of observations, 
starting from studies of renal cross-transplantation between the two 
strains (Bianchi et al., 1986). Recent genetic studies have demonstrated that 
a point m utation within the a-subunit of a heterodimeric cytoskeletal 
protein, adducin, increases Na-K-ATPase activity when transfected into 
renal epithelial cells (Tripodi et al., 1996). In vivo, this mutation affects 
blood pressure, accounting for 40% of the blood pressure difference 
between MHS and MNS, when interacting with a mutated p-adducin subunit 
(Bianchi et al., 1994).
Previous studies have established that MHS exhibits adrenocortical 
hypertrophy, together with higher steroid secretory rates and raised 
plasma corticosterone concentrations compared with MNS (Ferrari et al., 
1985; Stewart et al., 1993). There are also suggestions of mineralocorticoid 
excess in MHS, with extracellular volume expansion, plasma renin 
suppression and increased body sodium content (Fraser et ah, 1994). Taken 
together, these observations might suggest an abnorm ality of HPA-axis
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function, resulting in a reduced  negative feedback regulation  of 
corticosterone synthesis. Inefficient glucocorticoid activity may result 
from reduced access of hormone to the glucocortiocid receptor, or from an 
abnormality of the glucocorticoid mediated regulation of CRF and /o r  POMC 
gene transcription or secretion of ACTH from the hypothalamus. Any of 
these effects might result in raised plasma corticosterone concentrations, 
causing activation of mineralocorticoid receptors. Clinically, similar 
situations arise because of defects in steroid metabolism, or because of 
intrinsic abnormalities of the glucocorticoid receptor (Lamberts et al., 
1992; Arai and Chrousos, 1994; Bronnegard et al., 1996). Steroid metabolism 
has been shown to be different between MHS and MNS, but not in a way 
which would affect steroid binding to adrenocorticosteroid  receptors 
(Stewart et al., 1993).
Recent studies (Kenyon et al., 1994; Panarelli et al., 1995) have suggested 
that the glucocorticoid receptor from strain MHS has a significantly lower 
affinity for steroids (cortisol, aldosterone and dexainethasone and the 
glucocorticoid antagonist, RU486) compared with its normotensive control 
strain, MNS. All ligands tested competed for specific ^H-dexamethasone 
binding sites in the GR from both strains of rat. Ranking, in terms of 
affinity, was the same for e ither s tra in  and  followed the pattern; 
dexamethasome > corticosterone > RU486 > aldosterone.
a.) 120
o — d e xam eth aso n e  
□  — c o r t ic o s te ro n e  
A- — a ld o s te ro n e
MHS M NS
100
—  60
o<u
CL.
tO 4.0
20
0
Ligand (M)
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b.)
★ -  P <  0 .05
d e x a m e th a s o n e  c o r t i c o s t e r o n e  a ld o s te r o n e  R U 4 8 6
LIGAND
Fig. 5.1. Steroid binding in Milan rat liver cytosol extracts.
a.) C om petition  fo r ^H -dexam e thasone  binding sites in GR by se lected g lucocortico id  
agonists and the antagonist RU486 in MHS and MNS.
b.) Bar charts show ing  d iffe rences in a ffin ity for the same g lucocortico id  agonists and 
an tagon is t shown in a.). R eceptor num bers (Bmax) were not d iffe ren t between strains, 
(steroid binding affin ities were determ ined by C. J. Kenyon and M. Panarelli).
Competition binding curves for three of the ligands are shown in Figure
5.1. (for reasons of clarity, RU486 curves which overlap those of 
corticosterone are not shown). Aldosterone and corticosterone appeared to 
compete less effectively for GR binding sites in cytosol from MHS than 
from MNS rats. For all ligands tested, Kd values for MHS were greater than 
for MNS glucocorticoid receptors, indicating a reduced binding affinity 
(Fig. 5.1.). For RU486 the affinity difference did not achieve statistical 
significance. Scatchard analysis of homologous dexamethasone binding to 
GR indicated a one site interaction model for both MHS and MNS, with Kd 
values of 1.39 ±0.15 nM (MFIS) and 1.0 ±0.11 nM (MNS) respectively.
Differences in Kds between strains were greatest for the weaker ligands. 
Compared with MNS, Kd values for MHS GR were 1.39, 2.19, 2.06 and 4.12-fold 
greater  for dexam ethasone, corticosterone, RU486 and aldosterone, 
respectively. The com petition curves for MNS were similar to those 
reported previously for other normotensive strains of rat (Panarelli et al., 
1995; Soro et al., 1995). Bmax values (number of receptor protein molecules 
per unit of total protein) were not significantly different between strains; 
434 ±33 (MHS) and 382 ±43 (MNS) fmol/mg protein.
135
5.2.) Materials and methods
Animals
MHS and MNS rat used in steroid binding analysis were obtained from the 
Field Station, University of Sheffield, UK and were maintained at a constant 
tem perature on a 12 h dark, 12 h light cycle with free access to food and 
water. All F2 rats used for genetic analysis were bred in Milan and 
maintained as described by Bianchi eta/., (1994). FI hybrids were produced 
by crossing MHS with MNS. By intercrossing FI progeny, an F2 population 
was obtained, consisting of approximately equal numbers of offspring from 
each reciprocal cross (251 total individuals; 121 male and 130 female).
GR genotype determination
For routine genotyping of the Milan-held rats, genomic DNA was extracted 
from the tail according to a standard procedure (Laird et al., 1991). GR 
sequences spanning the triplet (CAG)n repeats were amplified in 20 ml 
reaction volumes, by combining 250 ng of genomic DNA with 10-20 pmoles 
of each PCR primer (p9 and p l9 : see Appendix 1) and 1U Taq DNA- 
polym erase (Bioline, Glasgow, UK) in a standard  reaction mixture 
containing 2 mM MgCl2, 67 mM Tris-HCl (pH 8.0) 16 mM (NH4)2SC>4, 0.01% 
Tween 20 and 125 |iM of each dNTP. Reactions were cycled 30-times at 94°C 
for 50s, 53°C for 50s and 72°C for 90s with a final extension at 72°C for 5 
min, using a Geneamp PCR system 9600 therm al cycler (Perkin Elmer, 
Norwalk, USA). DNA templates were initially denatured at 94°C for 3 
minutes. PCR products were resolved as described in chapter 3 at 50 watt for 
3 hours in lx  TBE buffer. Amplified GR sequences were identified after 
blotting onto a positively charged nylon membrane (Pall Biosupport 
Division, Portsmouth, UK) and hybridising with com plem entary PCR 
fragments, 2p-labelled using a random primer labelling kit (Statagene, 
USA). Hybridisations were carried out in 10-20 ml sodium phosphate buffer 
(0.5 M, pH 7.2) containing 7% SDS and 10 mM EDTA for 2-6 h at 55°C. 
Membranes were washed in 100-125 mM sodium phosphate buffer 
containing 0.1% SDS at 55°C until the background was sufficiently reduced 
and then autoradiographed, as described in chapter 3.
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Blood pressure measurements
At three months of age, under light halothane anesthesia, cannulae were 
inserted into the carotid arteries of F2 rats and exteriorised at the back of 
the neck through a subcutaneous tunnel. Animals recovered within 5 
minutes and 4 h later the cannulae were connected, without restraint, to a 
Gould BS 3200 blood pressure recorder. For each rat, average values of 
systolic and diastolic blood pressure and heart rate were calculated from 
simultaneous measurements taken at 1 minute intervals over a 1 hour 
period. The body weight was recorded just before surgery (see Table 5.1.).
Urinary volume and calcium excretion
Rats were acclimatised to metabolic cages over a two day period. Urine was 
collected for the following 24 h and the total volume recorded. Urinary 
calcium  c o n ce n tra tio n  was m easu red  by atom ic ab so rp tio n  
spectrophotom etry  (Perkin Elmer 1100B spectrophotom eter), in the 
presence of 0.2% LiCl. Results (Table 5.1.) are expressed as mmoles calcium 
excreted/2 4h.
Statistical analysis
Values of blood pressure, body weight and urinary calcium concentration 
in F2 rats (Table 5.1.), are expressed as the mean ± standard error of the 
mean (SEM). Data from receptor binding studies for cytosols prepared on 
the same day with the same reagents and incubation conditions for age 
matched MHS and MNS rats were compared by two way analysis of variance 
(ANOVA); P-values of <0.05 were considered significant. Data from linkage 
studies were analysed by one-way or two-way ANOVA with Neumann-Keul's 
correction test for multiple comparisons (SPSS statistical package).
Western Blotting
Samples of rat liver proteins extracted for steroid binding analysis were 
analysed by Western blot as described in section 2.2.22. of this thesis.
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5.3.) Results
5.3.1.) Expression levels of the 94 kd GR species in preparations 
of liver cytosol from MHS and MNS
a.)
MW MHS MNS
68 Kd —
43Kd —
b.) MHS MNS MHS MNS
94Kd
Fig. 5.2. Com parison of the levels of Milan rat liver glucocorticoid  receptor 
protein.
a.) Hepatic GR from rat strains MHS and MNS was fractionated into three distinctive 
bands by SDS-PAG E. Heavy bands at 94 Kd represent m ajor GR translations 
initiated from GR m e tl. Minor GR bands at 91 Kd and 79 Kd are most likely to result 
from internal translations initiated from GR met2 and met3 respectively (see text for 
details). MW, high m olecular weight protein markers (GIBCO-BRL). For each strain,
30-40 pg of liver cytosolic extract was loaded per lane.
b.) SDS-m inigels showing reduced amounts of cytosolic extract loaded per rat strain.
Total protein loaded was reduced from 20-30, to 10 pg (samples on left) and finally 
to 2 pg (samples on right). The work presented in this figure is my own.
The size, integrity and expression level of the major GR band (94 Kd) and 
minor translations from met2 (91 Kd) and met3 (79 Kd) (Miesfeld et al.,
1986) were the same for either strain of rat (see Fig. 5.2a.). Using further
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pairs of Milan rats, together with the loading of reduced quantities of 
protein onto SDS gels (30-40pg, down to 2 pg protein), this result was 
confirmed (Fig. 5.2b.).
5.3.2.) Association between GR genotype and phenotypes
The trinucleotide (CAG)n repeat difference between MHS and MNS was used 
to genotype F2 progeny of an MHS x MNS cross. There was no significant 
association between GR genotype and systolic blood pressure when the total 
F2 population was analysed (one-way ANOVA; Table 5.1.). When only 
homozygous animals were taken into account; MNS/MNS 150.1 ± 1.8 mmHg 
(n = 59) versus MHS/MHS 145.4 ± 1.3 mmHg (n = 54); p = 0.04. No significant 
association was found between GR genotype and diastolic blood pressure at 
any level. When the F2 population was analysed according to sex, female F2 
progeny homozygous for the MNS GR allele had significantly higher 
systolic blood pressures than either heterozygotes, or rats homozygous for 
the MHS GR allele (p = 0.02: Table 5.1.).
G lucocorticoid receptor genotype
Group M N S/M N S M NS/M H S M HS/M HS P-value
Systolic
blood
pressure
(mmHg)
all
male
female
150.1 ±1.8 
(n = 59) 
147.9 ±2.7 
(n = 22) 
151.4 ±2.4 
(n = 37)
147.7 ±1.0 
(n =132) 
149.1 ±1.6 
(n = 68) 
146.3 ±1.2 
(n = 64)
145.4 ±1.3 
(n = 55) 
146.2 ±1.9 
(n= 29)
144.4 ±1.7 
(n = 26)
p = 0.04 
NS
p = 0.02
Body
weight
(8)
male
female
439 ±11 
(n = 21) 
276 ±4 
(n = 36)
420 ±5 
(n = 65) 
276 ±3 
(n = 63)
406 ±7 
(n= 29) 
279 ±5 
(n = 26)
p <0.01
NS
Urinary
calcium
(mmol/
day)
male
female
29.6 ±4.8 
(n = 21)
55.6 ±7.6 
(n = 35)
24.0 ±2.2 
(n= 59) 
63.8 ±6.0 
(n = 63)
31.4 ±3.8 
(n = 25) 
89.7 ±8.9 
(n = 24)
NS
p <0.005
Table 5.1. Association between glucocorticoid receptor genotypes and blood pressure, 
body weight and urinary calcium excretion in F2 Milan rats.
P-values for each variable are derived from F2 rats of M HS/M HS verses M NS/M NS  
genotype. NS = non-significant. The raw data from which the values in this table were 
determined was generated by L. Torielli, G. Casari, L. Zagato and G. Bianchi, Milan Italy.
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The body weight of male, but not female F2 rats was associated with GR 
genotype; male rats homozygous for the MNS GR allele were 11% heavier 
than male MHS GR homozygotes (P <0.01). In parental MHS and MNS rats of 
the same age, body weights were also significantly different (MHS, 413 ±8; 
MNS, 387 ±8; P = 0.02, n = 10).
In female but not male F2 progeny, MHS GR homozygotes excreted 
significantly higher levels of calcium than MNS GR homozygotes (p<0.005); 
strain differences in calcium metabolism in Milan rats have been described 
elsewhere (Cirillo et al., 1989). There was no indication that heart rate and 
urine volume were different between strains (data not shown).
5.4.) Discussion
Previous studies of phenotypic differences between MHS and MNS have 
implicated renal function in the control of blood pressure (Persson et al.,
1985). The genes coding for the epithelial membrane protein adducin, were 
found to contain m utations giving rise to 40% of the blood pressure 
increase in MHS (Bainchi et al., 1994). One hypothesis was that an 
abnorm ality of GR function might account for part of the remaining 
difference in blood pressure between MHS and MNS. This was the subject of 
the investigation presented in this chapter.
Compared with MNS, the MHS strain of rat shows hypertrophy of the 
adrenal cortex with increased adrenocortical activity. The result is an 
increased cortical secretion rate and raised plasm a corticosterone 
concentrations (Mantero et al., 1983; Ferrari etal., 1985; Stewart etal., 1993; 
Fraser et al., 1994). Negative feedback control of pituitary ACTH secretion 
by GR in conditions of glucocorticoid excess would be expected to suppress 
overactivity of the adrenal cortex. Any deviations from normal GR function 
are therefore likely to be associated with abnormal patterns of hormone 
secretion (Mantero et al., 1983; Brandon et al., 1991; Hurley et al., 1991; Cole 
et al., 1993; Stewart et al., 1993; Keightley and Fuller, 1994). With reduced
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affinity of GR for its hormonal ligand, higher than normal concentrations 
of corticosterone, together with a possible up-regulation of GR expression 
would be required to maintain homeostasis. On the other hand, conditions 
of glucocorticoid excess which do not result from abnormalities of GR 
function, would be expected to result in down regulation of the GR message 
in order to compensate for the overproduction of glucocorticoids (see  
section 1.3. and references therein). A reduced receptor affinity (either as 
a primary or secondary mechanism) may therefore be a real phenomenon 
in MHS in vivo, since no evidence of hepatic GR down regulation was 
identified (Fig 5.2.).
Comparisons of steroid binding in hepatic cytosol from MHS and MNS rats 
have suggested that affinities for dexamethasone, corticosterone and 
aldosterone are lower in MHS. Differences in receptor affinity were least 
for the strongest ligand (dexamethasone) and greatest for the weakest 
ligand (aldosterone). Binding capacities (Bmax) were not significantly 
different between strains (see Figure 5.2.). This observation is supported by 
previous reports of non-significant differences in the levels of GR mRNA 
in both liver and kidney from these rat strains (Stewart et al., 1993). The 
apparent lack of GR down-regulation in MHS might be explained by a 
complementary reduction in steroid binding affinity accommodating the 
increase in plasma corticostreone levels. In patients with primary cortisol 
resistance (Arai and Chrousos, 1994; Bronnegard e ta l ,  1996), a lowering of 
GR binding affinity is predicted to cause an increase in blood pressure due 
to an increase in cortisol concentration acting on type I mineralocorticoid 
receptors. The resulting pathophysiology is similar to that found in MHS 
rats: increases in body sodium, plasma volume and plasma renin  
suppression.
The specificity and sensitivity of glucocorticoid horm one actions are 
controlled by a variety of factors including: 1.) access of hormone to the 
receptor which is regulated by enzymes and by cell membrane steroid 
transporters; 2.) a number of accessory proteins which, when complexed 
with the receptor, maintain a high affinity binding state and facilitate
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translocation to the nucleus and interaction with glucocorticoid response 
elements in the DNA; 3.) tissue-specific receptor expression; 4.) the 
primary structure of the receptor protein. Most of these factors can be 
excluded as likely explanations of the suggested differences in GR binding 
affinity. Lower hepatic llb -hydroxystero id  dehydrogenase (11(3-HSD) 
activity has been observed in MHS compared with MNS (Stewart et al.,
1993). The liver isoform of llp-HSD favours the reduction of 11- 
dehydrocorticosterone (biologically inactive) to produce corticosterone 
(Jamieson et al., 1992). Reduced levels of llp-HSD in MHS liver might 
therefore limit access of corticosterone to GR in vivo. However, reduced 
11 p-HSD activity is unlikely to be a cause of reduced receptor binding 
affinity in MHS in vitro for two reasons. Firstly, llp-HSD is a microsomal 
enzyme which would be absent from the cytosolic extracts used in these 
experiments. Without added co-factors, even residual activity would be 
negligible. Secondly, the ranking of the differences in affinity between 
MHS and MNS for the steroids tested (aldosterone > corticosterone > RU486 > 
dexamethasone) does not match substrate specificity for llp-HSD (Panarelli,
1994). The involvement of plasma membrane steroid hormone transporters 
in the regulation of receptor binding in cytosol is unlikely.
In clinical cases of steroid resistance, reduced binding affinity often 
resu lts  from  recep to r th erm o lab ility  (W erner e t al., 1992). 
Characteristically, for these receptors, steroid binding affinity is markedly 
decreased by prolonged incubation at elevated temperatures (up to 37°C) 
which is most likely the result of the dissociation of heat shock proteins 
(hsp) from the receptor. High affinity binding of GR is only observed 
when the receptor is complexed with other proteins including hsp90 and 
hsp70 (Pratt, 1993). Panarelli et al., (1995) were able to show that GR from 
the SHR strain of rat (see chapter 3), which has a higher affinity for 
dexamethasone than the WKY strain, also shows a greater thermostability. 
No such difference between MHS and MNS receptors was found (results not 
shown).
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Comparison of GR coding sequences from MHS and MNS strains of rat 
revealed no structural m utations which might explain the apparent 
differences in receptor steroid binding affinity. The only sequence 
difference identified was a polymorphism of the trinucleotide (CAG)n 
repeat (described in chapter 3). The MHS GR coding sequence has one CAG 
repeat less than that of MNS. While it is unlikely that the (CAG)n repeat 
polymorphism  would account for the suggested differences in steroid 
binding between strains ((CAG)n repeat expansions in the hum an 
androgen receptor have no m easurable effect on steroid  binding; 
Chamberlain et al., 1994) possible effects on the transcriptional regulatory 
properties of GR remain to be determined (see chapter 7). The lack of down 
regulation of GR by elevated plasma corticosterone levels (Stewart et al., 
1993 and pp 134-135 of this chapter) is suggestive of reduced GR activity in 
MHS.
The level at which glucocorticoids affect body weight is difficult to 
interpret. Low doses of glucocorticoid are required to m aintain normal 
growth (Kenyon et al., 1986) whereas supraphysiological doses are 
catabolic (Tonolo et al., 1988). Similar effects are seen in children whereas 
adult patients with Cushing's disease tend to develop central obesity. 
Transgenic mice expressing an antisense GR message (displaying partial 
and tissue specific depletion of GR) develop obesity (Pepin et al., 1992). 
Parental MHS rats are generally heavier than MNS, which is associated 
with hyperlipidaemia in the hypertensive strain. However, in F2 rats the 
MHS GR allele is associated with reduced body weight in male rats. It is not 
known whether this is due to changes in lipid metabolism or a difference 
in growth rate. Grl may represent a QJL which is in close linkage with 
another gene which affects weight gain. It is of in terest that a gap 
junction protein locus on chromosome 18 is also found associated with body 
weight (Katsuya et al., 1995).
Adrenal hypertrophy has been described in MHS, which appears to be 
caused by hyperplasia and hypertrophy of zona glomerulosa cells, rather 
than zona fasciculata cells (Mantero et al., 1983). Whether reduced negative 
feedback of ACTH secretion due to abnormal GR properties can account for 
adrenal hypertrophy in MHS is unclear.
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A significant association (p < 0.005) was found between the MHS Grl 
genotype and urinary  calcium content in female F2 homozygotes. 
Hypercalcuria in the Milan hypertensive stra in  has been reported 
previously  (Cirillo et al., 1989). Despite norm al serum  calcium 
concentrations, in fasting conditions, urinary calcium is increased, while 
bone calcium content is significantly reduced. These findings strongly 
suggest that hypercalciuria in MHS may be explained by altered renal 
calcium handling. The incidence of hypercalcuria in F2 rats homozygous 
for the MHS GR allele suggests the possibility of a mutation, either in Grl 
(in GR itself or more likely in a closely linked gene involved in calcium 
metabolism) or at another locus in close linkage with Grl. Why this 
phenotype is restricted to female rats is unclear. This difference may 
reflect the mechanistic complications of calcium metabolism, which is 
diversified still further by gender. As described in chapter 4, the Grl 
haplotypes between MHS and MNS show a high degree of genetic 
divergence which, on the basis of their geneologic relatedness, is likely to 
exist elsewhere in the Milan rat genomes, including Grl.
One way to show whether or not Grl has an effect in determining 
phenotype in MHS could be the development of congenic strains of rat, in 
which Grl is essentially expressed in vivo on a normal or 'control1 genetic 
background (Weil et al., 1997). The development of such strains in Milan is 
currently in progress, in which the MHS Grl locus will be recombined into 
the normotensive (MNS) genetic background by a process of cross­
breeding. The development of MHS Grl-linked phenotypes in the resulting 
hybrid strains might be indicative of a role for Grl in contributing to MHS 
phenotypes.
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Chapter 6 
Results 4
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Steroid binding by glucocorticoid receptor proteins expressed  
in tissue culture
6.1.) Introduction
Functionally, trip le t repeat expansions in the coding sequence of 
hormonally regulated transcription factors such as GR may be important at 
either of two levels: effects on steroid binding affinity and the ability of 
the molecule to function as a transcription factor.
Presented in this chapter is a detailed examination of the ability of rat GR 
proteins with variable length polyglutamine tracts to bind steroid ligands. 
Binding experim ents for two steroid ligands, dexam ethasone and 
corticosterone, were carried out for both natural and constructed GR alleles 
following expression in a selected cell line. Tissue culture cells provide a 
uniform system in which all cellular components, including proteins of 
the GR heterocomplex and concentrations of endogenous ligand, are 
standardised for each allele tested. This allows an unbiased functional 
assessment of GR variants.
Part 1
6.2.) Analysis of natural GR alleles expressed in COS-7 cells
6.2.1.) Methods for cloning of natural GR alleles
The expression clones pcDNAlNeo-rGR21, 20, and 7 were constructed from 
the following plasmids: pRBalll7 (see chapter 3, Fig. 3.2.); pSL301 
(Invitrogen, Abingdon, Oxon, U.K.), a 3.2 kb bacterial cloning vector 
containing a superliker housing 46 novel restriction sites. The plasmid also 
carries a ColEl replicon (promoting high copy number) and an ampicillin 
resistance gene; pcDNAlNeo (Invitrogen), a 7.0 kb eukaryotic expression 
vector carrying both colEl and SV40 polyoma replicons (promoting high 
copy numbers in bacterial and eukaryotic cells, respectively). Nine novel
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restiction sites are located in a short polylinker, preceded by a CMV 
prom oter. A kanamcyin resistance gene is included for selection of 
recombinants in E. coli. All methodology for DNA restriction and cloning 
steps were as described in sections 2.2.6. and 2.2.10. Resulting clones were 
verified either by restriction analysis or by sequencing across ligation 
junctions.
Step 1: Deletion o f  single Ncol site from pSL301
A convenient method of constructing natural rat GR cDNAs with differing 
triplet repeat lengths, was to substitute the 5' 317 bp from an existing rGR 
cDNA (e.g. from pRBalll7) with similar sequence, PCR-amplified from 
specific GR alleles containing triplet (CAG)n repeats of unique length. This 
was possible using a novel Ncol site in the GR coding sequence starting at 
n317 (relative to m etl) and similarly required a vector, either without an 
Ncol site, or a single Ncol site which could be deleted such as pSL301. Ncol 
site deletion from pSL301 was achieved by Ncol-restriction, followed by 
Klenow fill-in of 3' recessed ends (described in section 2.2.10.) and re­
ligation using T4 DNA ligase producing the vector, pSL301.1 (Fig. 6.1c.).
Superlinker
a.) pSL301
c.) pSL301.1
1
 ►
AmpR
B X
3.3 kb
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Fig. 6.1. Removal of Nco^ site from pSL301, producing pSL301.1.
a.) pSL301 native vector.
b.) Ncol restriction of eukaryotic expression vector pcD N A IN eo  and pSL301. pcD N AIN eo 
conta ins four A/co1sites, making it unsuitable for rGR Ncol m anipulations. Lanes 1 and 3, 1 
Kb DNA ladder; lane 2, pcD N A IN eo  cut with A/co1; lane 4, pSL301, uncut; lane 5, pSL301 
Nc o l cut. Linear vector migrates at an expected 3.3 Kb.
c.) M inimal restriction map of pSL301.1 (superlinker /Vco1 site deleted).
Step 2: PCR amplification o f  GR triplet repeat DNA, Cloning and sequencing 
Amino-terminal GR coding sequences of genotypes 20  (from rat strain 
MHS) and 7 (from rat strain BC: chapter 3, Table 3.3.), including the first 
ATG start codon and triplet (CAG)n repeat, were amplified from rat genomic 
DNA as described in section 2.2.3. using Vent^M p>NA polymerase in 
conjunction with PCR primers rGR19 (carrying a BamHl restriction site) 
and pG (Appendix 1). Vent IM DNA polymerase was necessary to produce 
mutation-free PCR products. Amplified DNA was digested using BamHl and 
Ncol, column purified to remove excess PCR primers and digested DNA ends 
(section 2.2.10.) and then ligated into the BamHl/Ncol cut pSL301.1. 
Following transformation of DS941 competent cells, a selection of colonies 
from each rat strain DNA-specific ligation were picked into 5 ml LB medium 
supplemented with ampicillin (50pg/ml) and grown overnight at 37°C as 
described in sections 2.2.11. and 2.2.12.
a.) 1 2 3 4 5 6 7 8  b.) 1 2 3 4 5 6 7 8
3.0 Kb
3.0 Kb
9 10 11 12 13 14 15 16
C.)
3.3 Kb
344 bp 
302 bp
Fig 6.2. Identification of pSL301.1 clones containing rGR trip let repeats.
a.) Examples of m iniprepped DS941 transform ed using pSL301.1-rGR trip le t repeats PCR 
product ligations (see text for details). Lanes 2-8, potential MHS (20-repeat) transform ants; 
lanes 10-16, potential BC (7-repeat) transformants; lanes 1 and 9, 1 Kb DNA ladder.
b.) C lones from panel a.) digested using BamHl and A/col. Lanes 3 and 14 identify potential 
recombinants; lanes 1 and 9, 1 Kb DNA ladder.
c.) Following BamHl and Ncol digestion, strain BC and MHS specific clones were identified 
by fractionation on 2% gels. Lane 1, I Kb DNA ladder; lane 2, pSL301.1 with no insert; lane 3, 
MHS triplet repeat positive clone; lane 4, BC triplet repeat positive clone.
Figure 6.2a. shows examples of plasmid miniprep DNA from each set of 
clones. A second round of BamHl/Ncol digestion was able to identify those
148
plasmids containing a PCR fragm ent of the expected size. Faithful 
amplifications from each GR allele were identified by sequencing 5-10 gg 
of plasmid DNA from sense and antisense primers p9 and p l9  respectively 
(Appendix 1), using sequenase version 2.0 for plasmid sequencing (section 
2.2.13.). Clones carrying mutation-free inserts were preserved by streaking 
onto LB-ampicillin plates. A clone of each GR genotype was grown as a 
midiculture to provide DNA for further subcloning.
Step 3: Subcloning o f  rat GR cDNA from pRBalll 7 into pSL301.1 
Manipulation of the rat GR coding sequence required an initial subcloning 
of the entire cDNA from pRBalll7  (containing one Ncol site) into the 
vector pSL301.1. The rGR cDNA (2.8 kb; comprised of the receptor open 
reading frame, plus 24 nucleotides of the 5' UT and the first 360 nucleotides 
of the 3'UT) was lifted from pRBalll7 by BamHl restriction and ligated bi- 
directionally into pSL301.1 at a unique BamHl site. Linearised vector DNA 
(Fig. 6.3b) was de-phosphorylated using calf intestinal phosphatase (CIP: 
see section 2.2.10.) to prevent vector re-annealing. This resulted in the 
clone pSL301.1-rGR22 (Fig. 6.3f.).
1 2 3 4 5 6 b.) 1 2 3
3.3 Kb 2.8 Kb
149
f.) pSL301.1-rGR 21
B N  X B X
AmpR
rGR 21 cDNA 3’UT
6.1 kb
Fig. 6.3. Subcloning of the entire rat GR cDNA into pSL301.1.
a.) Restriction analysis of pRBal117 confirmed authenticity. Restriction enzymes used were: 
lane 2, BamHl, Iane3, Bgl\l, Iane4, N ed ; Iane5, Xbal, lane 6 H/'ndlll. Lane 1, 1Kb DNA ladder.
b.) Band purified Bam HI-cut pSL301.1 vector (lane 2) and rGR cDNA insert (lane 3). Each 
lane shows a loading of approxim ately 50 ng of DNA. Fragments were ligated at a ratio of 
1:1.
c.) C lonal selection showing examples of potentially positive recombinants (lanes 3 and 8).
d.) and e.) Restriction analysis of recombinants to check orientation of possible rGR inserts, 
using d.) EcoR1, lanes 2-8. Lane 1, 1 Kb DNA ladder and e.) Bam Hl, lanes 2-5, BgHI, lanes 
6-8 and 10 and Ncol, lanes 11-14.
f.) Linear map of clone pSL301.1 -rGR27.
Step 4: Removal o f  3 '-BamHl site from pSL301.1-rGR21
The BamHl/Ncol subcloning required to produce GR triplet (CAG)n repeat 
length variants would be compromised by the presence of both 5' and 3' 
BamHl sites. The 3' site was therefore removed by Xbal restriction at sites 
closely flanking the 3' BamHl site, one in the rGR 3'UT (at position n2815: 
nucleotide coordinate taken from the published sequence) and the other at 
the 3' end of the pSL301.1 superlinker (Fig. 6.3f.)- pSL301.1-rGR21 was 
digested with Xbal, the 87bp Xbal/Xbal  fragment removed (isolation of 
larger clone fragment by gel electrophoresis followed by band excision 
and dialysis: section 2.2.10.) and the clone religated through common Xbal 
cohesive ends. The resulting clone was named pSL301.1-rGR2iX£>a (Fig.
6.4.).
pSL301.1-rGR 21 Xba
6.1 kb
rGR 21 cDNA
AmpR
3’UT
Fig. 6.4. Rat GR clone pSL301.1-rGR27Xba.
Removal of the 3' BamHl site from clone pSL301.1 -rGR27 gave rise to a clone with novel 
BamHl and Xba  I sites, thus allowing simple directional subcloning into the mammalian 
expression vector pcDN AINeo.
Step 5: Amino terminal BamHI/NcoI fragment replacement
The clone pSL301.1-rGR22X£>a was digested with BamHl and Ncol and the
larger vector fragment isolated and purified as described in section 2.2.10.
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pSL301.1-rGR clones containing mutation-free PCR amplified GR inserts of 
differing polyglutamine tract length (from step 1) were also digested (from 
midiprepped DNA) with BamHl and Ncol. Insert DNA fragments were band 
fractionated on 1.5% agarose gels, purified by dialysis (Fig. 6.5a.) and 
substituted directionally into the linearised clone pSL301.1-rGR21Xba (Fig.
6.5c.).
a.)
5.8 kb
b.)
344 bp 
302 bp
1
5756 bp
344 bp 
302 bp
c.) pSL301.1 rGR 20  and 7 Xba
B N
1
AmpR
i i
20
7
rGR cDNA
N
bd
21
B N
B N
d r i  pcr
20
7
rGR cDNA
6.1 kb
6.1 kb
Fig. 6.5. Replacem ent of trip let (C A G )n repeat containing am ino term inal fragm ent of 
rGR cDNA.
a.) Purified DNA fragm ents used in triplet repeat subcloning. Lane 2, 5.8 Kb BamH\/Ncd cut 
pSL301.1-rGR27 Xba ; lane 3, 344 bp strain MHS triplet repeat specific PCR product insert; 
lane 4, 320 bp strain BC triplet repeat specific PCR product insert. Lane 1, 1 Kb DNA ladder.
b.) Verification of positive trip le t repeat variant clones. Lane 2, BC specific; lane 3, MHS 
specific; lane 1, 1 Kb DNA ladder.
c.) S trategy for Bam\-\\/Nco\ fragm ent replacement, producing 20 and 7 CAG repeat variant 
clones.
Potential recombinants were selected as described in Figure 6.3 and 
verified by BamHl/Ncol  restriction (Fig. 6.5b.) which also demonstrates
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maintenance of the Ncol site in the coding sequence of rGR. Because no 
o ther manipulations were made, BamHl/Ncol digestion was considered a 
sufficient check for these clones.
Step 6: Subcloning o f  full length rat GR cDNAs into pcDNAINeo 
Clones pSL301.1-rGR2J, 20 and 7 Xba, together with pcDNAINeo (polylinker) 
were digested with BamHl and Xbal. rGR cDNAs and linearised pcDNAINeo 
were purified (Fig. 6.6c.) and ligated as described previously (Fig. 6.5.).
a.) pcDNAI Neo
7.0 kb
pCMV SV40 intron/pA SV40 Polyoma SV40 p4
b.) pSL301.1-rGR 21, 20, 7 Xba
B N
-hrt
rGR 21, 20, 7 cDNA
AmpR
3’UT
6.1 kb
c ) 1 2  3
7.0 Kb 
2.8 Kb
d.) pcDNAI Neo-rGR 21, 20, 7
B N
rGR 21, 20, 7 cDNA
pCMV
3 ’UT
SV40 intron/pA
9.8 kb
SV40 Polyoma/ 
SV40pA
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Fig. 6.6. Subcloning of rGR cDNA from pSL301.1 into m am m alian expression vector 
p cD N A IN eo.
a.) Liner map of vector pcDNAI Neo.
b.) General liner map of pSL301.1 -rGRXba clones.
c.) Band purified Bam HI/Xbal-cut pcD N A IN eo  (Iane2) and example of rGR cDNA (21 repeat: 
lane 3). Lane 1, 1 Kb DNA ladder.
d.) General liner map of pcDNAI Neo-rGRXba clones.
The orientation of rGR m etl ATG was confirmed for each pcDNAlNeo-rGR 
expression clone. Figure. 6.7c. shows part of the polylinker and ATG m etl of 
clone pcDNAlNeo-rGR21 as an example. Clone pcDNAlNeo-rGRJ8 was 
isolated following selection for pcDNAlNeo-rGR2D clones in DS941. The 
authenticity of this clone was verified by sequencing of the triplet repeat 
and immediate flanking sequences, and by restriction analysis (see Fig.
6.7.). Prior to COS-7 cell transfection, all rGR cDNA expression clones were 
purified by cesium chloride density gradient centrifugation (Fig. 6.7d.).
a )  1 2 3 4 5 6  b.) 1 2 3 4
c . )
T
A -
C
d ) 1 2 3 4 5
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Fig. 6.7. Analysis of pcD N A I Neo-rGR clones.
a.) R e s tric tion  an a lys is  of p c D N A IN e o -rG R 2 d  is show n as an exam p le . P lasm id  D NA w as 
d ig e s te d  w ith  B a m H l ,  Iane2; X b a l ,  Iane3 ; B am H l / Xba l ,  Iane4; BamH l / Nc o l ,  Iane5  and 
B am H I/E coR I, Iane6. Lane 1, 1 Kb DNA ladder.
b.) Nco l  res tric tion  ana lys is  of c lones  p cD N A I N eo-rG R 27, 2 0  and 7 (lanes 2-4, respective ly). 
Lane 1, 1 Kb DNA ladder.
c.) S equenc ing  o ve r m e tl ATG  con firm ing  o rien ta tion  of rGR cD N A  in p c D N A IN e o  c lones. 
C lones w ere  sequenced  from  the  an tisense  prim er, rG R 29 (A ppend ix  1). T he  le tte rs A, C, G 
and T  above  sequence  tracks rep resent te rm ina ting  nucleotides.
d.) p c D N A I N e o -rG R 2 7 , 2 0 ,  18  and 7 c lones, lanes 2-5, respective ly . 1 pg of p lasm id  DNA 
w as loaded per lane. Lane 1, 1 Kb DNA ladder.
Construction o f  triplet repeat negative clone, pcDNAI Neo-rGRg (-)
A GR clone in which the triplet (CAG)n repeat and first two start codons 
(metl and met2) were deleted, was constructed using the pSL301.1-rGRcDNA 
clone diagrammed in Figure 6.5c. In place of the subcloned rat strain 
specific PCR product, the BamHl/Ncol gap was closed using a BamHl/Ncol- 
ended double stranded oligo, constructed from oligo half sites rGR32 and 
rGR33 (Appendix 1).
a.) PSL301.1 rGR cDNA
B N
6.1 kb
rGR cDNA
AmpP
5 ' >  GATCCGCCGTTTCACTGTC < 3 ' -rG R 32
3 '>  GCGGCAAAGTGACAGGTAC < 5 '  -rG R 33
b.) pSL301.1 rGR p (-) cDNA
B N 5.8 kb
rGR cDNA
AmpP
Fig. 6.8. Rem oval of trip let (C A G )n repeat and first two start ATG codons from  rGR 
cDNA.
a.) pSL301.1 B a m H l / N c o l - c u t  The  insert o ligo  fragm en t is show n in red. O ligo  ha lf s ites  are 
deta iled  in A ppend ix  1.
b.) R esu lting  trip le t repeat nega tive  c lone  pS L301 .1 -rG R  p(-) cD N A . B, B am H l; N, Ncol ,  X, 
Xbal .
The resulting rGR cDNA was then subcloned into the expression vector 
pcDNAINeo as previously described.
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a.) pSL301
S uperlinker  
B X
AmpR
b.) pSL301.1
AmpR I
c.) pSL301.1-rGR 21
B N
Amp R
d.) pSL301.1-rGR 21 Xba
B N
rGR 21 cDNA
I
AmpR
rGR 21 cDNA
J
e.) pSL301.1 rGR 20  and 7 Xba
8 N rGR cDNA1
►
N
b d
21
Amp R
V
B X
B N 
t l j  PCR
20
7
B N
:i±
AmpR
20
7
rGR cDNA
X B X
3’UT
3'UT
3 . 3  k b
3.3 kb
6.1 kb
6.1 kb
6.1 kb
6.1 kb
Fig. 6.9. Summary of the subcloning of rat GR cDNA from clone pRBal 117 
into pSL301.1.
a.) Manipulation vector pSL301, showing superlinker w ith positions of unique A/col, 
BamH\  and Xb a  I restriction sites.
b.) Deletion of Ncol  site from  pSL301, producing vector pS301.1.
c.) BamHl  ligation of 2.8 kb rat GR cDNA from clone pR B a ll 17 into pS L301.1.
d.) Removal of 3 ’ BamHl site from cDNA cloning site.
e.) R eplacem ent of 5 ’ BamHl /Ncol  restriction fragm ent (genotype 21) ,  with sim ilar PCR 
am plified fragm ents of genotypes 2 0  and 7 (see text for details).
Restriction sites are as follows: N, Ncol: B, BamHl; X, Xbal:  H, Hind  III. AmpR- Ampicillin 
resistance gene. 3’UT, GR untranslated sequence. ORF, open reading frame. PCR, GR 
amplified PCR product DNA. kb, kilobase pair.
6.2.2.) Culture of COS-7 cells and transfection with pSVp-gal and
pcDNAlNeo-rGR clones
The initial cell line chosen for transfection and GR steroid binding 
experiments was COS-7, which contains trace levels of endogenous GR. COS- 
7 cells are derived from CV-1 cells but, unlike CV-1 cells, contain the SV40 
T-antigen, promoting high copy number of transfected plasmids carrying 
the SV40 origin of replication (Gluzman, 1981).
Pilot experiments of transient transfection into COS-7 cells using DOTAP 
were carried out with the constitutive p-galactosidase expression clone 
pSVp-gal transfected at varying concentrations, p-galactosidase expressing 
cells were identified 48 h post transfection by X-gal staining (section 
2.2.18.), which showed the relative num bers of transfected cells. For 
preliminary analysis of GR expression and subsequent GR expression for 
steroid binding, cells at 80% confluence, were transfected with varying 
quantities of pcDNAlNeo-rGR expression clones (10 \ig for steroid binding 
assay) DNA using DOTAP (section 2.2.17.). COS-7 cells were grown on 10 cm 
tissue culture dishes (Nunclon, GIBCO-BRL) in DMEM prior to and 
throughout the 'transfected' growth period.
6.2.3.) Western blotting using an rGR-specific monoclonal
antibody
Prior to the use of GR monoclonal antibody Mab250, an optimal working 
concentration was determ ined by dot-blot analysis (section 2.2.22.). 
Antibody at dilutions of 1:500 and 1:1000 were incubated with strips of PVDF 
membrane spotted with rat liver cytosol extract, prepared as described in 
section 2.2.21.. Cytosol was spotted at concentrations of: 0.01-0.02, 0.1-0.2, 2 
and 10 ng total protein.
GR protein from alleles, GrlCAG 18> 20> and 21 expressed in COS-7 cells was 
analysed on 15x20 cm 8% SDS-polyacrylamide gels (section 2.2.22.). Aliquots 
of transfected cells were lysed directly in SDS-gel loading buffer prior to 
gel loading to try and avoid unnecessary disruption of the GR protein. 
Samples were band fractionated against prestained high molecular weight 
protein standards and Sprague Dawley rat liver cytosol extract.
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Proteins were blotted onto PVDF membrane and probed using the rat GR N- 
term inal specific monoclonal antibody Mab250 at a dilution of 1:750. 
Specific antibody binding to rat GR was detected autoradiographically 
using the ECL Western blotting kit (see section 2.2.22.).
6.3.) Results
6.3.1.) Expression of p-galactosidase in COS-7 cells
Cells successfully transfected with pSVp-gal and therefore expressing (3- 
galactosidase appeared blue following staining with X-gal. Figure 6.10. 
shows the proportional increase in numbers of blue cells with increasing 
concentrations of transfected plasmid DNA (Fig. 6.10. panels a.) to c.)). The 
transfection of a completely unrelated vector (pcDNAINeo) produced no 
blue cells (Fig 6.10 panel d.)). Under optimum conditions, it is recommended 
that DOTAP can promote transfection efficiencies of up to 50% or more, 
depending on the cell type and the quality of transfected DNA. This level of 
transfection was considered attainable with around 5-10 i^g of pSVp-gal DNA 
(Fig 6.10. panels b.) to c.)). A quantity of 5 i^g was therefore chosen as the 
starting concentration of GR clone DNA in testing for the expression of GR 
proteins in COS-7 cells.
6.3.2.) Expression of rat GR proteins in COS-7 cells
Detection o f overexpressed GR proteins
Following 48h growth, COS-7 cells transfected with GR expression clones 
were harvested, disaggregated and counted using a haemocytometer. Cells 
were pelleted and washed twice in ice cold PBS (pH 7.4). Routinely, 1-2x10^ 
cells were harvested per 10cm plate. Figure 6.11b. shows the level of GR 
expression in approximately 1x10^ cells per GR clone.
All clones were expressed, producing similar levels of GR protein. No 
obvious differences in protein stability were found. A low level of 
endogenous GR was also detected in untransfected COS-7 cells (Fig 6.11., lane
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Fig. 6 .10 . C O S -7  ce lls  transfected  w ith  the co n s titu tive  [3-galactosidase 
expression clone pSVp-gal.
Cells were transfected with: a .) 2 pg, b.) 5 pg or c.) 10 pg pSVp-gal. Positively 
transfected cells (expressing (3-galactosidase) appeared blue following treatment with 
X-gal/IPTG. Cells transfected with native pcDNAINeo were unable to breakdown X-gal 
and remained unstained (panel d.)). All plasmid DNA was transfected using DOTAP 
(see text for details).
6). Transfection with the vector pcDNAlNeo alone (Fig. 6.11., lane 2) 
produced no noticeable increases in the level of GR.
Fig. 6 .11. Specific  binding of rat g lucocortico id  receptor prote ins  by rat GR 
monoclonal antibody Mab250.
a.) Dot blot of rat liver cytosol extract: dot 1, 0.1-0.2; dot 2, 1-2, dot 3, 10-20 and dot 4, 
100 gg total protein, probed with differing concentrations of Mab250; panel A, 1:500 
dilution. Panel B, 1:1000 dilution.
b.) Western blot of rat GR proteins expressed from different GR alleles in COS-7 cells and 
separated on an 8% SDS polyacrylamide midi-gel. Lane 1, 50 pg rat liver cytosol extract 
(Sprague Dawley: size standard). Lanes 2-5, COS-7 cells transfected with 5 pg each of: 
native pcDNAlNeo; lane 2 and pcDNAINeo-rGR27; 20 and 7, lanes 3-5, respectively. 
Lane 6, untransfected COS-7. Lane 7, Prestained high molecular weight size markers 
(GIBCO). Relative marker positions are shown. Each loading in lanes 2-6 represents the 
proceeds of 1x10® cells (see text for details).
Evidence o f  additional GR molecules
The size of the highest molecular weight GR band (Fig 6.11., lanes 1-6; 94 
kd) was verified using molecular weight size standards (GIBCO, U.K.) and
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Sprague Dawley rat strain hepatic GR run in parallel (Fig. 6.11, lanes 7 and 
1 respectively). Expression of rat GR proteins from the pcDNAlNeo vector 
produced evidence of an additional GR molecule which was not expressed to 
a significant level in rat liver (Fig. 6.11, lane 1). In COS-7 cells, this 
add itional GR species migrated faster than  full length (94 Kd) rGR, 
suggesting it might have arisen from an in ternal translation event. 
Expression of pcDNAlNeo-cloned rat GR alleles in CV-1 cells, (which is 
included at this point to help identify the problem with pcDNAlNeo clones 
and  will be discussed in greater detail in part 2 of this chapter) also 
produced an additional GR band. This migrated more slowly than the 94 Kd 
GR species (Fig. 6.12.), suggesting a translation initiation from within the 
pcDNAlNeo vector.
1 2 3 4
Fig. 6.12. Com parison between pcD N A lN eo  and pSTC-vector directed expression  
of the GR 21 allele in CV-1 cells.
Lane 1, high molecular weight markers (GIBCO). Lanes 2-4; GR protein expressed from 
clones; pSTCrGR3-556 (LBD (-) clone, described in part 2 of this chapter) (lane 2); 
pSTCrGR27 (Iane3) and pcDNA1Neo-rGR27 (lane 4). Lanes 2-4 were loaded with 20-30 
pg of total cellular protein extracted by sonication (detailed in section 2.2.21.)
This additional GR form was absent from rat liver cytosol preps and was 
undetectable in untransfected CV-1 cells (e.g. Fig. 6.20.), or the rat 
hepatoma cell line 2S-Fasa (e.g. Fig. 6.23.).
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Steroid binding by GR expressed in COS-7 cells
Pilot assays of dexamethasone binding by COS-7 cells transfected with and 
expressing GR allele 21 (from clone pcDNAlNeo-rGR2 1) were performed 
using a whole cell assay based on the general method outlined in section
2.2.21. 0 .5 x l0 6 cells were assayed at each concentration of unlabelled 
steroid. Untransfected COS-7 cells were used as a control to monitor for 
binding by endogenously expressed GR. Binding data, represented  as a 
Scatchard  plot in Figure 6.13., identified low levels of a high affinity 
binding site (Kd, 2.78 nM) in untransfected COS-7, characteristic of rat GR 
(see introduction to chapter 3 and chapter 5).
Bmax
(sites/ceil)
Kd
nmol/1A  0 .015  —i
1424Control Cells 2.73
Transfected Cells 
high affinity 
low affinity
3779
256049
0.01 -Lii
LLIcr
LL
Qz:3o
CD
0.005 “1
0.000
0 5 10 15 20 25 30 35
B O U N D
Fig. 6.13. Dexam ethasone binding characteristics of control and G R-transfected COS-7 
cells.
A; Scatchard plots of 3H-dexamethasone binding by rat GR proteins expressed in COS-7 
cells. Plot through open symbols; binding to control cells. Plot through solid symbols; binding 
to GR-transfected cells.
B; Measurements of Kd (nM) and Bmax (sites/cell) for control and GR-transfected COS-7 
cells.
In cells transfected with GR allele 21, there was evidence of two binding 
sites, one with similar binding characteristics to that of untransfected cells 
(low capacity, high affinity; Kd, 3.84 nM) and a second site of low affinity,
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high capacity (Kd, 774 nM). Consistent with the observations from 
untransfected cells and W estern blots (Fig. 6.11.), the most likely 
explanation for two apparent binding sites in transfected cells is that the 
high affinity site represents full length GR, partly endogenous receptor, 
partly expressed from GR allele 21 (Bmax of the high affinity species more 
than doubles in transfected, compared with untransfected cells), while the 
low affinity site may represent the lower molecular weight (79 Kd) species 
(see Fig. 6.11.).
6.4.) Discussion
The expression of rGR from pcDNAlNeo clones in COS-7 cells presented a 
number of fundamental problems in the analysis of steroid binding by GR:
1.) Because of the high transfection efficiency and level of expressed GR 
protein required for an optimal steroid binding assay, the use of DOTAP was 
adopted as the initial method of DNA delivery into COS-7. At the time this 
work was carried out in Glasgow, transfection with DOTAP was considered to 
be perhaps the most efficient method of transfection into this cell line. 
However, the efficiency of transfection was found to be inconsistent. The 
number of unsuccessful transfections (monitiored by (3-gal staining for 
pSVp-gal, or Mab250 detection of transfected and expressed GR protein 
following fractionation by Western blot) was high, at around 60-70% 
(results not shown).
2.) COS-7 cells express endogenous basal levels of GR. Although relatively 
low, this level of expression becomes significant in the analysis of 
transfected GR (Fig. 6.11b. and Fig. 6.13). Large numbers of transfected COS- 
7 cells would introduce significant levels of COS-7 GR into steroid binding 
assays which would contribute a significant proportion of the high 
affinity binding sites. This was found to hinder the interpretation of data 
generated from GR proteins expressed from transfected alleles (see Fig. 
6.13).
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3.) With the pcDNAlNeo expression system, there was the added 
complication of additional forms of GR. In COS-7 cells, rGR expressed from 
the pcDNAlNeo CMV promoter produced the expected 94 Kd species and an 
abundance of a lower molecular weight species of around 79 Kd (Fig. 6.11.). 
The obvious problems incurred by this molecule (generated from all 
pcDNAlNeo cloned rGR cDNAs) in steroid binding assays is shown in Figure 
6.13. The presence of a form of GR with a completely different steroid 
binding characteristic to the full length GR molecule would present 
problems in the final data analysis.
In CV-1 cells, expression of GR from pcDNAlNeo clones also generated an 
additional GR band on Western blots (Fig. 6.12.). In this case however, the 
extra GR molecule was of a higher molecular weight than the 94 Kd species, 
estimated at 115 Kd and consistent with a translation initiation starting 
from within the pcDNAlNeo CMV promoter (e.g. from ATG nl688: coordinate 
taken from the pcDNAlNeo vector). Although vector promoter initiations 
should be prevented by numerous in-frame stop codons, which occur 
before m etl of the cloned cDNA, the additional GR bands expressed from 
pcDNAlNeo clones in both COS-7 and CV-1 cell lines are difficult to explain. 
To date, there have been no reports in the literature of GR glycosylation, a 
common source of post-translational modification producing differential 
bands for m em brane proteins or proteins targeted  to subcellular 
compartments. The other possibility, that of phosphorylation, which is 
known to create larger molecular weight species in the case of the 
progesterone receptor (S. Rusconi, personal communication) can be ruled 
out in this case, since the transfer of the GR cDNAs to another expression 
vector (see end of this discussion and Fig. 6.12.) produces a single 94 Kd GR 
band from the same coding sequence.
The expression of the triplet repeat negative rGR clone pcDNAlNeo-rGR^(-) 
(diagrammed in Fig. 6.14.) in CV-1 cells also produced evidence of two GR 
molecules. One migrated at around 79 Kd, which is most likely to result from 
translation initiation from GR met3 which was relocated to the start of this 
truncated cDNA.
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1 2  3  4  5  6
100 kd (?)
/
-  97.4 kd 
79 kd (?)
- 68 kd 
-  43 kd
Fig. 6.14. Com parison of rGR and rGR g(-) alleles expressed in COS-7 cells.
Lanes 1-4, expressed pcDNAI Neo-rGR 7, 18, 20 and 21 alleles respectively showing extra 
band at around 115 Kd. Lane 5, clone pcDNAI Neo-rGR p(-) expressed to produce GR bands 
of around 100 and 79 Kd (see text for details). Lane 5, High Molecular Weight Markers.
The larger molecule migrated at around 100 Kd and was consistent with the 
expected size of a GR product generated from the removal of the first 106 
amino acids from the initially suggested 115 Kd species (i.e., 687aa [size of 
rGR p(-)]/795aa [size of full length rGR] x 115 Kd = 100 Kd (Fig 6.12.).
It was therefore proposed to find an alternative GR negative cell line 
expressing no, or only trace amounts of GR (e.g. CV-1, Gluzman, 1981; rat 
hepatoma cell lines EDR3, Cook et al., 1994, or 6.10.2., Miesfeld et al., 1986) 
and secondly, to alter the expression system to provide a more specific GR 
product. Figure 6.12., (lane 3) shows the specificity of GR produced from an 
alternative mammalian expression vector, pSTC. The rational for using this 
vector will be described at the beginning of part two of this chapter.
GR seems to be expressed naturally in vivo as a heterogeneous population 
of protein molecules, initiated from different methionine codons along the 
GR transcript (Miesfeld et al., 1986 and results presented in this thesis; Fig. 
6.11.). The main factor which determines choice of start codon in a protein 
coding sequence, is the arrangement of nucleotides around each ATG start 
site, referred to as the kozac sequence. This is particularly relevant to those 
ATGs at or close to the 5' end of the coding sequence and an optimal Kozak 
sequence has been described (Kozak, 1986). When the Kozak sequence 
around  m etl  matches this 'optimum' ((CC)ACCATGG) then maximum
1 6 2
transla tion  initiation can be expected, reducing the probability of 
initiations at other methionine codons further downstream. Because m etl 
of rat GR is preceded by a relatively poor Kozak sequence (S. Rusconi, 
personal communication), this may explain the additional initiations at 
met2 and met3, which have Kozaks closer to the optimum (met3 being the 
closest). Table 6.1. below, compares the first 5 methionine Kozak sequences 
of GR in the rat.
Kozak sequence ('optimum' = (CC)ACCATGG)
m etl met2 met3 met4 met5
ccaatgg
(1)
GTAATQG
(28)
TCCATQG
(107)
TATATGG
(111)
gtgatgg
(119)
Table 6.1. Comaparison of Kozak sequences in and around the first 5 methionine 
codons of the rat GR coding sequence.
The Kozak sequence closest to 'optimum1 (Kozak, 1986) for translational initiation, is shown in 
italics. Numbers in parentheses below ATG start codons give amino acid positions relative to 
m e tl. A comparison of initiation codons at each of these sites is compared for the GR of 
different species in the general discussion (Table 7.1).
The use of multiple possible start codons in the rat GR message might 
explain the different translation patterns seen in COS-7 and CV-1 cells. 
However, the mechanisms which control the choice or extent to which 
individual start codons are used remains unclear.
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Part 2
6.5.) Expression of GR alleles in CV-1 cells
6.6.) Cloning of natural and construct GR alleles in vector pSTC
The following plasmids were used to construct further GR alleles based on 
the mammalian expression vector pSTC:
p S T C r G R 2 1  (a gift from  S. Rusconi, U niversity  o f Fribourg, 
Sw itzerland): a 7.3 kb rat GR cDNA eukaryotic expression clone. The rGR 
expression is driven by a CMV promoter linked to a thymidine kinase leader 
and AUG start codon (leading directly into the rGR coding sequence). The 
core plasmid sequence is based on a modified version of pSP64 and carries 
an ampicillin resistance gene. Replication in eukaryotic cells is driven by 
an SV40 replicon.
pSP64-4, 6 and  8-CAG series (a gift from  S. Rusconi): pSP64 vectors 
containing polymers of 4, 6 and 8-CAG repeats.
Subcloning o f natural rGR cDNAs from pcDNAlNeo clones into the vector 
pSCT.
The expression of rGR cDNAs from pcDNAlNeo clones (part 1 of this 
chapter) generated  significant levels of additional GR isoforms. 
Preliminary assays indicated that these would have presented problems in 
the interpretation of steroid binding assays, which for GR assume a one- 
site interaction model (Panarelli, 1995).
The solution to this problem was to clone the rGR cDNAs into a suitable 
expression vector at a site which would allow modification of transcription 
and translation initiation from GR. This was achieved by linking the start 
of the GR coding sequence to a thymidine kinase leader and ATG start codon 
in the vector pSTC.
The clone pSTCrGR21, already containing a full length GR cDNA provided a 
convenient base for subcloning. Using appropriate restriction sites, a 1381
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bp rGR Bsu36l/Sphl cDNA fragment from previously generated pcDNAlNeo 
plasmids (part 1, Fig. 6.6) was subcloned into the pSTC vector as described in 
Figure 6.15. below.
a.) pcDNAI Neo-rGR 20, 18, 7
B Bsu
rj n
9.8 kb
WM -Mi
rGR cDNA 20, 18, 7 3’UT
pCMV SV40 intron/pA SV40 Polyoma 
SV40 pA
b.) pSTCrGR27
B Bsu
d - 7.25 kb
rGR cDNA 21
pCMV TK
3'UT
AmpR
c . )
3.87 kb —
1 2 3 4 5 d . ) 1 2 3
e.) 1 2 3 4 5
3.87 kb —
—  2.48 kb
—  1.38 kb 2.48 kb — 1.34
1.38
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h.) pSTCrGR 20, 18, 7
B Bsu
7.25 kb
rGR cDNA 20, 18, 7 3’UT
pCMV TK AmpR
Fig 6.15. Subcioning of rGR cDNA variants from pcD N A lN eo  into pSTC.
a.) M in im a l re s tr ic tio n  m ap of p c D N A lN e o , sh o w in g  re s tr ic tio n  s ite s  used  in cD N A  
subc lon ing .
b.) M in im al restric tion  m ap of exp ress io in  vec to r pSTC .
c.) D igestion  of c lone  pS TC rG R 27  using Bsu36\/Avr\\ (lanes 2 and 3) and Sph\/Avh\ (lanes 4 
and 5). Lane 1, 1 kb DNA ladder.
d.) D igestion  of c lone  p cD N A I N e o -rG R 27X ba  using Bsu36\/Sph\ (lanes 3 and 4). Lane 1, 1 
kb D NA ladder.
e.) S ize  v e r if ic a tio n  of p u rifie d  D N A  fra g m e n ts  used  in s u b c lo n in g . La n e  2, 3 .87  kb 
pS TC rG R 27  Bsu36\/Avr]\ v e c to r fra g m e n t; lane 3, 2 .48  kb pS T C rG R 2 7  Sph\/Avr\\ ve c to r 
fragm en t; lane 4, 1 .34-1 .39  kb p c D N A IN e o -rG R 2 7 X b a  Bsu36\/Sph\ rG R cD N A  fragm en t. 
Lane 1, 1 kb DNA ladder.
f.) S C O P  a n a lys is  of co lo n ie s  ca rry in g  p o ten tia l re co m b in a n ts  and se le c tio n  of c lones  of 
a round 7.0  kb.
g.) T yp ica l res tric tion  ana lys is  of po ten ta il recom b inan t c lones. Lane2, Sphl, lane 3, Apal, 
lane 4, Xbal, Iane6, Sph\/Apa\ ; Iane7, Sph\/Xba\ ; lane 9 Ba/7?HI/8su36l. Lanes 1, 5 and 8, 1 
kb DNA ladder.
h .) M in im al restric tion  m ap of recom b inan t pS TC rG R  c lones. B, BamHI; Bsu, Bsu36l, S, Sphl; 
X, Xbal, A, AviII.
Construction o f  rGR cDNAs containing novel trip le t (CAG)n repeat 
sequences.
pSTCrGRlO, 20, 40 and 80 and pSP64 clones carrying triplet (CAG)n repeats 
of 4, 6 and 8 were kindly provided by S. Rusconi. GR clones with triplet 
repeats of 4, 6 and 8 were constructed in a standard way. Using unique 
restriction sites, pSTCrGRSO (Fig. 6.16a.) was digested into three fragments 
comprising the entire pSTC vector plus the majority of the rGR cDNA, but 
without the triplet (CAG)n repeat. Variable length triplet repeats were 
subcloned separately from the corresponding pSP64 plasmids as described 
in Figure 6.16..
a.) pSTCrGRSO
rGR cDNA 80
pCMV TK AmpR
1 6 6
b.) pSP64-CAG 4, 6, 8
polylinker 
X K
3.03 kb
SP6
AmpR
C-) 1 2 3 4  5 6
”ssa I — 3.9 kb
d .) 1 23  4 5 6 7
1.1 kb
2.2 kb
e )  1 2  3 4
—  3.11 kb
f.) 1 2n
—  37-46 bp
g .) 1 2 3 4 5 6 7
3.9 kb
2.2 kb
1.1 kb
h.) 1 2 3 4 5 6 7 8 9101112 i.) 1 2  3
7.25 kb
j.)  1 2 3 4 5 6 7  8 9
_  4 .48  kb 
—  2.77 kb
k.) pSTCrGR4, 6, 8
XK Sph Sfi
1 m  , I 7.2 kb
—  ■—in r  i------------------ 1—
 ►  ^  4 rG R cD N A 3’UT  ^
pCMV TK 6  AmpR
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Fig. 6.16. Subcloning of novel (CAG)n repeat lengths into pSTC cloned rGR cDNAs.
a.) Minimal restriction map of pSTCrGRSO showing positions of restriction sites used in 
subcloning.
b.) pSP64 clones carrying (CAG)n repeat lengths of 4, 6 and 8.
c.) pSTCrGR clones 10, 20, 4 0  and 80  cut with Xhd, (lanes 2-5, respectively). Lane 6, 
pSTCrGRSO Sfi-cut, libertaing 3.9 kb vector band.
d.) pSTC rG R 80 clone cut with Kpn\, lane 2; Sphl, lane 3; Kpn\/Sph\, lane 5 and Sph\/Sfi\, 
lane 7. Lanes 4 and 6 ,1  Kb DNA ladder.
e.) pSP64 clones 4-8 CAG cut with Xhd. Lane 1,1 Kb DNA ladder.
f.) Example of pSP64 clone (8 CAG) cut with Xho\/Kpn\. Lane 1,1 Kb DNA ladder.
g.) Gel purified cloning fragments for pSTCrGR 4, 6  and 8  construction: 3.9 kb vector band, 
lane 2; 2.2 kb vector band, lane 3; 1.1 kb rGR cDNA band, lane 4; 37-46 bp triplet (CAG)n
repeat bands, lanes 5-7. Lane 1, 1 Kb DNA ladder.
h.) Potential positive recombinant pSTCrGR 4 and 6  clones. Lanes 2-5, 4 CAG variants. 
Lanes 6 -1 1 ,6  CAG variants. Lane 12, pSTCrGR 10 size control. Lane 1 ,1  Kb DNA ladder.
i.) Initial BamH\ restriction analysis to check potential 4 CAG and 6 CAG recombinant 
pSTCrGR clones. Lane 1,1 Kb DNA ladder.
j.) BamH\/Nco\ restriction analysis of potential recombinant pSTCrGR4 (lanes 2-4) and 6 
(lanes 5-7) clones. Lane 8, pSTCrGR80. Lane 9, pSTCrGR21. Lane 1, 1 Kb DNA ladder,
k.) Minimal restrictrion map of pSTCrGR 4, 6 and 8  recombinants.
Coding sequence differences between natural and construct rGR alleles 
It must be clarified at this point that the production of novel triplet (CAG)n 
repeat lengths in the rGR coding sequence (Fig. 6.18.) was only possible in 
a realistic time frame in a way which resulted in amino acid differences in 
the encoded GR proteins. A small number of residues flanking the triplet 
repeats (part of the pSP64 cloning fragments) in construct GRs were 
therefore different to wild type. The pSTCrGR clones could therefore be 
subdivided into two groups based on CAG repeat length and the status of the 
encoded rGR cDNA. The following list describes rGR variants on the basis of 
triplet (CAG)n repeat length: 7, 18, 20 and 21 (natural alleles) and 4, 8, 10, 20 
and 80 (construct alleles). Figure 6.17. below shows the difference in amino 
acids between each set of clones.
20Q_ (natural allele):
66 67 68 69 70 71 72 73 74 75-76 77 78-96 97 98 99 100 101 102 103 104 105 106 107
NH2>F S K G S T S N V  (Q)2 R (Q) is P G L S K V S L S M  GcCOOH
2 0Q. (construct allele):
66 67 68 69 70 71 72 73 74 75 76 77 78-98 99 100 101 102 103 104 105
NH2>F S T L A C G S L E E D  (Q)20 g v  r  y  g  m  g  <cooh
Fig. 6.17. Amino acid differences between natural and construct rat GR alleles.
A comparison is given between natural and construct 20-CAG repeat GR alleles in the region 
of the polyglutamine sequence. Amino acids are shown in the single letter code. Residues 
common to both cDNAs are shown in bold type. Numbers above each residue indicate 
position relative to m e tl.
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6.7.) PCR am plification of CAG repeats and  Sequencing
Trinucleotide (CAG)n repeat lengths of pSTCrGR cDNA clones carrying 
constructed GR alleles were verified by direct sequencing of PCR products.
a.)
80-C AG
A C G T
1.36-1.58 kb
b.)
4-C A G  6-C A G  
A C G T  A C G T
SStf*
20-C AG
A C G T10-CAG
A C G T
8-C A G
A C G T
MB
pp
40-C A G
A C G T
.
>«*«• *
.," »■■
■ ■
<. .> > ,a... %/m   ^ 1
 «
*'"S .4 X <I
Fig. 6.18. Sequence verification of construct GR allele triplet (CA G )n repeat lengths.
a.) PCR am p lifica tion  of trip le t repea t sequences from  co n s tru c t rG R a lle les . Lanes 2 and 3 
d u p lic a te  a m p lif ic a tio n s  from  pS T C rG R 4 ; lanes  4 and  5 d u p lic a te  a m p lif ic a tio n s  from  
pSTCrGRSO; lane 6, no DNA nega tive  contro l. Lane 1, 1 kb DNA ladder.
b.) C o m p a riso n  of tr ip le t (C A G )n repea t sequences  from  co n s tru c t rG R  a lle les. S equences 
are of the  an tisense  DNA strand. A, C, G, T, rep resent te rm ina ting  nuc leo tides.
169
Target sequences were amplified by combining 1-5 ng of clone DNA with 
10-20 pmoles of PCR primers: rGR34-BIO (pSTC vector specific) and rGR22 
(Appendix 1) in a standard reaction mixture containing 1.5 mM Mg^+ (see 
section 2.2.3.)* Reactions were performed for 26 cycles with an annealing 
temperature of 56°C. Figure 6.18. shows the specificity of primer annealing 
under these reaction conditions. PCR products from each rGR clone were 
purified  using Hybaid PCR purification columns and 250-500 ng 
immobilised onto D y n a b e a d s ™  for sequencing using primer pG.
6.8.) Functional assays in CV-1 cells
Plasmids
In addition to pSTCrGR clones, a number of other plasmids were used in the 
analysis of rat GR function in tissue culture cells.
pSTC-MMTV-lacZ: Contains the lac Z coding sequence linked to the mouse 
mammary tumour virus (MMTV) long terminal repeat, which contains at 
least two known functional GREs (Payvar et al., 1983; Yamamoto, 1985 and 
references therein). This vector contains an inducible GR-responsive 
promoter, and was used in pilot studies of GR function.
pSTC-CMV-CAT: This plasmid played no role in GR functional assays and 
was used as a 'fill-up1 plasmid in the composition of transfection mixes (see 
Table 6.2.).
pSTC-CMV-TAG: Contains the SV40 large T-antigen. Expression is driven 
by a CMV promoter. The core plasmid sequence is based on a modified 
version of pSP64 and carries an ampicillin resistance gene. Replication in 
eukaryotic cells is driven by an SV40 replicon. This plasmid was used to 
complement the growth of plasmid clones in CV-1 cells carrying an SV40 
origin of replication since this cell line does not carry an integrated SV40 
large T-antigen as does COS-7 (see part 1 of this chapter).
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pSTCrGR-3-556: A rat GR cDNA clone in which the ligand binding domain 
from amino acid position 556 to the end of the coding sequence has been 
deleted. This clone was used as a negative control in transactivation assays.
All of these clones were gifts from S. Rusconi, University of Fribourg, 
Switzerland.
Densitometry o f  plasmid clones
The DNA concentration of each pSTCrGR clone, in addition to routine 
spectrophotometry was confirmed by densitometry (see section 2.2.17.). 
Figure 6.19a. shows a gel loading of 200 ng of each GR clone.
a-) 1 2 3  4 5  6 7 8  9 1 0 1 1 b ) 4 6 7 8 10 18 20 21 40 80
7.2- 
7.5 kb
c.) 1 2  3 4
Fig. 6.19. Plasmid clones used for GR functional assays in CV-1 cells.
a.) Side-by-side comparison of pSTCrGR clones on 1% agarose gel. 200 ng of DNA was 
loaded per lane in order of GR allele CAG repeat length: 4, 6, 7, 8, 10, 18 20, 21, 40 and 80 
CAG repeats, lanes 2-11 respectively. Lane 1, 1 kb DNA ladder.
b.) Densitometric comparison of the amount of DNA in each gel lane from panel a.).
c.) Check of the quality of other plasmid clones used in GR functional assays. Lane 2, pSTC- 
MMTV lacZ; lane 3, pSTC-CMVCAT; lane 4, pSTC-CMVTAG. Lane 1, 1 kb DNA ladder. 1 mg 
of DNA was loaded per lane.
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A total of 10 jLxg (6 cm dish) or 20 ng (10 cm dish) of DNA was used in each 
transfection experiment. Table 6.2. below summarises the components of 
the different functional assays. The high integrity of the supercoiled 
plasmid DNA required for efficient transfection is shown in Figure 6.19a. 
and b.
DNA component: Quantity (mg):
10 cm 6 cm 
dish dish
For lac Z transactivation
MMTV-lac Z (reporter gene) 6 3
CMV-CAT (fill-up plasmid) 2-2.5 2.5-2.9
pSTC-GR clone (transactivator) 0.5-1 0.1-0.5
Calf thymus (CT) DNA (carrier DNA) 10 4
For rGR steroid binding assays
pSTC-GR clone (expression clone) 10 .
pSTCCMV-TAG (translational enhancer) 1 -
Calf thymus (CT) DNA (carrier DNA) 9 -
Table 6.2. Typical components of transfection mixes used in rGR functional assays.
Cell culture and transfection
CV-1, 2S-Fasa, EDR3 and HEK293 cells were routinely m aintained as 
described in section 2.2.16. Transient transfections into CV-1, EDR3 and 
HEK293 cells were carried out at a confluence of 80% using the CaP0 4  
coprecipitation method. Prior to transfection, medium serum supplements 
were reduced to 3% FCS which was m aintained throughout the 
'transfected' growth period (48h).
p-galactosidase assay
Each of the pSTC cloned GR alleles (natural and construct) were tested for 
the ir ability  to function as tran scrip tion  factors in a crude 
transactivation assay. CV-1 cells in 6 cm tissue culture dishes were co­
transfected with the lacZ gene (cloned in pMMTV-lacZ) together with 
identical quantities (0.5 |iig and then 0.1 i^g) of each GR allele (see Table
6.2. above). The transactivation function of GR was stimulated by the 
addition of 5 nM dexamethasone to the cell medium, both in the 12-16 h
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incubation period with DNA-CaP0 4  precipitates and in the following 
'transfected' growth period. Transfected cells expressing p-galactosidase 
were identified in one of two ways: either directly, where cells were 
stained blue following breakdown of the chromagenic p-galactosidase 
substrate X-gal (section 2.2.18.), or photom etrically following the 
breakdown of ONPG to p-nitrophenol by p-galactosidase containing cell 
lysates (section 2.2.19.). For both types of experiment, transfections of 
each allele were performed in triplicate.
p-galactosidase assays were also used to assess the transfectability of 
different cell lines which were potentially useful as host cells for the 
assay of GR steroid binding. CV-1 cells, originally derived from African 
green monkey kidney have been maintained in culture to the point 
where they contain no detectable levels of steroid receptors, by Western 
blot or by steroid binding assay (Giguere et al., 1986; Arriza et al., 1987). 
This property makes them ideally suited to experiments assaying for 
functional properties of GR. However, because the efficiency of 
transfection into CV-1 cells by the calcium phosphate coprecipitation 
method is generally not very high (of the order, 30-40%), other cell types 
were also investigated. To be considered a suitable alternative, other cell 
types have to be transfected at least as efficiently as CV-1 using a suitable 
transfection technique and have negligible levels of endogenous GR. The 
rat hepatoma cell line EDR3 (Cook et al., 1994) which is also a GR negative 
cell line may be better suited to assays of rat GR because of species 
compatibility. The human embryonic kidney cell line HEK293 might be 
considered useful because of its very high transfectabilty (up to 80-90%) 
and insensitivity to corticosterone. Both EDR3 and HEK293 lines were 
therefore compared with CV-1 for efficiency of transfection. Each cell 
type grown on 6 cm tissue culture dishes was transfected with the GR 
clone pSTCrGR21 by calcium phosphate coprecipitation and assayed for p- 
galactosidase activity following staining with X-gal.
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6.8.1.) Western blotting of CV-1 expressed GR proteins
Prior to functional assays, GR proteins from natural and construct GR 
alleles expressed in CV-1 cells were analysed on 8% SDS-polyacrylamide 
minigels for levels of expression and intactness and compared with GR 
protein from rat liver or 2S-Fasa cells. In each case, protein samples (4-5 
mg total protein extract) were band fractionated, blotted onto PVDF 
membrane and probed using the rat GR N-terminal specific monoclonal 
antibody Mab250 (section 2.2.22.).
6.8.2) Steroid binding assays
Cytosol extracts from rat liver tissue and from tissue culture cells (CV-1, 
2s-Fasa and HEK293) were prepared as described in section 2.2.21.
Pilot experiments of GR steroid binding in cytosol extracts from rat liver 
and from 2s-Fasa, a constitutive GR expressing rat hepatoma cell line 
(Garland, 1986), were used to establish an optimal experimental strategy 
for the assay of GR proteins expressed in CV-1 cells. Binding assays were 
performed as described in section 2.2.21. A total of 50 i^g of cellular 
protein extract per assay point was used in all experiments.
Kd (Dex), Kd (B) and binding capacities (Rl) were derived from Scatchard 
plots using the curve fitting program LIGAND, performed as described in 
section 2.2.21.
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6.9.) Results
6.9.1.) Expression of GR alleles in CV-1 cells
Prior to steroid binding assays, GR proteins expressed in CV-1 cells were 
compared on SDS-minigels (Fig. 6.20.). In terms of coding sequence, alleles 
could be subdivided into natural or construct, on the basis of sequence 
differences flanking the triplet CAG repeat (see Fig. 6.18., p 165). Within 
subgroups, the only difference between alleles was in the length of their 
CAG repeats. In transfected CV-1 a major GR band was detected for all 
alleles, which migrated at around 94kd. No significant difference was 
detected between alleles in the intensity of this GR band (Figs. 6.20 and
6.21.). Quantitatively minor bands were observed at around 91 and 79 kd. 
These are likely to be polypeptides for which translation initiated at the 
second or third methionine codons, met2 or met3 in the GR transcript (Fig.
6.20.; Miesfeld et al., 1986). No GR bands were detected in untransfected CV-1 
cells.
4 6 7 8 10 18 M W  20 21 40 80 CV-1
Fig. 6.20. GR proteins expressed from natural and construct GR alleles in CV-1 cells.
N um bers above  each lane re p re se n t the  num bers  of g lu ta m in e  co d o n s  in tra n s la te d  GR 
prote ins. The size d iffe rence  of 11 kd be tw een the la rgest (80 -repea t) and sm a lles t (4-repeat) 
a lle les is c le a rly  v is ib le . M W , H igh M o lecu la r W e igh t p ro te in  m arke rs ; C V -1 , un trans fec ted  
C V -1 . S izes in kd on the right m ark the positions of p ro te ins  of the  s ize m arker. S izes in kd on 
the left ind ica te  the  pos itions of the  th ree  m ajor GR products . Each lane rep resen ts  a loading 
of 2x104 ce lls lysed d irectly  in gel load ing buffer.
Western blots of GR-transfected CV-1 cell lysates derived by NP-40 lysis 
showed GR to be present exclusively in nuclear exctracts (see general
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discussion). This information was useful in the design of large scale GR 
steroid binding assays (see section 6.9.2.).
4 6 18 10 2 0 N 20 C M W
—  Smmm mwmtmtmuM. . .....jMianic7‘-n\u iMW i -  97.4  kd
-  68 kd
M'
4 -  43 kd
• i # - 2 9  kd
Fig. 6.21. Dem onstration of the consistency of GR allele expression in CV-1 cells.
A se le c tio n  of G R  a lle le s  inc lud ing  20 -C A G  na tu ra l (N) and  2 0 -C A G  co n s tru c t (C) w ere 
e xp re sse d  in CV-1 ce lls  (see te x t fo r d e ta ils ). 2 x 1 0 4 ce lls  from  each  tra n s fe c tio n  w as 
ana lysed  as in Fig. 6.20. A cons is tency  of trans fec tion  w as obse rved , w h ich  extended  to both 
20-C A G  natu ra l (N) and 20-C A G  construc t (C) a lle les. N um bers  above  each lane represent 
GR a lle le  po lyg lu tam ine  repeat length. MW , H igh M o lecu la r W e igh t m arkers.
6.9.2.) Functional assays of GR alleles expressed in CV-1 cells
(3-galactosidase assays
X-gal staining of CV-1 cells cotransfected with pSTC-cloned GR alleles and 
lacZ demonstrated that the expressed GR proteins were functional in the 
presence of 5 nM dexamethasone. Comparison of the number of blue cells 
generated (average of 10 fields of view of the microscope: magnification, 
4 /0 .1 )  per allele revealed no gross functional differences. Figure 6.22. 
shows, as a representative example, the level of staining and hence p- 
galactosidase activity following expression from 0.5 ,ug of allele GR2J in 
various cell lines. In the absence of steroid, no blue cells were identified, 
implying that GR was not activated (Fig. 6.22c., compared with a. and b.). 
Calcium phosphate transfection of the GR negative rat hepatoma cell line 
EDR3 under exactly the same conditions proved unsuccessful with 0.5 pg of 
transfected DNA (efficiency estimated from p-galactosidase activity: Fig.
6 .22d.). In contrast, the hum an embryonic kidney cell line HEK293 
transfected with an efficiency of 80-90% (Fig. 6.22e.).
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Analysis of GR function by ONPG assay also indicated comparable ability of 
each allele to activate lacZ. Table 6.4. shows the extent of ONPG conversion 
to yellow p-nitrophenol by CV-1 cell extracts expressing p-galactosidase.
GR Allele: 41 60. XI 80. ICQ. 18(1
OD4 2 0 : 0.88 1.07 1.10 0.79 1.02 0.90
GR Allele: 20d 21(1 40d 80Q, 21Q.(H-) GR (3-556)
OD4 2 0 : 0.95 1.03 1.04 1.03 0.20 0.15
Table 6.3. Indirect measurement of GR induced p-galactosidase activity by ONPG 
conversion.
ONPG conversion to yellow p-nitrophenol was measured by absorbance at 420 nm. Values 
represent the average from three separate transfection experiments (using 0.5 pg GR clone 
DNA/6cm dish). For each allele, GR activity was stimulated using 5 nM dexamethasone. The 
negative control 21Q (H-) received no dexamethasone. Clone pSTCrGR 3-556 has no 
hormone binding domain, but recieved 5 nM dexamethasone. The letter Q following each 
allele length refers to the single letter amino acid code for glutamine.
Steroid Binding Assays
Pilot assays of steroid binding to GR were performed on cytosol extracts 
from rat liver and the cell line 2S-Fasa, to establish a reliable experimental 
strategy.
a .)
b .)
Table 6.4. Raw cpm for a.) 2S-Fasa and b.) untransfected CV-1 cell extracts bound with 
^H-dexamethasone at differing concentrations of unlabelled competing ligand.
Curves were prepared in duplicate for each competing ligand. Dex, dexamethasone; B, 
corticosterone.
C oncen tration  of un labe lled  ligand  (nM)
0 0.5 1.58 5.0 15.8 50.0 158.0
cpm bound at each concentration of unlabelled ligand
Dex
Dex
B
B
218.2 245.2 207.6 146.1 92.6 56.5 45.5
242.1 218.1 174.1 144.1 95.6 66.5 40.0
239.6 234.1 210.1 205.6 141.1 107.1 61
241.2 222.7 231.7 229.6 151.6 114.1 60.5
Dex
Dex
B
B
48.5 42.0 40.0 54.5 42.0 44.5 39.5
39.5 40.5 47.0 54.5 47.5 44.5 47.0
49.0 45.5 48.0 50.5 62.0 58.5 51.5
42.5 54.5 44.0 53.5 59.0 69.0 58.0
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c.)
Fig. 6 .22 . Express ion  of (3-galactosidase in tissue culture cells transfected  with  
cloned rat GR and lacZ.
a.)-c.) CV-1 ce lls  tra n s fe c te d  w ith: a.), 0 .5  pg pSTC rG R 21 + 5 nM d e xa m e th a so n e  (dex);
c .), 0 .5  p g  p S T C rG R 2 1  w ith  no a d d e d  dex. b.) is th e  sam e as a .), b u t a t h ig h e r 
m agn ifica tion  to show  cons is tency  of transfection .
d.)-e.) E D R 3 sh ow ing  one  trans fec ted  cell (d.) and H E K 293 show ing a round  80%  of ce lls  
trans fec ted  (e.) w ith  0 .5  pg pSTC rG R21 + 5 nM dex.
Competition assays for ^H-dexamethasone binding to GR proteins were 
performed using unlabelled dexamethasone or corticosterone as competing 
ligand. As an example Table 6.4. shows the levels of counts obtained at each 
co ncen tra tion  of unlabelled  ligand for 2S-Fasa cells com pared  with 
untransfected CV-1 cells. Plots of % specific bound counts against ligand 
concentra tion  (Fig. 6.23.), together with calculated Kd and  R1 values 
produced data similar to that reported  elsewhere for rat GR (Panarelli, 
1994). Untransfected CV-1 cells produced no measurable specific binding 
(Table 6.4.).
120120 -  
100 
80  
60  
40  
20 
0 J
L IV E R  b.) FAZA
c.)
94 kd —
1 2  3 4
-  97 .4  kd 
~  68 kd
-  43  kd 
” 29 kd
[Ligand] nM
d.)
Kd (Dex) Kd (B) R1
M M nmoles/ 
g protein
L ive r cy toso l 3.79x10-9 7.72x10-9 3.0x10-9
2S -F asa 3.97x10-10 l 1.63x10-9 2.02x10-10
Fig. 6.23. Pilot assays of GR steroid binding in cytosol extracts from  rat liver and rat 
liver cell line 2S-Fasa.
a.) and  b .)  C o m p e titio n  b in d in g  cu rve s  fo r ra t liv e r c y to s o l and  2 S -F a s a  ce ll e x tra c ts , 
respective ly .
c.) W e s te rn  b lo t sh o w in g  sa m p le s  o f 20  pg each  of u n tra n s fe c te d  CV-1 (lane  1), ra t live r 
cy toso l (lane 2) and 2S -F asa  cell extracts . Lane 4, H igh M o le cu la r W e igh t p ro te in  m arkers.
d.) Kd (D ex), Kd (B) and R1 va lues  fo r GR from  rat liver and  2 S -F a sa  ce lls.
Competition assays for ^H-dexamethasone binding by cloned GR alleles 
were performed on protein preparations from transfected CV-1 cells using 
the methodology optimised in pilot experiments. Figure 6.24. shows the
178
a.)
21 repeat120 120 20 repeatrac
'■£o
in
a)
c
otora
100 1 00  -
80 - 80 -
0  - 21 re p e a t  
O  - 20 re p e a t  60 _60 -
40 -
20 -
0)
E 0.5 5.0 50 0.5500 5.0 50.0 5rax
03QI
XMUU-'o
03a.
CO
18 repeat120
1 00  -
0  - MNS 
O - MHS80 -
60 -
40 -
20 -
0
.5 5.0 50.0 500
60 -  
40 -  
20 - 
0 -
DEXAMETHASONE
0.5
7 repeat
[L igand ] nM
5.0 50.0
CORTICOSTERONE
b.)
80 repeat
100
03c
T3
C
in
03c 0 .0 5 5 .0 0 5 0 0
03acn
oto
CO
s z
10 repeat100
03
E
<13
X
03QI
X
o
0 .0 5 5 .0 0 5 0 0o
4 repeat100
80
60
4 0
5 .0 00 .0 5 5 0 0
c.)
94kd
[Ligand] (nM)
20 repeat
0 .0 5 5 .0 0 5 0 0
8 repeat
0 .0 5 5 .0 0 5 0 0
1 2 4 5 6 MW
-  97.4 kd
— 68 kd
-  43 kd
- 2 9  kd
Fig. 6. 24. Com petitive steroid binding by CV-1 expressed natural and construct GR alleles.
a.) and b.) Com bined data for each natural and construct GR allele respectively. Plots are of % specific 
bound coun ts  aga inst ligand concen tra tion  (nM ). Open c irc les, dexam ethasone ; c losed  c irc les, 
corticosterone.
c.) Com parison of GR proteins from whole cell lysates and sonicates of the same CV-1 transfections. The 
gel was divided into two halves. Samples on the left represent whole cell loadings. Those on the right, cell 
sonicates. Lanes 1 and 2, the proceeds of duplicate 10Q and lane 3, 20Q construct a lle le  transfections 
(2x104 cells loaded per lane). Lanes 5-7 were loaded with the same alleles as in lanes 1-3, but using 20 mg 
of sonicated cell extract in place of whole cells. Lanes 4 and 8, High M olecular W eight protein markers.
effect of ligand concentration on its binding to GR for the combined data 
for a.) natural alleles; GrlCAG7, 18, 20, 21 ancj 5  ) for constructed alleles; 
QrlCAG4, 8, 10, 20, 80' Table 6.5. shows the means and standard errors for Kd
rGR (Q)n allele Kd (Dex) 
nM
Kd (B) 
nM
R1
pmole/mg total 
protein
Natural 
21Q a 1.45 11.9 1.37
21Q b 1.91 11.0 1.0
21Q c 2.54 11.1 0.6
21Q d 0.43 1.31 0.37
21Q e 0.73 3.7 0.92
21Q f 0.76 5.25 0.9
21Qg 1.08 10.9 0.29
21Q h 0.56 - 0.61
21Q i 0.31 1.66 0.67
21Q j 0.54 2.91 o.77
21Q k 0.96 2.91 0.73
mean (n= ll) 1.0 6.27 0.75
SE 0.21 1.39 0.27
20Q a 0.92 9.54 0.82
20Q b 0.8 5.37 1.49
20Q c 1.91 9.72 0.83
20Q d 0.78 6.8 0.97
20Q e 0.9 - 0.95
20Q f 0.79 - 0.8
20Q g 1.35 - 0.91
20Q h 1.1 - 0.88
mean (n=8) 1.01 7.8 0.96
SE 0.14 1.51 0.79
18Q a 1.58 13.9 0.92
18Q b 1.92 11.1 1.11
18Q c 3.12 12.1 0.44
18Q d 0.84 - 0.67
18Q e 0.89 - 0.75
mean (n=5) 1.67 12.37 0.78
SE 0.42 0.82 0.11
7Q a 0.93 11.1 0.7
7Q b 1.56 10.5 1.28
7Qc 1.05 10.1 0.51
7Q d 1.34 8.25 0.8
7Q e 0.88 15.1 0.42
7Q f 1.27 3.77 1.3
7Qg 0.62 6.15 0.83
mean (n=7) 1.1 9.28 0.83
SE 0.12 1.39 0.13
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b.) rGR(Q) n allele Kd (Dex) 
nM
Kd (B) 
nM
R1
pmole/mg total 
protein
Construct 
80Q a 0.30 1.48 0.57
80Q b 0.24 0.97 0.46
80Q c 0.59 2.94 0.47
80Q d 0.62 2.4 0.55
80Q e 0.53 1.66 0.45
mean (n=5) 0.46 1.89 0.50
SE 0.08 0.35 0.03
20Q a 0.18 0.77 0.28
20Q b 0.25 0.79 0.40
20Q e 0.17 0.63 0.28
20Q f 0.50 2.83 0.53
20Q g 0.53 3.29 0.57
20Q h 0.72 4.01 0.44
20Q i 0.74 3.65 0.59
mean (n=7) 0.44 2.28 0.44
SE 0.09 0.57 0.05
10Q a 0.24 1.08 0.27
lOQb 0.52 1.53 0.35
lOQc 0.15 0.46 0.51
mean (n=3) 0.30 1.02 0.37
SE 0.11 0.31 0.07
8Q a 0.15 0.78 0.32
8Q b 0.45 2.01 0.34
8Qc 0.26 1.40 -
8Q d 0.46 2.51 -
8Q e 0.61 2.50 -
mean (n=5) 0.30 1.40 0.33
SE 0.15 0.62 0.01
4Q a 0.28 1.58 0.34
4Q b 0.60 1.74 0.44
4Qc 0.58 3.66 0.52
4Q d 0.71 2.36 0.51
mean (n=4) 0.54 2.34 0.45
SE 0.09 0.47 0.04
Table 6.5. The effect of polyglutamine tract length on steroid binding activity of natural 
(a.) and constructed (b.) glucocorticoid receptor variants.
Binding affinities (Kd) and receptor capacity (R1) for dexam ethasone (Dex) and 
corticosterone (B) are given for each allele. Results are expressed as the mean ± SEM; n = 
number of separate Scatchard determinations.
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(dex), Kd (B) and Bmax for each natural (a.) and construct (b.) allele. 
Examples of plots of raw data, which demonstrate the reproducibility of 
these experiments is shown in Appendix 2. To Check that sonication had no 
qualitative effect on GR stability, sonicates of transfected cells were 
analysed against samples of whole cell lysates from the same transfection 
(Fig. 6.24c.). No noticeable difference in the integrity of GR proteins was 
observed.
Polyglutamine repeat length was found to have no significant effect on Kd 
for either dexamethasone or corticosterone, or the receptor capacity (Rl) 
within each group of natural or construct alleles (Fig. 6.24. and Table 6.5.). 
Natural 20 and 21 repeat Milan rat alleles GrlCAG20> 21, also showed no 
difference in affinity for dexamethasone or corticosterone, implying that 
any difference in steriod binding which may have existed between these 
alleles in vivo was no longer apparent (see general discussion and Fig. 
6.24a.). In support of this observation, values of Rl from GR alleles 
expressed in tissue culture were comparable with those measured in vivo 
for rat hepatic cytosol preparations (Panarelli, 1995).
In contrast, the direct comparison of the entire competition data for the 
natural versus the construct GR alleles, revealed a significant increase in 
recep to r affinity (reduction in Kd) for both dexam ethasone and 
corticosterone (Table 6.6.). This result is supported  by a leftward 
displacem ent of steroid binding curves for the natural alleles for each 
ligand (Fig. 6.25a.). Taking the 20-repeat alleles as the closest comparison 
between natural and construct alleles, the displacements in competition 
binding and difference between Kds (for dex and B) were maintained 
betw een alleles (Fig. 6.25b.). Presenting the 20-repeat data for 
dexamethasone competition in the form of a Scatchard plot, in which the 
individual points for each curve represent the mean data  from all 
experiments, provided confirmatory indication of a significant difference 
in kds (dex) between natural and construct alleles (Fig. 6.26).
Statistical analysis
The significances of difference in Kds and Rl values between chosen 
allelic comparisons were determined by parametric (two-tailed t-test) and 
non-parametric statistics (Mann Whitney U-test) where appropriate (Table 
6.6.). Values of Kd (dex) Kd (B) and receptor capacity Rl were significantly
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Fig. 6 .25. Com petition curves for natural and construct GR alleles.
A; C om petition  curves for pooled natural (open circles) and construct (solid circles) GR alleles.
B; C om petition  curves for pooled natural 20 repeat (open circles) and construct 20 repeat (solid circles) 
GR alle les.
In both cases, each point plotted represents the mean of the pooled binding data collected from  all of 
the alle les at each concentration of unlabeiled com peting ligand.
Kd (dexamethasone) 
nM
Kd (corticosterone) 
nM
Binding capacity 
pmol/mg protein
20-repeat 
natural allele 1.01 ± 0.14 7.8 ± 1.51 0.96 ± 0.79
(n) (8) (4) (8)
21-repeat 
natural allele 1.0 ± 0.21 6.27 ± 1.39 0.75 ± 0.27
(n) (11) (10) (11)
P-value NS NS NS
Kd (dexamethasone) 
nM
Kd (corticosterone) 
nM
Binding capacity 
pmol/mg protein
All
natural allele 1.16± 0.11 8.17 ± 0.82 0.83 ± 0.05
(n) (31) (24) (31)
All
Construct
allele
(n)
0.43 ± 0.04 
(24)
1.96 ± 0.21 
(24)
0.44 ± 0.023 
(21)
P-value < 0.001 < 0.001 < 0.001
Kd (dexamethasone) 
nM
Kd (corticosterone) 
nM
Binding capacity 
pmol/mg protein
20-repeat 
natural allele 1.01 ± 0.14 7.8 ± 1.51 0.96 ± 0.79
(n) (8) (4) (8)
20-repeat
construct
allele
0.44 ± 0.09 2.28 ± 0.57 0.44 ± 0.05
(n) (7) (7) (7)
P-value < 0.001 < 0.01 < 0.001
Table 6.6 Statistical comparison between chosen groups of alleles.
Kd values were compared by Mann Whitney tests, binding capacities were compared by two 
tailed t-tests.
different between natural and construct allelic groups, but not within 
groups, which included the Milan rat alleles, 21.
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Fig. 6.26. Scatchard plots of dexam ethasone binding data for 20 repeat natural and 20 
repeat construct alleles.
Com petition binding data used in the calculation of Kds (dex) for 20 repeat allele were pooled 
at each concentration of cold com peting ligand. Plots are therefore  of mean data from 20 
repeat natural (solid circles) and 20 repeat construct (open circles) alleles.
6.10.) Comment
Prior to the use of the different GR alleles in steroid binding assays, it was 
important to establish their gross functional competence. The ability of 
each of the expressed GR proteins to induce similar levels of activation of 
the lacZ gene cloned in pSTC-MMTVlacZ (Table 6.3.) demonstrated that all 
proteins were functional. Induction of GR activity in the presence of 5 nM 
dexamethasone implied that in each case, GR was folded correctly and 
complexed with HSP90 in a way which was compatible with endogenous GR 
function. These results also suggested that all GR variants were equally
1 8 2
competent as transcriptional activators, able to interact with a GRE with a 
similar level of efficiency.
Statistical comparison of Kd values between natural and construct alleles 
(Table 6.5.) suggests significant differences in affinity  for both 
dexam ethasone and corticosterone (summarised in Table 6.6.). Most 
importantly, a comparison of affinity differences between natural and 
construct 20-repeat alleles, supports this observation. The possible 
implications of these differences are discussed in chapter 7.
M easurem ents of receptor capacity (R l), were also found to be 
significantly different between natural and construct alleles. The reasons 
for this difference are unclear. It could be that, compared with natural 
alleles, the construct alleles are inherrently less stable, although Western 
blots (Fig. 6.20. and 6.21., pp 175-176 and Fig. 6.24.) do not support this. 
Alternatively, these alleles may have been less able to bind stabilising 
proteins or molybdate under steroid binding assay conditions, making them 
more prone to degradation over time. There was sufficient overlap in 
steroid binding assays to rule out the possibility of experimental drift.
Conceptually, the assay of receptor function in cell lines such as CV-1 is 
useful in that possible secondary effects on receptor function which might 
arise in vivo, are eliminated, providing a consistent assay system. Such 
effects might result from differences in circulating endogenous hormone 
levels or from the action of a host of different modulators of receptor 
function, reviewed in chapter 7 (pp 191-197).
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Chapter 7 
General Discussion
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General Discussion
7.1.) Coding sequence differences and distribution of GR alleles 
in inbred and wild rats
The primary aim of the work described in this thesis was to seek variation 
in the coding sequence of rGR and to determine what effect this may have 
on the function of GR in different inbred strains of rat. A further objective 
was to determine the extent to which polymorphisms of GR might account 
for previous observations of differences in steroid binding affinity and the 
role of glucocorticoids in rat models of essential hypertension (Kenyon et 
al., 1994; Panarelli et al., 1995, chapter 3, p 87) and obesity (White and 
Martin, 1990).
Initial findings were positive, in that sequence variation was found in the 
triplet (CAG)n repeat sequence in the GR modulatory domain. In addition, 
silent substitutions in GR codons at nucleotide positions 198, 531, and 711 
were also identified which do not lead to changes in amino acid sequence 
(see Fig. 7.1.). The four sites of genetic variation lie in close proximity in 
GR, constituting distinct haplotypes with an exceedingly low frequency of 
recombination, which were used to investigate genetic origins of different 
rat strains (discussed in detail in chapter 4).
The distribution of CAG repeat lengths in GR was investigated for both 
inbred strains (Chapter 3, part 1) and wild rats (Chapter 4) of the species R. 
norvegicus and was found to be similar. Neither set of animals had CAG 
repeat lengths of less than 7, or between 7 and 17, producing a clear 
discontinuity in the allelic distribution. In the sample populations analysed 
in this thesis, it was considered unlikely that the 'missing' subset of rGR 
alleles arose due to sampling bias. The similarity in the distribution of 
alleles found in sufficiently separated populations of wild rats (sampled 
from Scotland and England) would argue against this. The possibility of 
genetic drift is also unlikely. The same distribution of rGR alleles was found 
in wild rat populations from all capture sites and in the inbred rats
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analysed. Work is currently in progress to determine whether the GR 
alleles identified at chosen locations were fully representative of the 
resident rat population(s).
Complementary to the distribution of GR alleles found in R. norvegicus, it 
would be interesting to see whether this distribution pattern is typical of 
other rat species or is species specific. The answer to this question would 
require the analysis of GR alleles, both in other populations of R. 
norvegicus  and in other species of rat, such as R. rattus. An interesting 
extension of this work might also include other readily accessible rodent 
species such as hamster, or squirrel to determine the variability and 
distribution of GR alleles with respect to CAG repeat length in other distinct 
rodent populations.
The absence or significant under-representation of alleles may have 
resulted from the mechanism by which these alleles diversified (discussed 
in chapter 4, pp 128-131). Alternatively, the observed rGR alleles may have 
a selective advantage through their function as transcription factors. This 
latter possibility is currently being addressed. Studies are in progress in 
collaboration with Dr. Bernd Groner and co-workers, Institute for 
Experimental Cancer Research, Freiburg, Germany, to determ ine the 
functional effect of individual rGR repeats in the context of GR modulated 
transcription and will be discussed in greater detail in section 7.2.2.
7.2.) Expression of natural and construct GR alleles in CV-1 
cells and assays of GR function
7.2.1.) Steroid binding
The main focus of this thesis was the analysis of structure-function 
relationships of rGR. To determine whether the polyglutamine tract length 
of the receptor had an effect on affinity for steroid, different GR triplet 
repeat alleles, with lengths of less than 7, between 7 and 17 and greater 
than 23 CAG repeats were constructed and expressed in CV-1 cells (pp 164- 
183). The binding affinities of natural or constructed rGR variants for the 
glucocorticoids, dexamethasone and corticosterone were not different 
between alleles in either natural or construct group. This implies that the
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intra-allelic differences in the length of the polyglutamine tract on its 
own is unlikely to have immediate effect in determining the affinity of rat 
GR for steroid, although tissue specific effects on steroid binding or 
p rom oter  specific effects on transcrip tion  should  not be ruled out, 
particularly in vivo. More noticeable from these studies, however, was the 
significant difference in affinity between natural and construct GR alleles 
for glucocorticoids (PcO.OOl for dex and B; see Table 6.5). In the comparison 
of alleles through the natural and construct 20 repeat variants, having the 
closest possible sequence similarities, the significance of difference in Kds 
was maintained (for dex, p < 0.001-0.0015; for B, p < 0.01-0.08). This 
difference in affinity was n o t  the result of inter-allelic differnces in the 
length of the long homopolymeric repeats in the different alleles. The 
increase in affinity of the constructed alleles may have resulted from the 
codon su b s ti tu tio n s  in tro d u ce d  into the sequences  flanking the 
polyglutamine repeat as part of the construction process. Possible effects of 
the arginine residue, located at the amino-terminal end of natural GR 
polyglutamine tracts and missing from construct GR alleles can not be 
ruled out. The difference in sequence between the natural and construct 
alleles is shown on p i 68.
1 2 3 4 5
97.4 kd 
68 kd
43 kd
Fig. 7.2. The cellular location of rGR proteins overexpressed in CV-1 cells.
Rat GR proteins expressed from all rGR CAG repeat a lle les in CV-1 cells transloca te  
com pletely to the nucleus in the absence of hormone. Lanes 1 and 3, nuclear extracted 
proteins from cells transfected with 21 and 4 CAG repeat alle les; lanes 2 and 4, cytosol 
extracted proteins from cells transfected with 21 and 4 CAG repeat alle les, respective ly. 
Sample loadings were of the order, 20 pg/lane. Lane 5, high m olecu lar weight protein 
markers.
The mechanism by which coding sequence varia tion  in the amino 
terminus of GR might affect affinity for steroid at the C-terminal end, or
94 kd m  M
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even the perform ance of GR as a transcriptional regulator remains 
unclear. Gross molecular effects may be ruled out, given that all of the GR 
variants overexpressed in CV-1 cells behaved as expected, showing 
translocation to the nucleus, consistent with Martins et al., (1991), which 
by Western blotting appeared to be complete. Figure 7.2., above compares 
representative samples of cytosolic and nuclear protein extracts from CV-1 
cells transfected with natural allele GrlCAG21 and construct allele GrlGAG4.
7.2.2.) Transcriptional activity
In contrast to effects on steroid binding, the construct GR alleles showed a 
similar ability to activate MMTV-lacZ following hormonal induction as the 
natural alleles, indicating that none of the structural differences between 
GR molecules had any major effect on their ability to bind a GRE and 
activate transcription (Table 6.3. p 177). This contrasts with reports in the 
literature which describe possible regulatory roles for polyglutamine 
tracts in the control of transcription (see chapter 1, section 1.9.4.). In most 
cases, the molecular mechanisms for such effects are unclear. It is possible 
tha t the polyglutam ine trac t of rGR has an undefined  role in 
transcriptional regulation, which is simply not identified following GRE 
activation in the MMTV-lacZ system. It remains possible that certain 
transcriptional regulatory effects are limited to specific promoter contexts, 
implying a level of tissue specificity in GR mediated gene regulation.
An interesting extension of the work of this thesis would therefore be to 
consider the transactivation properties of both natural and construct GR 
alleles in their ability to function as modulators of transcription, which 
appears to depend on the promiscuity of protein-protein intractions 
attributed to most gene regulators, rather than their ability to bind DNA. In 
the studies of Stocklin et al., (1996) discussed in chapter 1 (pp 24-25), the 
glucocorticoid receptor has been shown to act as a synergistic coactivator 
for the transcription factor STAT5, which mediates responses in mammary 
epithelial cells to the lactogenic hormone, prolactin. Following transient 
expression in COS cells, GR modulates STAT5-mediated transcription, 
independently of a GRE. Compared with untreated cells, prolactin induces 13- 
casein prom oter activity -10-fold, an effect which is either absent or 
minimal following glucocorticoid treatment. Simultaneous induction of (3- 
casein activity with both prolactin and glucocorticoids on the other hand
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significantly increases prom oter activity ~40-fold. Conversely, in the 
presence of a GRE-containing promoter, STAT5 represses GR-mediated 
transactivation. The level of glucocorticoid-dependent promoter induction 
m ediated by STAT5, not only provides sufficient scope for identifying 
possible GR functional variants, but does so by capitalising on the ability of 
d ifferent transcrip tion  factors to co-regulate one ano ther through 
interaction at, so far, unrecognised transcriptionally active surfaces.
Thus, while simple promoters give a preliminary index of glucocorticoid 
signalling or GR activity, extrapolation to endogenous genes should be 
exercised with caution. The regulation of the p-casein prom oter through 
the interactions between STAT5 and GR may introduce a level of complexity 
which more closely parallels the in vivo  situation in which subtle 
alteration in the primary structure of GR may be of greater functional 
consequence.
7.3.) Effects of amino terminal substitutions on GR function
Although the steroid binding difference between natural and construct 
alleles is not great, it is interesting to see that the probable effect of the 
engineered flanking substitutions around the polyglutamine tract is to 
increase steroid binding affinity. This could mean that the m utant 
structure of the rGR amino terminus is able to modulate the activity of the 
steroid binding pocket. This raises the more general question of whether 
the amino and carboxyl termini are able to affect each other's activity, 
either by contact, or through a mediator such as HSP90. Unfortunately, the 
complete three dim ensional structure of rGR and proximity of its 
interactive surfaces is not available. However, a model describing the 
influences of GR carboxyl terminal structure on amino terminal function 
has been described. In this model, changes in structure at the carboxyl 
terminus are predicted to affect the flow of inform ation within GR, 
resulting in effects on transcriptionally active surfaces (Guido et al., 1996).
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The molecular mechanisms of GR are complex, requiring the concerted 
effect of a num ber of interactive elements which are induced by the 
binding of ligand. Since GR is expressed at similar levels in almost all 
tissues and cell types it follows that additional systems must be in place to 
help regulate activity in a tissue or prom oter specific fashion. In the 
studies of Guido et al., (1996), different steroidal ligands, even those with 
the same essential properties, agonistic or antagonistic, have been shown 
to be capable of stimulating prom oter specific receptor function, most 
likely by inducing unique receptor conformations (Agarwal, 1994; Chen et 
al., 1994). Agonists and antagonists differ in substituents, stereochemistry 
and the degree of saturation at various positions around the steroid 
nucleus. For example, GR antagonists possess an ll-(3 aryl substitution 
charactetristic of many of these compounds. RU38486 and ZK98299, receptor 
antagonists which differ only in the substituents on C17 (Guido eta/., 1996) 
can stimulate GR prom oter activity in vivo, but with quite different 
versatilities and with a dependency on prom oter context. RU38486, 
norm ally viewed to be exclusively antagonistic, can induce GR 
transcriptional activity in HepG2 cells, an activity which is unattainable 
with ZK98299 and is absent in CV-1 cells. The binding of ZK98299 to GR in 
Hek293 cells is able to prevent the efficient interaction between GR and the 
DNA and results in transcriptional repression (Heck et al., 1994). In vitro, 
there is no evidence of ZK98299-GR binding to GREs of either simple or 
complex promoters. It is likely that the conformation of RU38486 and 
ZK98299-GR complexes differ significantly from that of the unliganded 
receptor since without ligand, GR has no known transcriptional activity. 
Apart from the effects of different ligands on receptor activity, there is 
also evidence of unique tissue specific factors interacting with specific 
liganded forms of GR, which play a role in GR modulated transcription 
(Cavin and Buettik, 1995).
These data suggest interactions between the carboxyl and amino-terminal 
ends of liganded GR, such that ligand-specific conformations of GR impose 
unique influences on amino terminal function. By analogy, the flow of 
signalling information may also occur in the opposite direction, whereby 
alteration in the primary polypeptide sequence of the GR amino terminus
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has an effect on receptor steroid binding. Preliminary investigations of 
steroid binding affinity by GR proteins expressed in COS-7 cells (pp 157-159 
has indicated that a truncated GR isoform in which the first 100 or so amino 
acids were predicted to be missing, has a significantly lower affinity for 
dexamethasone (see Fig. 6.13.), supporting the probability of interaction 
between the receptor amino terminus and ligand binding domain.
7.4.) Association of Milan ra t GR alleles with glucocorticoid related 
phenotypes and expression of GR alleles in CV-1 cells
The polymorphism in the GR triplet (CAG)n repeat between the Milan 
hypertensive (MHS) and normotensive (MNS) strains of ra t was used 
successfully as a genetic marker in breeding experiments. In F2 animals 
resulting from a cross between MHS and MNS, linkage analysis showed a 
significant association between the MHS GR allele and hypercalcuria and to 
a lesser extent with reduced systolic blood pressure in females and reduced 
body weight in male rats, indicating that either the GR gene or a closely 
linked locus influences these phenotypes. These data have already been 
reported as preliminary findings (Heeley et al., 1996b) and a more detailed 
account has also been submitted for publication.
In terms of GR function, this thesis also shows that in CV-1 cells, the Milan 
alleles GrlCAG2°  and GrlGAG21 are expressed as polypeptides to an equal 
extent (Fig. 6.20.) and have indistinguishable steroid binding affinities and 
capacities (Fig. 6.24. and Table 6.5., pp 179-180). If this applies to these 
alleles in vivo, then it is unlikely that alleleic differences in GR perse 
between the Milan strains of rat, and hence variation in the steroid 
binding activity would account for the differences in gross phenotype 
between MHS and MNS. However, the possibility of other affectors of GR 
steroid binding affinity should not be ruled out. It is not known whether 
the differences in polyglutamine tract length in rat GR would cause a 
difference in its transactivation properties in vivo.
191
7.5.) Modulators of glucocorticoid activity
The contrast in binding characteristics between Milan rat alleles in cytosol 
from rat liver and CV-1 cells may signify the existence of a cytosolic 
factor(s) which is present in liver, but not CV-1 cells. Such a component 
could be a metabolite, for example, of steroid biosynthesis or an actively 
expressed regulator of steroid receptor function. Several possible 
extranuclear affectors of glucocorticoid activity have been identified, 
which includes the following; 1.) heat shock proteins (HSPs), 2.) 
cholesterol and fatty acids, 3.) aminophosphoglycerides, 4.) 'unknown' 
cytoplasmic factor(s) and 5.) calreticulin. For rat GR, there is the added 
possibility of m odulation of steroid binding by truncated GR isoforms 
which result from translation initiations downstream of m etl in the GR 
message. The relevance and possible association of each of these factors 
with altered GR binding affinity, described in this thesis for rat strains 
MHS and Zucker obese, is considered below.
7.5.1.) Heat shock proteins (HSPs)
The critical effects of heat shock proteins, particu larly  HSP90, in 
determ ining sensitivity to glucocorticoids is well docum ented (see 
Bamberger et al., 1996 and references therein). However, a role for HSP90 
as a modulator of steroid binding in MHS and Zucker obese rats has not 
been determined. There is no evidence of amino acid substitutions within 
the HSP90 binding domain of GR from either strain of rat which might 
affect interactions between these two proteins. Mutations in HSP90, 
however, are still possible although recent observations by Panarelli et al.,
(1995) suggest no difference between MHS and MNS in tem perature 
sensitivity of GR to steroid binding.
7.5.2.) Truncated GR iso forms
Rat GR expressed both in vivo and in tissue culture shows evidence of 
additional isoforms which are predicted to result from translation events 
downstream of m etl in the rGR message (Miesfeld e t al., 1986; see also 
chapter 6, part 1, pp 157-163). In COS-7 cells, expression of GR allele 
G r l C A G 2 1  fr0m vector pcDNAlNeo produces two distinctive bands
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immunoreactive with GR monoclonal antibody Mab250, one of around 94 kd 
and the other around 79 kd (p 157). The smaller product is indicative of 
translation from GR met3. This is likely to be a tissue specific effect, since 
the isoforms expressed in CV-1 cells and in liver were either different or 
expressed to a different degree. Steroid binding assays performed on whole 
cell preparations of COS-7 cells expressing the 94 and 79 kd forms of GR (see 
p 159) indicated two distinctive and independent binding entities, one with 
the characteristics for dexamethasone binding of full length native GR 
(high affinity, low capacity) and the other of a much lower binding 
affinity. In vivo, such a molecule could act as a modulator of GR binding 
activity by competing for steroid hormone. However, this is an unlikely 
explanation for the Milan strain differences given the similarities in the 
levels of these isoforms in each strain (Ch 5, Fig. 5.2.).
In other species, including mouse and man (having a similar arrangement 
of Kozak sequences at the beginning of the GR mRNA to that of rat: see 
Table 7.1., below), alternate GR translation products may also be generated. 
Such products have so far not been reported. Their expression may have a 
strict species or tissue-specific dependency.
Species Kozak sequence ('optim um ' = (CC)ACCATGG)
metl met2 met3 met4 met5
Rat ccaatgg gtaatgg TCCATQG TATATGG GTGATGG
Mouse CCAATGG GTGATGG TCCATGG TATATGG GTGATGG
Human CTGATGG GTGATGG TCAATGG TATATGG GTGATGG
Guinea
Pig
GGAATGT GTAATGC TCAATGG TATATGG GTGATGG
Table 7.1. Comaparison of Kozak sequences in and around the first 5 methionine 
codons of GR from different species.
The Kozak sequence closest to 'optimum' (Kozak, 1986) for translational initiation, is shown in 
italics.
7.5.3.) Cholesterol and fatty acids
The apparent glucocorticoid resistance in MHS and Zucker obese rats is 
correlated with elevated plasma cholesterol levels, a phenotypic variable 
also found in normal human subjects with reduced affinity for cortisol
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binding (Panarelli et al., 1994; Walker et al., 1995). A possible association 
between glucocorticoid activity and cholesterol m etabolism  is well 
established. However, the level at which the glucocorticoid and cholesterol 
metabolic pathways interact, is unclear. One body of evidence suggests that 
glucocorticoids may have a direct effect on cholesterol synthesis. For 
example, glucocorticoids have been dem onstrated to inhibit cholesterol 
biosynthesis in mouse thymocytes by a mechanism  which requires 
functional GR (Picard e t al., 1980). In addition, the blockage of 
glucocorticoid signal transduction in partial GR knockout mice in which 
the num ber of active GR molecules is reduced (Pepin et al., 1992) is 
manifest as obesity.
Alternatively, the increased levels of cholesterol may have the capacity to 
interfere with steroid binding by GR. It is concieveable that any molecule 
with the basic steroid ring structure and appropriate substitutions is able to 
interact with steroid receptors, affecting steroid binding. Cholesterol, the 
precursor of steroid biosynthesis might be an excellent candidate. It should 
be stressed that this possibility is least likely, given that the binding of all 
steroid ligands should be affected in a similar way. The binding of 
dexamethasone to GR in the Milan and Zucker rat models is not as greatly 
affected compared with control strains. On the other hand, dexamethasone 
is considered a stronger ligand than corticosterone and thus, may escape 
these modulating effects.
Hypercholesterolaemia and hyperlipidaem ia are often associated with 
reduced GR function. It is therefore possibile that the function of GR in 
these rat strains is also affected by fatty acids. For example, the short chain 
fatty acid, sodium butyrate affects GR interaction with its GRE by 
preventing nucleosome displacem ent and represses transcrip tion by 
inducing a modification of chromatin (Bresnick etal., 1990). The decreased 
binding of dexamethasone to rat liver cytosol glucocorticoid receptors has 
also been demonstrated by physiological concentrations of non-esterified 
fatty acids, with a dependency on dose, degree of unsaturation and chain 
length (Vallette etal., 1991). The effects of fatty acids would be particularly 
applicable to the Zucker obese rat. Hepatocytes from the obese strain in
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culture show evidence of fatty acid-like deposition, absent in lean rat cells 
(personal observations). The possible added influence of fatty acids might 
explain the steroid binding difference between MHS and MNS rats (MHS are 
mildly hyperlipidaemic).
7.5.4.) Aminophosphoglycerides
Novel ether aminophosphoglycerides, also known as modulators have been 
isolated from rat liver preparations, which inhibit GR activation by 
interfering with its dissociation from heat shock proteins (Bodine and 
Litwack, 1990; Robertson et al., 1995). From a functional standpoint, 
modulator represents the endogenous molybdate factor, stabilising both the 
activated and unactivated forms of GR. These molecules appear to further 
interfere with GR function by inhibiting translocation to the nucleus. The 
molecular effects of modulators may be commonplace among steroid 
receptors. The activity of rat distal colon MR is also affected by these 
molecules (Schulman et al., 1992). Interestingly, in five unrelated patients 
with the syndrom e of aldosterone resistance, no m utations of 
pathophysiological significance, either in the MR coding sequence, or in 
0.9 kb of the 5' regulatory region were identified, which would explain the 
resistance of these patients to aldosterone (Arai and Chrousos, 1995). These 
authors suggest that the defect responsible is at a postreceptor level.
7.5.5.) ’Unknown' cytoplasmic factor(s)
In humans, glucocorticoid resistance may be inherited, as an autosomal 
recessive trait, or may be acquired (Bronnegard et al., 1996 and references 
therein). Natural animal models of glucocorticoid resistance are also seen 
in certain species of New World primate. These are the species of 
predominantly canopy-dwelling tree monkeys, including squirrel monkey, 
owl monkey and cotton-top tamarin, some of which are strikingly resistant 
to all of the steroid related hormones. The squirrel monkey for example has 
elevated cortisol levels and glucocorticoid resistance. In this species, levels 
of plasma free cortiosol, 100-times higher than in man are maintained by 
higher ACTH and cortisol synthesis rates, a cortisol binding globulin with 
decreased capacity for cortisol and a decreased rate of clearance of cortisol 
from the circulation. These monkeys, however, do not show signs of
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clinical glucocorticoid excess. They have norm al levels of plasma 
electrolytes. The binding affinity of lymphocyte GR in this species is 5- 
times lower than in human (Kd, 20.9 ± 1.8 vs 4.3 ± 0.2 nmol/L, n=3). The LBD 
of the squirrel monkey GR contains 4-amino acid differences when 
com pared to the hum an GR, which are present in other New World 
primates. The amino terminal domain contains 22 differences. None of the 
LBD differences appear to be compatible with mutations known to affect 
steroid binding in other species. When expressed in a reticulocyte lysate 
system, the affinities of human and squirrel monkey GR were similar (Kd, 
5.9 ± 1.2 vs 4.3 ± 0.5 nmol/L, n=3). These results suggest that the 
substitutions in the LBD of the squirrel monkey GR are not responsible on 
their own for the observed resistance to cortisol binding. Rather, the 
binding affinity is most likely influenced by cytosolic factors which affect 
GR function. In cotton-top tamarin B95-8 cells, inhibitors which interfere 
with glucocorticoid and vitamin D receptor binding have been identified 
(Brandon et al., 1995) and a cytosolic cortisol binding protein has been 
proposed (Brandon et al., 1994). It is not yet known whether similar factors 
exist in squirrel monkey cells.
Steroid resistance in squirrel monkey may result from a low expression of 
HSP90, or from the expression of a mutant form of this protein (Cadeponed 
et al., 1994). Mutant forms of HSP90 or low levels of HSP70 have been given 
to explain glucocorticoid resistance in some human luekemic cell lines 
(Kojika et al., 1996). The mechanisms of glucocorticoid resistance in the 
squirrel monkey are likely to be different to those reported for the guinea 
pig (cavia porcellus). Guinea pig GR also has low affinity for cortisol with a 
compensatory increase in the plasma (Keightley and Fuller, 1994). The LBD 
of the guinea pig GR differs in 24 places from that of human. Only four of 
these substitutions (Gly6i2> Thr5 4 5 , G1U6 7 2  and Leu7 5 5 ) are shared with 
squirrel monkey, rat and mouse, leaving 20 which might contribute to the 
differences in steroid binding between guinea pig and hum an GRs. 
Preliminary studies suggest the unique substitution at position 539 (Tyr- 
His) is at least partly responsible for the low binding affinity of the guinea 
pig GR (Keightley and Fuller, 1994).
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The detailed molecular mechanism of steroid resistance in New World 
primates remains elusive. These species may harbour a global inhibitor of 
steroid receptor action; steroid-specific cytosol binding proteins only 
explains some aspects of the paradigm. The model answer requires a global 
solution which applies to all steroid receptors.
7.5.6.) Calreticulin
The general concept of steroid resistance may be explained in part by the 
protein calreticulin, a widely distributed multifunctional protein found in 
the endoplasmic reticulum  where it acts as a major calcium-binding 
protein and in the nucleus where its presence implies a possible role in 
transcriptional regulation. Calreticulin binds a polypeptide motif KLGFFKR, 
which constitutes part of the DNA binding domain shared by all known 
members of the steroid hormone receptor superfamily (Fuller, 1991). It is 
therefore reasonable to suppose that abnormal expression of calreticulin 
might affect glucocorticoid sensitivity (Burns et al., 1994; Dedhar et al., 
1994). The regulation of calreticulin expression is complex involving both 
transcriptional and post-translational steps. Integrin molecules are also 
bound by calreticulin at the cell surface. The cytoplasmic domain of all 
integrin  a-subunits contain an almost identical polypeptide sequence 
motif, KXGFFKR (where X can be either G, A or V), to that found in steroid 
hormone receptors. Calreticulin has also, been shown to inhibit AR 
binding to its DNA response element in vitro and AR and retinoic acid 
receptor gene regulatory activities in tissue culture, thus implying a 
general role in m odulation of gene transcription by steroid receptors 
(Dedhar et al., 1994). Despite the implied general role of calreticulin in 
modulating the activity of steroid hormone receptors, effects of this 
molecule on steroid binding are unlikely.
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Appendix 1
PRIMERS: For PCR, Reverse Transcription and Sequencing.
Primer Sequence length location in GR Application
name (5'-3') (mers) relative to metl
pG AATGCTTTCTTCCAGAAGCCG 2 1 n 421-441 Reverse PCR
PA CCTGGCAGTTTGCTTGGCCAA 2 1 n 46-66 Forward PCR
p9 AAAGGC TC CACAAGCAATGTG 2 1 n 2 0 2 - 2 2 1 Forward PCR
pl9 GACAGTGAAAC GGC TTTGG 19 n 299-317 Reverse PCR
rGRl GTTGAAC CACATGGAC TTGG 2 0 n 2756-2775 Reverse
Transc11
rGR2 C TATAAAC CACATGTAC TGC G 2 1 n 2582-2602 Reverse PCR
rGR6 CACTTGACGCCCACCTAACAT 2 1 n 1747-1767 Reverse PCR
rGRlO GGAGCAAAGCAGAGCAGGTT 2 0 n 1909-1928 Reverse PCR
rGRl 8 TGATACGCCTATTTTGGATCC 42 n 421-441 Reverse PCR/
AATGCTTTCTTCCAGAAGCCG Cloning
rGRl 9 ATGTTTGACAGCTTAGGATCC 42 n “6-15 Forward PCR/
TTGCCAATGGACTCCAAAGAA Cloning
rGR20 TGGGCAGTTTTTCCTTCGAAT 2 1 n 1459-1479 Reverse PCR
rGR21 GTTCAGAGC C C CCAAGGAAGT 2 1 n 1186-1206 Reverse PCR
rGR22 GGGGGAGCAAAGTTCAATGAA 2 1 n 907-927 Reverse PCR
rGR23 GGAC C CAGC GGAAAAC TC CAA 2 1 n 652-672 Reverse PCR
rGR25 TACAAGACAAATTGATAAGTT 2 1 n 2390-2411 Reverse PCR
rGR28 TTGC CAGTTGTGAC TGGAGTT 2 1 n 2173-2194 Sequencing
rGR29 ATTGC TTGTGGAGC C TTTC GA 2 1 n 199-219 Sequencing
o lig o - AGCAGCAGCAGCAGCAGCCAGC 2 2 n 362-384 Hybridisation
CAG probe
rGR32 GATCCGCCGTTTCACTGTC 19 Complementary Cloning
to fragment
n 304-317 half-site
(sense)
rGR33 CATGGACAGTGAAACGGCG 19 Complementary Cloning
to fragment
n 304-321 half-site
(antisense)
rGR34 ATGGGAC TTTC C TAC TTGGCA 2 1 n 266-286 pSTC-specific
forward PCR
primer
Biotinylated Primers
pG-BIO B -  AATGC TTTC C AGAAGC C G 2 1 n 421-441 Reverse PCR
rGR5- B - ATTCAGCAAGCCACTGCAGGA 2 1 n 1555-1575 Forward PCR
BIO
rGR 19- B-ATGTTTGACAGCTTAGGATCC 42 n “6-"15 Forward PCR
BIO TTGCCAATGGACTCCAAAGAA
rGR31- B-TTCCTTCTCGAAGGGGACACG 2 1 n 763-783 Forward PCR
BIO
Compilation of oligonucleotides.
Primers are listed for use in PCR, reverse transcription, sequencing, Southern hybridisation and 
oligonucleotide half sites for the construction of DNA cloning fragments. Each oligonucleotide is 
referred to by a unique reference notation. Positioning in the rat GR cDNA sequence, together with 
length in bases is given. For PCR primers, forward and reverse orientation is stated.
I
Appendix 2
The following graphs (1-26) show a point-by-point plot of counts bound to 
CV-1 expressed GR following competition for ^ H - d e x  binding sites by cold 
dexamethasone or corticosterone. From a total of 55 independent Scatchard 
determinations, the data for the 20 repeat natural and construct alleles is 
shown.
Counts (x-axis) are normalised as % counts bound for each curve. The 
example below shows the calculation of % bound counts, from original 
counts.
20 CAG Natural: Dex (C):
cpm Adjusted cpm Bound cpm % Bound cpm
177.1 283.4 186.1 50.6
290.7 465.1 367.8 100
241.1 385.8 288.5 78.4
197.7 316.3 219.0 59.5
144.4 231.0 133.8 36.4
93.6 149.8 52.5 14.3
74.8 119.7 22.4 6
69.6 111.4 14.1 4
60.8 97.3 0 0
cpm Adjusted cpm Bound cpm % Bound cpm
164.4 263.0 145.3 44.5
277.7 444.3 326.6 100
263.1 421.0 303.2 92.8
224.1 358.6 240.8 73.7
146.4 234.24 116.5 35.7
107.8 172.5 54.7 16.7
81.8 131.0 13.12 4
73.6 117.8 0 0
76.4 122.2 4.48 1.3
Tables of raw data of duplicate cpm for ^H-dex binding to GR 
allele 20 CAG Natural (C).
Values of cpm are volume adjusted to take account of the fraction of the 
total reaction volume taken for counting.
Key:
Circled points, (pages 13, 22 and 26) indicate a set of values in which one of 
the pair was a clear outlier. In these cases, the outlying point has been 
adjusted to match that of the value lying closest to the trend of the 
remaining points.
II
Points marked by an asterisk (y-axis), pages 9, 14, 15, 16, represent a pair of 
values which were clearly spurious in the original data. In these cases, the 
outlying points were omitted from calculations of Kd and Bmax. For the 
purpose of data plotting, an appropriate value was calculated by averaging 
the preceding and following data point in respective curves.
Appendix 2
Graph Original total Page
counts bound
20 CAG N atural: Dex (A) 199.5/185.6 1
20 CAG N atural: Dex (B) 212.5/214.6 2
20 CAG N atural: Dex (C) 283.4/263.0 3
20 CAG N atural: Dex (D) 506.1/501.8 4
20 CAG N atural: Dex (E) 422.9/405.1 5
20 CAG N atural: Dex (F) 405.6/382.1 6
20 CAG N atural: Dex (G) 351.2/383.7 7
20 CAG N atural: Dex (H) 362.4/348.3 8
20 CAG Construct Dex (A) 464.8/381.8 9
20 CAG Construct Dex (B) 451.5/452.9 10
20 CAG Construct Dex (E) 173.3/153.8 11
20 CAG Construct Dex (F) 204.8/186.6 12
20 CAG Construct Dex (G) 478.6/403.5 13
20 CAG Construct Dex (H) 408.1/374.7 14
20 CAG Construct Dex (I) 436.3/372.3 15
20 CAG N atural: Corticosterone (A) 152.6/158.2 16
20 CAG N atural: Corticosterone (B) 213.4/200.3 17
20 CAG N atural: Corticosterone (C) 327.2/387.7 18
20 CAG N atural: Corticosterone (D) 513.8/493.9 19
20 CAG Construct: Corticosterone (A) 342.7/401.6 20
20 CAG Construct: Corticosterone (B) 477.6/411.8 21
20 CAG Construct: Corticosterone (E) 162.9/161.6 22
20 CAG Construct: Corticosterone (F) 207.4202.9 23
20 CAG Construct: Corticosterone (G) 361.9/359.4 24
20 CAG Construct: Corticosterone (H) 327/346.7 25
20 CAG Construct: Corticosterone (I) 345.6/370.7 26
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